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chapter 1
introduction
Introduction
Pelvic floor disorders, including pelvic organ prolapse (POP) and stress urinary incontinence 
(SUI), are a major burden to the well-being of women. A US based prevalence study showed 
that in  community dwelling women over 20 years of age the proportion of women reporting 
at least one pelvic floor disorder ranged from 9.7% in women between ages 20 and 39 years 
to 49.7% in those aged 80 years or older1. Although conservative management is usually the 
first line of treatment, more than one out of ten women will have had at least one operation 
for either POP or SUI at the age of 80 years2-4. 
 Previous studies have shown an association between pelvic floor disorders and female 
sexual dysfunction5-10. In women awaiting surgery for SUI, 66 per cent mentioned that their 
incontinence impacted on their sexual life11. Similarly, up to 60 per cent of sexually active 
women with POP awaiting pelvic reconstructive surgery found their sex life was negatively 
affected by their prolapse12. Sexual dysfunction is an important contributor to quality of life13 
and is one of the main facilitators for seeking treatment for pelvic floor disorders14. Under-
standing and awareness of female sexual dysfunction amongst healthcare professionals in-
volved in the care of women suffering with pelvic floor disorders is therefore crucial.
 This thesis is dedicated to enhance understanding of sexual dysfunction in the field of 
urogynaecology, focussing on the prevalence of sexual problems in urogynaecology clinics, the 
clinical attention of the urogynaecologist to female sexual dysfunction, the impact of POP, 
SUI and pelvic floor surgery on the sexual functioning of the female patient, as well as the im-
pact on the sexual functioning of her partner. This introductory chapter describes the definitions 
and ways of assessment of female sexual dysfunction, as well as an overview of the current 
literature on sexual dysfunction in urogynaecology. At the end of this chapter the research 
questions and outline of this thesis are presented.
Female sexuality: what is normal, what is dysfunction?
According to the World Health Organization “Sexual health is a state of physical, emotional, 
mental and social well-being in relation to sexuality; it is not merely the absence of disease, 
dysfunction or infirmity”15. 
 Traditionally, the female sexual response is depicted the same as that of the male. This 
model of the female sexual response assumes a linear progression from sexual desire to sexual 
arousal, resulting in orgasm and satisfaction. The most commonly used diagnostic systems, 
the DSM-IV16 and ICD-1017, rely heavily on this model in the diagnosis of female sexual 
dysfunction. Female sexual dysfunction is defined as the absence or impairment of the sexual 
response or the physical reactions during sexual activity despite adequate stimulation. Both 
DSM-IV and ICD-10 subdivide sexual dysfunction into four broad categories, including: 
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incentives for engaging in sexual activity other than simply sexual desire. More commonly, 
women begin a sexual encounter from a point of sexual neutrality. Appropriate sexual stimuli 
can cause arousal which triggers a sexual desire to continue the sexual encounter which is 
described as responsive desire. Sexual neutrality or being receptive to rather than initiating 
sexual activity, is considered a normal variation of female sexual functioning. Furthermore, 
in contrast to men, a psychologically and physiologically rewarding outcome does not neces-
sarily need to involve orgasmic release(s)21. 
 Importantly, all classification systems recognise that the inclusion of a woman’s distress 
caused by the sexual disorder is an essential criterion to merit a diagnostic label. The DSM-
IV and the AFUD consensus-based classification system provide outcome criteria of “causes 
marked/personal distress” and “interpersonal difficulties”, while the ICD-10 uses the broader 
outcome criterion of “being unable to participate in a sexual relationship as she would wish”. 
Assessment of female sexual dysfunction
In the field of urogynaecology female sexual function is most commonly evaluated through 
the use of sexual function questionnaires. Questionnaires measure “subjective” informa-
tion in an “objective” fashion and as such  provide a discrete and reproducible method for 
evaluating female sexual function. Physical exam measures such as the measurement of 
vaginal length and caliber are not predictive of sexual (dys)function22-25, while ultrasound 
evaluation of clitoral blood flow or vaginal plethysmography are not considered useful in 
clinical practice.
 Sexual function questionnaires can be divided into validated and non-validated ques-
tionnaires. The questionnaire validation process involves multiple stepwise statistical proce-
dures to ensure a questionnaire meets established psychometric principles, including validity, 
reliability and responsiveness. The validity of a questionnaire determines whether the ques-
tionnaire is measuring what it is intended to measure. The reliability refers to the ability of 
the questionnaire to measure in a reproducible fashion and the responsiveness is the ability to 
detect effect of treatment and clinically meaningful change. Not all validated questionnaires 
have undergone all the aspects of the validation process. In particular, the responsiveness of a 
questionnaire is often only ascertained when the questionnaire is already in use26.
 Early studies on sexual function in urogynaecology mostly used non-validated ques-
tionnaires. Recently, more validated questionnaires are available, which can be further sub-
divided into general or condition-specific types. General sexual function questionnaires, in-
cluding the Female Sexual Function index (FSFI)27 or Golombok-Rust Inventory of Sexual 
Satisfaction28, often make use of broad diagnostic categories and are not designed to assess 
changes in sexual health specifically caused by pelvic floor disorders. General sexual function 
questionnaires may not be sensitive enough to detect a difference in sexual function due to the 
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sexual desire disorder, sexual arousal disorder, orgasmic disorder and sexual pain disorder. 
 In this thesis a more recent consensus-based definition and classification system for 
female sexual dysfunction was used which was devised by the American Foundation for Uro-
logic Disease (AFUD) in 199818, with revisions in 200419 and 201020. The final system uses 
the four major categories as described in DSM–IV and ICD-10, but the definitions of several 
disorders were changed to reflect current clinical and research practice (Table 1). This consensus-
based classification system reflects the current believe that sexual responding of females does 
not follow one set linear pattern, and that desire doesn’t need to be present before sexual 
arousal21. According to the current understanding, women provide a variety of reasons and 
Table 1 Definition and classification of female sexual dysfunction18-20
Sexual interest/desire disorder
There are absent or diminished feelings of sexual interest or desire, absent sexual thoughts or fantasies and a lack of respon-
sive desire. Motivations (here defined as reasons/incentives) for attempting to become sexually aroused are scarce or absent. 
The lack of interest is considered to be beyond the normative lessening with lifecycle and relationship duration.
Sexual arousal disorder
Subjective sexual arousal disorder
Absence of or markedly diminished feelings of sexual arousal (sexual excitement and sexual pleasure) from any type of sexual 
stimulation. Vaginal lubrication or other signs of physical response still occur.
Combined genital and subjective arousal disorder
Absence of or markedly diminished feelings of sexual arousal (sexual excitement and sexual pleasure) from any type of sexual 
stimulation as well as complaints of absent or impaired genital sexual arousal (vulval swelling, lubrication).
Genital sexual arousal disorder
Complaints of absent or impaired genital sexual arousal. Self-report may include minimal vulval swelling or vaginal lubrication 
from any type of sexual simulation and reduced sexual sensations from caressing genitalia. Subjective sexual excitement still 
occurs from nongenital stimuli.
Persistent genital arousal disorder
Spontaneous, intrusive and unwanted genital arousal (e.g., tingling, throbbing, pulsating) in the absence of sexual interest and 
desire. Any awareness of subjective arousal is typically but not invariably unpleasant. The arousal is unrelieved by one or more 
orgasms and the feelings of arousal persist for hours or days.
Orgasmic disorder
Despite the self-report of high sexual arousal/excitement, there is either lack of orgasm, marked diminished intensity of orgas-
mic sensations or marked delay of orgasm from any kind of stimulation.
Sexual pain disorders
Dyspareunia
Persistent or recurrent pain with attempted or complete vaginal entry and/or penile vaginal intercourse.
Vaginismus
Persistent or recurrent difficulties for a woman to allow vaginal entry of a penis, a finger, and/or any object, despite the 
woman’s expressed wish to do so. There is often (phobic) avoidance and anticipation/fear/experience of pain, along with vari-
able involuntary pelvic muscle contraction. 
Other sexual pain disorders
Recurrent or persistent genital pain induced by non-coital sexual stimulation.
disease process of POP or urinary incontinence (UI). Therefore, condition-specific question-
naires may be more appropriate to evaluate sexual function in women suffering with these 
conditions26. The Pelvic Organ Prolapse – Urinary Incontinence Sexual Function Question-
naire (PISQ)29 and its short-form PISQ-1230, are currently the only validated female sexual 
function questionnaires specifically developed to assess sexual function in women with POP 
and UI. 
 Although the PISQ is the primary measure used to assess sexual function in women 
with UI and POP, limitations of the questionnaire have been reported as well. These limita-
tions include: not being validated in a population of women with anal incontinence, not being 
validated in a population of homosexual women, and, furthermore, the questionnaire does 
not screen for sexual activity26. Other limitations in the use of the questionnaire include the 
absence of a cut-off value to discriminate between “normal” sexual function and sexual dys-
function and the lack of a defined value for what is considered to be the minimally clinical 
relevant difference in PISQ score. 
 Recently the IUGA created a revised version of the original PISQ: the PISQ IUGA-
Revised (PISQ-IR)31. The PISQ-IR addresses two limitations of the original PISQ. First, the 
PISQ-IR was developed to create a condition-specific measure of sexual function not only in 
women with UI and POP, but in women with anal incontinence as well31. Secondly, in addi-
tion to evaluating women who report being sexually active, the PISQ-IR was also designed to 
evaluate the impact of pelvic floor dysfunction on a woman’s decision not be sexually active31. 
The PISQ-IR has shown to be a valid, reliable, and responsive measure of sexual function in 
women with pelvic floor disorders31. This measure is now available for international valida-
tion in a variety of languages and cultural contexts.
Sexual dysfunction in urogynaecology clinics
In patients presenting for urogynaecological care, the prevalence of sexual complaints is high. 
In sexually active women seeking urogynaecological care 64% were reported to have sexual 
difficulties32. However, in another study measuring sexual difficulties causing distress, the 
prevalence was 48%33. 
 Previous population based studies showed that women are hesitant to seek help for 
their sexual concerns as only one in five women with sexual concerns contact a healthcare pro-
vider34-36. Barriers for women to seek help could be embarrassment, believing that the health-
care provider would not be able to provide help37, and the perception that sexual problems are 
not a “severe” health problem38.  Therefore, in order to identify sexual problems a proactive 
attitude from the physician is warranted. For example, the complaint of incontinence during 
coitus is rarely voluntarily mentioned by patients during a consultation with a urogynaecolo-
gist, but on direct questioning the presence of this complaint can be discovered39. However, 
so far urogynaecologists may not have paid enough clinical attention to sexual dysfunction. 
A survey of members of the American Urogynecologic Society (AUGS) showed that only a 
minority (22%) screen all patients for sexual dysfunction with lack of time being the most 
important barrier40. As cultural believes are an important factor in discussing sexual issues, 
the question is whether this lack of clinical attention is isolated to the USA or whether this is 
a more general problem present in urogynaecologists in other countries as well. 
 The use of a standardised questionnaire may ease the identification of patients with 
sexual problems. Short screening tools can be very useful in discovering sexual problems that 
women are reluctant to volunteer themselves without adding lots of time to the clinic visit41. 
However, to date the possibility of identifying sexual problems using a short screening tool 
has not been studied in women seeking urogynaecological care.
Sexual dysfunction associated with POP and SUI
In women with POP a dissatisfying sex life is most commonly a result of a sensation of ob-
struction during penetrative intercourse or significant vaginal laxity42. Furthermore, recent 
work has suggested that the impact of POP goes beyond a local effect. Sexual dysfunction 
may be related to a decrease in women’s self-perceived (genital) body image43,44 as women 
with POP can feel less sexually attractive and less feminine45,46. Common sexual complaints 
in women with SUI are urinary leakage during intercourse and anxiety about urinary leakage 
during intercourse, anxiety during intercourse about odour, embarrassment due to the need 
for pads and lack of spontaneity in sexual activity due to the need for frequent visits to the 
toilet or the need to wash11,47-49. 
 Results on how POP and SUI affect the different female sexual dysfunction categories 
are inconsistent. For example, Handa et al.6 showed that POP and UI were associated with 
decreased arousal and infrequent orgasm. In contrast to these findings, Rogers et al.50 showed 
that although overall sexual function, as measured by the PISQ29, was lower in women with 
POP and UI, no differences were noted in arousal and orgasm. These conflicting results could 
be explained by discrepancies in patient characteristics and culture, discrepancies in the defi-
nition and severity of the pelvic floor disorders, as well as by differences in the measurement 
of outcome as a result of the use of different sexual function questionnaires. Owing to the 
subjective nature of sexual function there is no gold standard for the assessment of sexual 
dysfunction. To explain these conflicting results a qualitative study can be useful as it does 
not rely on reported behaviour as is the case with questionnaires. Using qualitative interviews 
the interviewer is able to have an open and direct interaction with the person under study. 
This can result in the accumulation of richer and more in-depth information compared to 
information obtained using a written questionnaire51. A qualitative study not only describes 
the perceptions of the women themselves, but also explains the context of the experiences of 
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the women and ‘why?’ and ‘how?’ POP and SUI impact on the different sexual dysfunction 
categories51,52.
Sexual function following pelvic floor surgery
Assuming sexual dysfunction is caused by the physical effect of POP and SUI, surgery to cure 
these conditions should automatically lead to an improvement in sexual function. However, 
current evidence on sexual function following pelvic floor surgery is conflicting. Some studies 
have shown overall improvement in sexual function following pelvic floor surgery23,53-58, while 
others showed no change25,59,60 or even deterioration61,62.
 Improvement in sexual function is commonly ascribed to improvement in POP and 
SUI symptoms11,53-55,58,63. This includes the cure of coital incontinence58,60,64,65 with the associated 
reduction in embarrassment and fear of incontinence during coitus11,58,60,65-67. With the reso-
lution of POP symptoms following POP surgery an improvement in women’s self-perceived 
body image is also evident, which is, in addition to the physical cure of POP, associated with 
an improvement in sexual function as well68. 
 On the other hand, surgery is potentially harmful which can have a negative effect 
on the sexual response. Vaginal narrowing or scarring, vaginal erosion of synthetic mesh, as 
well as damage to the vascularisation and innervation of the vaginal wall, are possible factors 
detrimental to sexual function following pelvic floor surgery. In addition to this, altered per-
ception of genital health after surgery, with associated apprehension and fear of damage to the 
internal organs, can also be contributory factors with a negative impact on sexual function. 
 A decrease in sexual function following surgery has often been ascribed to an increase 
in dyspareunia59,61,69. In this respect, controversy exists whether certain operational tech-
niques, including posterior colporraphy23,57,59,70,71 and mesh augmented POP repair72,73, are as-
sociated with an increased risk of dyspareunia. Furthermore, a reduction in the improvement 
of sexual function can be seen following anti-incontinence surgery as a result of de novo or 
persistent urge incontinence symptoms58.
 The discrepancies in outcome of sexual function following surgery might be a reflec-
tion of differences in patient characteristics, differences in the technique of the operation and 
the experience of the surgeon, length of follow-up, or differences in the measurement of out-
come, i.e. the measurement of sexual function. The current condition-specific sexual function 
questionnaire (PISQ)29 focusses on the impact of pelvic floor disorders on sexual function and 
is validated and optimised to discriminate between women with and without sexual dysfunc-
tion within the group of women suffering with pelvic floor disorders. Currently the usefulness 
of the PISQ for evaluation after pelvic floor surgery is being questioned54,59. As the majority 
of women will be cured of their prolapse or incontinence symptoms after surgery, a general 
index for sexual function may be more appropriate. Despite showing responsiveness to change 
after pelvic floor surgery53,55, the PISQ may not be optimal to detect sexual dysfunction following 
treatment. This is particularly the case if only selective aspects of sexual function improve, or 
new aspects due to the treatment itself become relevant. However, before we either confirm 
or reject the PISQ29 as a valid tool for diagnosing sexual dysfunction following pelvic floor 
surgery, it needs to be established whether or not the questionnaire covers all relevant aspects 
of sexual function following surgery.
The impact of POP and SUI on the partner’s sexual experience
Sexual functioning is a dynamic issue which generally occurs with, and is highly dependent 
on the partner. Sexual dysfunction in one half of a couple can therefore result in sexual dys-
function of the partner as well. However, scanty studies assessed sexual function in partners 
of women suffering with POP or SUI. The few studies focusing on the partner showed that 
female bladder problems had a negative effect on the sexual life of one out of five male part-
ners74 and that female UI was associated with lower male sexual functioning and sexual satis-
faction75. In contrast to women, most of the male partners do not worry about the possibility 
of the woman having urinary leakage during intercourse and if it does happen only 35% of 
men consider this a problem74. Unfortunately, more specific information regarding the nega-
tive effect of POP or SUI on the partner’s sexual life is not available. 
 Pelvic floor surgery seems to have a positive effect on the sexual function of the male 
partner. Using the Brief Male Sexual function Inventory (BMSI), a validated questionnaire to 
characterise male sexual function, Kuhn et al.76 showed an improvement in the male partner’s 
overall satisfaction, sexual interest and drive following female POP surgery. Furthermore, 
59% of male partners reported an increase in sexual desire one year after their partner’s surgical 
treatment for SUI in semi-structured telephone interviews77. However, when sling erosion occurs 
after suburethral sling insertion for female SUI, male sexual function can be negatively affected 
by the occurrence of ‘hispareunia’, i.e. male dyspareunia78. Previous studies evaluating the im-
pact of POP and SUI on the male partner’s sexual function did not yield specific information 
regarding the male partner’s individual thoughts and experiences with regards to this either 
before or after surgery. Such specific information can only be gathered by using a qualitative 
research design. 
Research questions
This thesis is dedicated to increasing understanding of sexual dysfunction in the field of urogy-
naecology. Both POP and SUI have a large impact on female sexual function and can impact 
on the sexual functioning of the partner as well. An increased understanding of sexual dysfunction 
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in women with POP and SUI amongst healthcare professionals has the potential to improve 
the evaluation and management of sexual dysfunction prior to and after pelvic floor surgery. 
Furthermore, they will be able to counsel more effectively  prior to treatment.
This thesis aimed to answer the following research questions:
1.  What is the prevalence of sexual problems in women attending urogynaecology clinics 
when using a short screening tool? 
2.  Is assessment of female sexual dysfunction part of routine practice for British uro-
gynaecologists? 
3. How do POP and SUI impact on the different sexual dysfunction categories? 
4a. How does pelvic floor surgery impact on the sexual functioning of the female patient? 
4b.  Does the current condition-specific sexual function questionnaire (PISQ29) cover all 
relevant aspects of  sexual function following pelvic floor surgery? 
5.   What are the partner’s individual thoughts and experiences with regards to the effect 
of female POP and SUI, as well as pelvic floor surgery, on his/her sexual life? 
Outline of thesis
All patients enrolled in the studies described in this thesis were recruited at Croydon University 
Hospital in Croydon, United Kingdom. Croydon University Hospital is a large university hos-
pital within the municipality of Croydon; a large town in the south of London. The popula-
tion of Croydon is multi-ethnic and socio-economically diverse.  The urogynaecology clinic 
within Croydon University Hospital is run by two consultant urogynaecologists who perform 
or supervise all urogynaecological surgeries within this hospital. 
 The different research questions will be answered in 5 chapters. To discover sexual problems 
during a clinic visit, the use of a short standardised screening tool can be very useful without 
adding lots of time. However, to date the possibility to identify sexual problems using a short 
screening tool has not been studied in women seeking urogynaecological care.  In chapter 
2 the prevalence of sexual problems in new patients attending the urogynaecology clinic of 
Croydon University Hospital will be established by using a short screening questionnaire 
based on the one introduced by Plouffe79. This questionnaire has been shown to be as effective 
as a detailed enquiry in detecting sexual problems and consists of three questions: (1) Are 
you sexually active? If not, state reason (2) Do you have any problems with sex? If yes, state 
problems, and (3) Is sex painful? A fourth question was later added to this questionnaire to 
address which sexual problems were bothersome, as personal distress is an essential criterion 
in the diagnosis of female sexual dysfunction. 
 In chapter 3 the clinical practice of members of the British Society of Urogynaecology 
with regards to the assessment of sexual function is described, and barriers for screening 
for female sexual dysfunction are identified. Furthermore, results of practice in the UK are 
compared to that of members of of the American Urogynecologic Society (AUGS) published 
before40.  
 Chapter 4, 5 and 6 present the results from a mixed quantitative and qualitative study 
conducted to gain an in-depth understanding of sexual function in women with POP and 
SUI, before and after surgery, along with that of their partners. Chapter 4 presents the results 
of the qualitative data on sexual function in the women prior to surgery aiming to gain a 
more in-depth understanding of the impact of POP and SUI on the different categories of 
female sexual dysfunction. In chapter 5 the postoperative quantitative and qualitative data 
are compared to establish whether the current condition-specific sexual function question-
naire (PISQ)29 provides full insight in, and covers all relevant aspects of, sexual (dys)function 
following pelvic floor surgery. Chapter 6 of this thesis will present the results of the qualitative 
analysis of the face-to-face interviews conducted with the partners, both before and after surgery. 
The aim was to establish the partner’s individual thoughts and experiences with regards to the 
effect of female POP and SUI on his/her sex life, as well as the effect of pelvic floor surgery.
 This thesis ends with a discussion of the results and presents a number of conclusions 
and recommendations for future research (chapter 7).
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Introduction
Female sexual dysfunction (FSD) is a common problem that can have a devastating effect on 
a woman’s quality of life and social and sexual relationships. A national British survey found 
that, in the preceding year, 54% of women reported at least one sexual problem lasting for at 
least 1 month1. Studies have shown that women suffering from pelvic floor disorders are at 
risk of suffering from sexual problems as a result of pelvic organ prolapse or lower urinary 
tract symptoms2-5. Sixty-four percent of sexually active patients presenting to a urogynecology 
practice suffer from FSD6, although the prevalence of FSD appears to be comparable to women 
seeking gynecological care7. Geiss et al.7 showed that 50% of sexually active gynecology pa-
tients compared to 48% of urogynecology patients showed signs of FSD.
 Despite the reported high prevalence, only one in five women seek help for their sexual 
concerns1,8,9. Help-seeking behavior is dependent on age, type of sexual problem, and culture8. 
Furthermore, when sexual problems cause distress, women are more likely to seek medical 
attention9. Barriers for seeking help could be embarrassment, believing that the physician will 
not be able to provide help10, and the perception that sexual problems are not a “severe” health 
problem11. Therefore, in order to identify sexual problems, a proactive attitude from the phy-
sician is necessary. A study on current attitudes towards sexual function amongst physicians 
showed that they infrequently raise the topic of sexual health during clinic visits with the most 
important barrier being lack of time12. Screening for sexual problems does not need to be 
time-consuming; making a brief assessment of sexual function part of the review of systems 
is very effective and indicates to the patient that the discussion of often embarrassing sexual 
concerns is appropriate13.
 The aims of this study were, firstly, to assess the prevalence of sexual problems in pa-
tients attending general gynecology and urogynecology clinics, using a quick and simple 
screening tool. Secondly, we aimed to compare the prevalence between patients presenting 
with gynecological and urogynecological complaints.
Materials and Methods
This cross-sectional study includes women attending the gynecology outpatient clinic in 
Croydon (Mayday) University Hospital between May 2008 and February 2010. As part of our
routine practice, new patients attending general gynecology and urogynecology clinics and 
who are able to read and write in English, were asked to complete a health questionnaire
(see “Appendix”). Women have time to complete the questionnaire in the general waiting area 
while waiting to see the gynecologist, and completion of the questionnaire takes only a couple 
of minutes. Women attending oncology and fertility clinics were not included.
 The health questionnaire addresses the primary complaint and includes a gynecological, 
Abstract
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“bother”. Of these, 37% had a sexual complaint and only 45% found them bothersome. Multivariate analysis showed 
that urogynecological complaints were significantly associated with sexual complaints.
Conclusions
As most women only volunteer symptoms when asked directly, clinicians should be vigilant in identifying sexual 
problems but always establish the question of bother to avoid over-diagnosis.
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obstetrical, surgical, medical, and family history, as well as questions regarding allergies and 
medications, and constitutes a part of the routine practice in our gynecology and urogyne-
cology clinics. To assess sexual function, three questions are included: (1) Are you sexually 
active? (yes/no). If not active, state reason. (2) Is sex painful? (yes/no). (3) Do you have any 
problems with sex? (yes/no). If yes, state problem. These three questions were based on a 
previous questionnaire, which has been shown to be as effective as a detailed enquiry in de-
tecting sexual problems14. Upon analysis of the collected data at the end of August 2009, it 
became apparent that these questions did not address the issue of bother which can lead to 
over-diagnosis of sexual dysfunction. This led to the introduction of a fourth question: Are 
any of your sexual problems bothersome? (yes/no). It was then decided that data collection 
would continue until February 2010.
 Health questionnaires were collected after several clinic sessions each week based on 
the schedule and availability of the researcher who was not involved in the direct clinical care 
of the patient. Selection bias, however, is considered to be absent as questionnaires were col-
lected for all patients attending a specific clinic session and the availability of the researcher 
was at random. The collected questionnaires are considered to be a random selection of the 
group under study. After the collection of questionnaires, a further review of the medical 
notes was performed in order to complete the medical and surgical history where necessary.
 Statistical analysis was performed by calculating the frequencies of responses. The 
main outcome measure was the mentioning of any sexual complaint on the health question-
naire. A division was made between dyspareunia and “other sexual problems.” An analysis of 
continuous variables was done using Student’s t-test and an analysis of dichotomous variables 
was done using chi-square test. For the purpose of comparison, subjects were divided into gy-
necology or urogynecology patients based on their primary complaint. We corrected for pos-
sible confounding factors by fitting a binary logistic regression model. Included in the analysis 
as possible confounders were: age (comparing over and under 60 years of age), parity, smoking, 
diabetes, hypertension, previous hysterectomy, previous vaginal repair, previous incontinence 
surgery, cardiovascular disease, chronic rheumatic disease, psychological diseases, HRT use, 
and sexual activity. These variables were selected based on previously published15 or expected 
associations. Odds ratios (OR) were calculated on multivariate analysis and are presented 
with their 95% confidence interval. A p-value of less than 0.05 was considered significant. 
Analysis was conducted using SPSS for Windows software (version 16.0; SPSS Inc, Chicago, 
IL, USA).
 All collected data formed part of our routine evaluation of new patients attending our 
gynecology clinics. Therefore, no ethical approval was deemed necessary. A favorable opinion 
to exempt this study from seeking approval was given by the Croydon University Hospital 
Research and Development committee.
 
Results
During the period between May 2008 and February 2010, a total of 1,215 questionnaires were 
collected. Twenty-one (1.7%) women were excluded from the analysis because of missing data 
on sexual activity. The demographics of the 1,194 remaining women are presented in Table 1.
 Of the 1,194 women, 739 (62%) were sexually active. The differences in demographic 
factors between sexually active and inactive women are presented in Table 1. The reasons 
given for sexual inactivity by the 455 sexually inactive women (multiple answers possible) 
include: not being in a sexual relationship in 146 (32%), older age in 29 (6%), pain in 37 (8%), 
partner has a problem in 30 (7%), prolapse or pessary use in 10 (2%), no desire in 16 (3.5%), 
urinary problems in 10 (2%), and mutual agreement in 11 (2%) women. Other problems like 
dryness or marital problems were cited by less than 2%, while 142 (31%) did not comment.
Table 1 Patient characteristics presented as N (%)
  Sexually active  
 Total (n= 1,194)  Yes (n= 739) No (n= 455) p-valuea
Age b 47 (15.9) 41 (12.0) 56 (17.0) <0.001
Parity b 2.0 (1.5) 1.85 (1.45) 2.21 (1.61) <0.001
Diabetes 66 (5.5%) 22 (3%) 44 (10%) <0.001
Hypertension 211 (18%) 71 (10%) 140 (31%) <0.001
Hysterectomy 131 (11%) 48 (6.5%) 83 (18%) <0.001
Prolapse repair 59 (5%) 20 (3%) 39 (9%) <0.001
Incontinence surgery 52 (4%) 25 (3%) 27 (6%) 0.036
Cardio-vascular disease 62 (5%) 11 (1.5%) 51 (11%) <0.001
Chronic rheumatic disease 74 (6%) 27 (4%) 47 (10%) <0.001
Psychiatric diseases 118 (10%) 66 (9%) 52 (11%) 0.160
Smoking 196 (16%) 143 (21%) 53 (13%) 0.002
HRT use 64 (5%) 36 (5%) 28 (6%) 0.339
a Comparing sexually active and inactive women
b Presented as mean (SD)
 Overall 437 (37%) women had a sexual complaint; 320 (27%) complained of dyspareu-
nia and 202 (17%) of “other sexual problems” (multiple answers possible). Forty (3%) women 
complained of bleeding during or after sexual activity. These complaints were not considered 
as sexual problems. The nature of the “other sexual problems” is noted in Table 2. Examples 
of problems associated with prolapse were: “avoiding sex because of lump”, “afraid of making 
prolapse worse”, and “embarrassed to let him see or touch vagina.” Problems associated with 
urinary incontinence were: “no partner as leak urine,” “wetting on penetration”, “embarrassed 
because of pad use/about bladder problem,” and “too wet for sex.”
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Table 2 Nature and frequency of occurrence of "other sexual problems"
"other sexual problems" (n=202)a N (%)
Bladder problems – cystitis 35 (17%) – 6 (3%) 
Partner problems 34 (17%)
Loss of libido 29 (14%)
Prolapse  20 (10%)
Dryness 14 (7%)
Vulval problems (enlarged labia / lumps / swelling) 11 (5%)
No or reduced sensation   9 (4%)
Other health issues 9 (4%)
Vaginal laxity 5 (2%) 
No orgasm 5 (2%)
Itching / irritation 5 (2%)
Bowel problems 4 (2%)
Vaginismus 1 (0.5%)
Others 13 (6%)
Not commented 21 (10%)
a Multiple answers possible
 Of the 437 women with a sexual complaint, 75 (17%) volunteered this in the question-
naire as part of their main complaint while the remaining only admitted to it when completing 
the three screening questions regarding sexual function. Sexual complaints were classified 
as gynecological complaints (46, 61%) unless they were associated with urogynecological 
complaints (29, 39%). The distribution for women who were sexually active and those who 
were inactive is presented in Fig. 1. Sexually active women were significantly more likely to 
volunteer their sexual complaint as compared to women with sexual complaints who were 
not sexually active (p=0.006). Furthermore, women who volunteered their sexual complaint 
were younger (mean (SD) 36 (11.8) vs 46 (14.3), p<0.001) and had a lower parity (mean (SD) 
1.4 (1.3) vs 2.0 (1.3), p=0.002) than women who only admitted to having problems on ques-
tioning. They were also less likely to be suffering from hypertension (p=0.02) and chronic 
rheumatic diseases (p=0.02) and to have undergone a hysterectomy (p=0.03). There were no 
significant differences in the other confounding factors studied.
 Based on the primary complaint, patients were divided into gynecology (641, 54%) 
and urogynecology patients (553, 46%). The nature of gynecological complaints is mentioned 
in Table 3. The differences in patient characteristics between gynecology and urogynecology 
patients are presented in Table 4. The results of the screening questions were compared be-
tween gynecology and urogynecology patients and are presented in Table 5.
Table 3 Nature of gynecological complaints
Gynecological complaints (n= 641) N (%)
Menstrual problems (dysmenorrhea/menorrhagia/intermenstrual bleeding) 209 (33%)
Abdominal pain 115 (18%)
Vulval abnormalities 64 (10%)
Incidental findings (cysts / polyps / fibroids) 49 (8%)
Postmenopausal bleeding 43 (7%)
Insertion / removal of coils  24 (4%)
Sterilization request 27 (4%)
Female Sexual Dysfunction 22 (3%)
Amenorrhoea 11 (2%)
Postcoital bleeding 12 (2%)
Abnormal discharge 14 (2%)
Infertility 5 (1%)
Others 46 (7%)
 Multivariate analysis was performed to identify factors independently associated with 
the presence of a sexual complaint. This showed that (after adjustment for confounding factors) 
having a urogynecological complaint independently increased the risk of having a sexual 
complaint (OR 1.51, 1.13–2.01; p=0.005) and “other sexual problems” (OR 4.15, 2.79–6.17; 
p<0.001), but not dyspareunia (OR 0.95, 0.69–1.31; p=0.756).
 Furthermore, an increased risk of the presence of a sexual complaint was found for: 
smoking (OR 1.59, 1.14– 2.20; p=0.006) and women aged under 60 years (OR 2.35, 1.48–3.73; 
p<0.001).
Figure 1 Sexual problems in sexually active and inactive women
Sexually active
N= 739 (62%)
Sexually inactive
N= 455 (38%)
Sexual problems
N= 303 (41%)
Sexual problems
N= 134 (29,5%)
Overtly presented
N= 62 (20,5%)
On questioning
N= 241 (79,5%)
On questioning
N= 121 (90%)
Overtly presented
N= 13 (10%)
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Table 5  Results of sexual screening questions, presented as n (%) with 95% confidence interval, 
compared between gynecology and urogynecology patients
 Gynecology Urogynecology p-valuea
 N= 641  N= 553 
Sexually active 467 [73% (69-76)] 272 [49% (45-53)] < 0.001
Any sexual complaint 226 [35% (32-39)] 211 [38% (34-42)] 0.30
- Dyspareunia 199 [31% (28-35)] 121 [22% (19-26)] < 0.001
- Other sexual problems 60 [9% (7-12)] 142 [26% (22-29)] < 0.001
Volunteered sexual complaint 46 [20% (16-26)]b 29 [14% (10-19)]b 0.07
a Difference between gynecology and urogynecology patients using chi-square test
b As a percentage of women with any sexual complaint
Table 4 Differences in characteristics between patients presenting with gynecological 
 complaints and those with urogynecological complaints in N (%)
 Gynecology Urogynecology p-value
 N= 641  N= 553 
Age a 40.7 (12.8) 54.5 (15.9) <0.001
Parity a 1.65 (1.4) 2.38 (1.5) <0.001
Diabetes 22 (3.4%) 44 (8.0%) 0.001
Hypertension 61 (9.5%) 150 (27.1%) <0.001
Previous hysterectomy 19 (3.0%) 112 (20.3%) <0.001
Previous vaginal repair 9 (1.4%) 50 (9.0%) <0.001
Previous incontinence surgery 9 (1.4%) 43 (7.8%) <0.001
Cardio-vascular disease 10 (1.6%) 52 (9.4%) <0.001
Chronic rheumatic disease 21 (3.3%) 53 (9.6%) <0.001
Psychiatric diseases 50 (7.8%) 68 (12.3%) 0.009
Smoking 129 (21.9%) 67 (13.7%) 0.001
HRT use 23 (4%) 41 (7%) 0.003
a Presented as mean (SD)
 Dyspareunia was positively associated with age under 60 years (OR 3.77, 1.95–7.29; 
p<0.001), smoking (OR 1.67, 1.18–2.36; p=0.003), and being sexually active (OR 1.97, 1.39–
2.81; p<0.001). “Other sexual problems” were positively associated with age under 60 (OR 
1.95, 1.14– 3.36; p=0.015).
 A total number of 290 (24%) questionnaires included the question on “bother”: 116 
(40%) gynecology patients and 174 (60%) urogynecology patients. Of these, 106 (37%) women 
had one or more sexual complaints. Forty-eight (45%) found one of their sexual complaints 
bothersome, 30 (28%) said it was not bothersome, and 28 (26%) did not answer this question. 
There was no difference in patient characteristics between those who found their sexual com-
plaints bothersome and those who found them not to be bothersome other than the presence 
of chronic rheumatic diseases (0% and 10%, respectively; p=0.025); however, the numbers 
were small.
Discussion
By using a simple and quick tool to screen for sexual problems in a clinical setting, we dem-
onstrated that sexual complaints are highly prevalent in women attending gynecology and 
urogynecology clinics. Although these three simple questions have previously been used as an
interview-based screening tool14,16, we did not find any publications which describe it be-
ing used as part of a written questionnaire (PubMed search, until August 2010, keywords 
(female) sexual (dys)function, prevalence, questionnaire). Plouffe14 showed that 45% of women 
admitted to a gynecology ward on an elective basis had a sexual complaint. Following its pri-
mary publication by Plouffe14, Walters et al. used the screening tool in women with urinary 
incontinence16. They found that 35% of women with detrusor instability and 32% of women-
with genuine stress incontinence admitted to having sexual problems. We were able to iden-
tify sexual complaints in 37% of women visiting outpatient gynecology and urogynecology 
clinics. Furthermore, we found that less than one in five women overtly presented with these 
concerns, demonstrating that screening for sexual problems increases our ability to detect 
them without it being time consuming. A similar result was found in a study by Bachmann 
et al.17 who screened women seeking gynecological evaluation by asking them two questions 
on their sexual functioning during history taking. Although they found a lower prevalence of 
19% reporting sexual problems, only 17% of these overtly complained. Using a standard ques-
tionnaire for all new patients that includes questions on sexuality indicates to the patient that 
a sexual history forms part of a routine gynecological assessment. This may help put patients 
at ease and make them more comfortable to express their concerns.
 Women with urogynecological complaints were more likely to suffer from sexual prob-
lems. Although there was no difference in dyspareunia, “other sexual problems” were more 
common. A higher percentage of women with gynecological complaints (31%) compared to 
those presenting with urogynecological complaints (22%) presented with dyspareunia. How-
ever, a multivariate analysis showed that this difference was not caused by the type of com-
plaint per se but by the fact that women with gynecological complaints were more likely to be 
sexually active and were of younger age.
 Interestingly, women under the age of 60 were more likely to suffer from sexual com-
plaints. This is in contrast to previous literature. It is generally accepted that following meno-
pause sexual desire is decreased. A previous large population-based study conducted in the 
USA showed that sexual problems, including low desire, arousal, and orgasm, were more 
common in women aged over 65, but sexually related personal distress was lowest in this 
age category18. Our screening questions did not include specific questions inquiring about 
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desire, arousal, and orgasm. It is possible that sexually inactive women would not mention 
sexual complaints that do not create personal distress, like low desire and low arousal, if not 
specifically asked about these. Most sexually inactive women will be of older age and therefore 
self-reported sexual problems would be lower in this category.
 In order to decide when clinical intervention is necessary, one should assess the “per-
sonal distress” caused by the sexual problem. This is in accordance with the definition of FSD 
by the International Consensus Development Conference on FSD, which considers a sexual 
problem as dysfunction only when it causes personal distress19. This is an important consideration 
in order to prevent excessive medicalisation and overtreatment of a sexual problem based on 
what society believes is normal. By introducing a fourth question (“Are any of your sexual 
problems bothersome?”), we showed that only 45% of the women with sexual complaints 
actually found them to be bothersome. The previous prevalence estimates of sexual dysfunc-
tion might have over-estimated FSD by not including the distress factor into the definition of 
sexual dysfunction. This is supported by the findings of a previous study in which only 28% of 
sexual problems in a general female population were associated with distress18.
 A limitation of our study is that, first, we did not use a validated questionnaire to assess 
sexual problems. However, the aim of our study was to use a simple and quick screening tool and, to 
the best of our knowledge, there is currently no validated screening tool for FSD available. Further-
more, our screening questionnaire was not designed to differentiate between the different domains 
of sexual dysfunction. We decided to use this screening questionnaire over others17,20,21 as this ques-
tionnaire, although not validated, has been shown to be as effective as a detailed enquiry in detect-
ing sexual problems14. If, by answering the screening questions, a woman admits to having sexual 
problems, a validated condition-specific questionnaire like the Pelvic Organ Prolapse–Urinary In-
continence Sexual Function Questionnaire22 could be administered to urogynecology patients and 
a general validated questionnaire like the Female Sexual Function Index23 could be administered to 
gynecology patients. Secondly, our results could have been affected by the fact that there was 
limited privacy, as women completed this questionnaire in the waiting area and not in a private 
room. This could result in less women admitting to sexual problems. The fact that there was no 
specific definition of the time period in which sexual problems were measured (for example, over 
the last month/year) as well as the fact that both sexually active and inactive women were included 
could be reasons for the lower prevalence of sexual problems found in the present study compared 
to that recently reported in women seeking (uro)gynaecological care6,7.
 We feel that the results of this study are generalizable to women attending other gyne-
cology outpatient clinics in secondary care settings. Results are expected to be different in 
women presenting with gynecological problems to a primary care setting where the severity 
of complaints may be different.
 Sexual problems in the gynecology clinic: are we making a mountain out of a molehill? This 
study shows that although sexual complaints are common amongst women presenting to gynecology 
and urogynecology clinics, by enquiring about bother with this four-question screening tool, we 
have identified that nearly half of women with sexual problems do not find them bothersome. This 
is highly relevant because, by definition, sexual problems cannot be classified as FSD unless they 
cause distress. Previous prevalence estimates of sexual dysfunction might have over-estimated FSD, 
making a mountain out of a molehill.
 However, this study does highlight that the vast majority of women experiencing sexual 
problems only volunteer symptoms when asked directly. By using a simple and quick screening 
tool, sexual problems were five times more likely to be identified by the physician. As urogyneco-
logical complaints were independently associated with sexual problems, this screening tool 
could be included as part of the initial evaluation of these patients.
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References Appendix
GYNAECOLOGY CLINIC - HEALTH QUESTIONNAIRE
NAME:                                                    TODAY’S DATE:        /        /
DATE OF BIRTH:        /        /  AGE:  YOUR WORK?
PLEASE STATE YOUR REASONS FOR COMING TO THE GYNAECOLOGY CLINIC TODAY 
IF YOUR PERIODS HAVE STOPPED  (MENOPAUSE) PLEASE MOVE TO QUESTION 2
1. ABOUT YOUR PERIODS: Date of last period;        /        /        Duration of periods…..days
Periods regular (every 28 to 32 days)  YES / NO Heavy periods?  YES / NO Any Clots?  YES / NO
Any bleeding in between periods?  YES / NO    Painful periods?  YES / NO
2. ARE YOU SEXUALLY ACTIVE?  YES / NO  If Not Active, State Reason
Is Sex Painful?  YES / NO   Do You Have Any Problems With Sex?  YES / NO                           
If Yes State Problems:
Are Any Of Your Sexual Problems Bothersome?  YES / NO Do You Bleed During Sex?  YES / NO                            
DATE AND RESULT OF YOUR LAST CERVICAL SMEAR TEST?        /        /                 Normal / Abnormal
WHAT TYPE OF CONTRACEPTION DO YOU OR YOUR PARTNER USE? (please circle)
PILL      CONDOM      COIL      VASECTOMY      STERILISATION      OTHER (please state) 
DO YOU HAVE CHILDREN?  YES / NO  HOW MANY?  AGE OF OLDEST
     AGE OF YOUNGEST
HAVE YOU HAD ANY OPERATIONS (INCLUDING CAESAREANS) PREVIOUSLY? ( date and type of operation)
DO YOU SUFFER FROM ANY OTHER MEDICAL CONDITIONS? Please tell us what these are
WHAT MEDICATIONS ARE YOU TAKING?
ANY ALLERGIES?   HOW MANY CIGARETTES SMOKED PER  DAY?
ANY BLADDER PROBLEMS?   ANY BOWEL PROBLEMS?
ANY FAMILY HISTORY OF CANCER?  YES / NO
IF YES, STATE CANCER TYPE   AGE OF ONSET
OTHER COMMENTS
Weight ......................... kg Height ......................... cm        BMI ......................... 
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Introduction
Female sexual dysfunction (FSD) is defined as a sexual desire, sexual arousal, orgasm, and/or 
sexual pain disorder, which causes personal distress1. Although it is a highly prevalent condi-
tion, a very small proportion of women consult a physician. In a UK-based survey, a total of 
54% of women reported at least one sexual problem lasting at least 1 month during the last 
year which caused 62% of them to avoid sex. Only 21% of women with problems had sought 
help for it of which 74% consulted their general practitioner2. A web-based survey of 3,807 
women in the USA revealed that the most important barriers for women to seek help were 
embarrassment and feeling that the physician would not be able to provide help. Only 42% of 
this cohort sought help from their gynecologist3. The high prevalence of sexual dysfunction 
and reluctance of women to seek help is a reflection on physicians’ attitude and ability to com-
municate with female patients about their sexual function.
 Fifty percent of sexually active women attending a gynecology outpatient clinic4 and 
up to 64% of sexually active women attending a urogynecology clinic suffer from FSD5. Re-
cent literature on FSD after pelvic floor surgery is inconclusive with regards to outcome. It is 
suggested that surgery for prolapse and incontinence deteriorates sexual function, but im-
provement has also been shown6. Even in this high-risk population, FSD is unlikely to be the 
sole complaint, i.e., the reason for women to consult their urogynecologist. Only seven of 70 
women with FSD5 presented for assessment of these problems at a urogynecology clinic.
 We are not aware of any literature that describes the patient’s wish for the doctor to 
address and treat FSD when presenting with complaints of pelvic floor dysfunction. In our 
experience, there appears to be two major groups of women suffering from FSD, namely, 
those who volunteer symptoms and those who prefer not to broach the subject and perhaps 
hope that the discussion will emerge during the consultation. We, therefore, are of the opinion 
that, given that this is a taboo subject, doctors should be proactive and endeavor to identify 
the problem and offer the patient a choice of options.
 A recent survey of members of the American Urogynecologic Society (AUGS) showed 
that only a minority screen all patients for FSD. Lack of time, uncertainty about therapeutic 
options, and older age of the patient were cited as potential reasons for failing to address 
sexual complaints as part of routine history7. The aim of this study was to determine whether 
members of the British Society of Urogynaecology (BSUG) consider sexual function as a part 
of general patient assessment and to identify any barriers in screening for FSD. Secondly, we 
aimed to compare practice in the UK to that of members of AUGS.
Abstract
Introduction and hypothesis
The aim of this study was to assess the practice of members of the British Society of Urogynaecology (BSUG) with 
respect to female sexual dysfunction (FSD) and compare it to members of the American Urogynecologic Society 
(AUGS). 
Methods
A web-based anonymous electronic questionnaire was sent to all (n=150) BSUG members. Frequencies of responses 
and chi-square test for association with demographics were calculated. 
Results
One hundred questionnaires were returned of which 95 were sufficiently filled. Fifty percent regularly screened for 
FSD at clinic visits and 49.5% after surgery, compared to 77% and 76% of AUGS members, respectively. The most 
important barrier was lack of time. Only 2% said FSD was not an important problem. Seventy-six percent found 
training for FSD unsatisfactory.
Conclusions
FSD is not part of normal practice for half of BSUG members. There is, therefore, a need for better implementation 
of education and training at both undergraduate and postgraduate levels.
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Materials and Methods
In 2006, we designed a web-based electronic questionnaire (see Appendix 1), which was sent 
to all members of the BSUG to complete online and submit anonymously. The questions were 
designed to specifically assess FSD-related practices at clinic visits and following surgery, as 
well as attitudes, beliefs, and overall impressions of FSD. We obtained permission from the 
author of a previously published survey of the members of AUGS7 to use the same question-
naire but, in addition, changes were made to adapt the questionnaire for use in the UK in 
order to acknowledge differences in clinical practice and terminology between the UK and 
the USA. The changes included practice composition, practice area, and type of practice. One 
question addressing the number of physician partners was taken out, and one question con-
cerning access to a psychosexual counselor was included. The question regarding training for 
FSD was phrased differently so that it could be answered by all responders. The final question-
naire consisted of 20 multiple-choice questions.
 Statistical analysis was performed calculating frequencies of responses. Associations 
between demographic factors and frequency of screening for sexual dysfunction were calcu-
lated using chi-square tests. A p value <0.05 was considered significant.
Results
 Of the 150 BSUG members invited to complete the questionnaire, 100 responded (re-
sponse rate 67%). Five responders were excluded from the analysis because less than 25% of 
questions were completed. 
 Of the 95 responders, 57 (60%) were male and 71 (75%) were over 40 years of age. 
Overall, 60% had been a consultant for over 5 years, 22% had been a consultant for less than 
5 years, and 16% were still training. The responders were predominantly based in England 
(84%) and the area population size consisted of 50,000 to 500,000 inhabitants in 64%. Fifty-
nine percent worked in a teaching- or university-based hospital and 38% in a general district 
hospital. The practice composition was all urogynecology patients in 12% and mainly uro-
gynecology in 68% (Table 1). 
 Sixty percent of responders were familiar with one or more questionnaires for assess-
ing female patients for sexual dysfunction. The Pelvic Organ Prolapse–Urinary Incontinence 
Sexual Function Questionnaire (PISQ) was cited by most of them (90%), either alone or in 
combination with others. The Female Sexual Function Index (FSFI) and the Sexual Function 
Questionnaire (SFQ) were familiar to 33% and 28%, respectively.
 Nearly all responders acknowledged screening for FSD was important compared to 
other medical conditions they deal with and only 2% thought screening for FSD was not 
important. Fifty-one percent believed screening for FSD is somewhat important, 36% said 
it is very important, and 10% found it to be extremely important. When compared to the 
responses by AUGS members, we found similar results (47%, 42%, and 9%, respectively).
 Screening for FSD was done either most of the time (50%) or rarely (47%) (Table 2). 
When screening most of the time, responders (n=47) were asked how the information was 
elicited from the patient. The majority did this by asking questions directly to the patient 
(79%) and 19% used a form which the patient was asked to fill. Different domains of sexual 
function were explored and the majority asked one or two questions about sexual activity 
(87%) and dyspareunia (94%). Other sexual domains addressed were libido (47%), arousal/
lubrication (36%), and orgasm (36%). Thirteen percent used a validated questionnaire to 
screen for sexual dysfunction.
 All responders were asked what barriers they have for screening for sexual dysfunc-
tion. Most responders cited more than one, but 10 (11%) did not respond to this particular 
question. The majority (66%) said not enough time was their barrier for screening for FSD, 
20% did not know what or how to ask, 25% were unsure about therapeutic options, and 20% 
said most of their patients are elderly and found this a barrier for screening for sexual func-
tion. Table 3 shows the comparison to the AUGS survey.
 We aimed to find out if differences across demographics would have an impact on 
frequency of screening for FSD. For comparison, age was divided into three groups, name-
ly, 20–40, 41–50, and over 50 years. The years of practice as a consultant were divided into 
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Table 1 Demographics of responders (n = 95)
Demographics N (%)
Practice composition
      All urogynecology 11 (12)
      Mainly urogynecology, some general gynecology 65 (68) 
      Mainly gynecology and some urogynecology 16 (17) 
      General gynecology 2 (2)
      Missing 1 (1) 
Practice length 
      Still in training 15 (16)
      Consultant < 5 years 21 (22)
      Consultant 5-10 years 34 (36)
      Consultant 11-20 years 20 (21)
      Consultant > 20 years 2 (2)
      Retired consultant 1 (1)
      Missing 2 (2) 
Area of clinic/practice 
      England 80 (84.2)
      Scotland 7 (7.4)
      Wales 1 (1.0)
      Northern Ireland 3 (3.2)
      Missing 4 (4.2) 
Population of area of clinic/practice location (no. of inhabitants)
       < 50,000  3 (3.2)
       50,000 – 500,000  61 (64.2)
       > 500,000  26 (27.4)
       Missing 5 (5.2) 
Type of clinic/practice 
       Teaching hospital 32 (34)
       University District General Hospital 24 (25)
       District General Hospital 36 (38)
       Private Practice 1 (1)
       Independent Hospital 1 (1)
       Missing 1 (1) 
Gender 
       Female 35 (37)
       Male 57 (60)
       Missing 3 (3)
Age (years)
       20 – 30 1 (1)
       31 – 40 21 (22)
       41 – 50 52 (55)
       51 – 60 18 (19)
       > 60 1 (1)
       Missing 2 (2)
more or less than five, practice composition into mainly or all urogynecology compared to 
mainly or all general gynecology, and practice population less than 500,000 compared to over 
500,000. There was no significant difference based on gender (p=0.432), age (p= 0.439), years 
of practice (p=0.546), practice composition (p=0.365), and practice population (p=0.890).
 All responders, but two who did not answer the question, estimated that less than 60% 
of patients they see in their clinic experience sexual dysfunction. The majority believed the 
percentage was less than 30% (75%) compared to 49% amongst AUGS members. Compared 
to the rest of the group, of those who believed the prevalence for FSD to be over 30%, 67% 
thought screening for FSD was very/extremely important compared to 38% (p=0.023) and 
86% stated that they screened for FSD most of the time compared to 41% (p<0.001).
 The second part of the questionnaire consisted of questions related to FSD after sur-
gery for pelvic organ prolapse or incontinence. Postoperatively, patients were never screened 
for FSD by one responder, 28 (29.5%) screened rarely, 47 (49.5%) screened most of the time, 
and 19 (20%) did not respond to this question. In AUGS members, screening for FSD after 
surgery was always done by 26%, 50% screened most of the time, and 24% never or rarely 
address sexual function after surgery. Responders who never or rarely screened for FSD post-
operatively (n= 29) were then again asked about barriers for screening for sexual dysfunction, 
but this time postoperatively. Most physicians cited more than one barrier, but 4 (14%) did 
not respond. Fifty-two percent claimed there was not enough time, 21% did not know what or 
how to ask, 14% thought surgery was not related to FSD, 28% were unsure about therapeutic 
options, and 21% quoted their patients were mostly elderly. Table 4 shows the comparison to 
the AUGS survey.
 The 47 responders who screen most of the time after surgery were asked what methods 
they use; more than one answer was allowed. Eighty-seven percent asked one or two ques-
tions about sexual activity and 98% about dyspareunia. A minority asked about libido (26%), 
arousal/ lubrication (17%), and orgasm (11%). Only 4% used a validated questionnaire after 
surgery. The majority (92%) elicited this information by asking the patients the questions 
directly.
 The last two questions of the survey addressed training for FSD and accessibility of a 
psychosexual counselor. When asked to rate the training with respect to FSD, 76% said it was 
unsatisfactory, 18% found it to be somewhat satisfactory, 3% said it was very satisfactory, and 
one respondent (1%) thought it was extremely satisfactory. In the survey of AUGS members, 
this question was asked only to the 59% of responders who reported having completed some 
postresidential training in urogynecology. Of those 59%, 50% found training with respect to 
FSD unsatisfactory, 40% said it was somewhat satisfactory, 8% were very satisfied, and only 
2% extremely satisfied. Sixty-six percent of BSUG members responded positively to having 
access to a psychosexual counselor.
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Table 2 Screening for FSD in BSUG members and AUGS members at clinic visits
Table 3 Barriers for screening for FSD at clinic visits in BSUG and AUGS members
Table 4 Barriers for screening for FSD after surgery in BSUG and AUGS members
 BSUG (%) AUGS (%)
Never/Rarely 47 23
Most of the time 50 55
Always 0 22
Missing 3 -
 BSUG (%) AUGS (%)
Not enough time 66 78
Unsure about therapeutic options 25 28
Do not know what/how to ask 20 8
Most patients are elderly 20 20
Afraid to offend patients 19 7
Others: not interested in the field, patient denial, patient 4 3.2
will bring it up anyway, concern of sexual harassment, 
don’t have any barriers, language, and cultural
 BSUG (%) AUGS (%)
Not enough time 52 41
Do not know what / how to ask 21  7
Do not think surgery is related to changes in sexual function  14 10
Unsure about therapeutic options 28 21
Most of my patients are elderly 21 17
Afraid to offend patients 7 8
See patients too early to determine if there is a problem 0 41
Others: most patients bring it up, don’t follow up all  12 4
patients, relevance to clinical presentation, sexual function 
improved postoperatively 
Discussion
Until recently, little attention has focused on FSD with our understanding being based on 
studies primarily in men. Unlike in men, the sexual response in women is complex with the 
subjective inputs of thoughts and emotions governing arousal in women receptive to sexual 
stimuli, which in turn triggers desire and orgasm. Understanding this interplay of physical 
and psychosocial factors in context with illnesses, medical, and/or surgical interventions will 
help the clinician in managing FSD.
 A number of studies have demonstrated an association between pelvic floor disorders, 
including pelvic organ prolapse and urinary incontinence, and FSD8-11. A recent study of 
women over 40 seeking outpatient gynecological or urogynecological care found women 
with a higher burden of pelvic floor symptoms to be more likely to report infrequent orgasm, 
decreased arousal, and increased dyspareunia11. This indicates that women who seek urogy-
necological care will be of greater risk of having sexual function disorders and urogynecologists 
should be aware of this problem. However, to the best of our knowledge, this is the first time 
that a group of urogynecologists have been surveyed regarding patient assessment of FSD in 
the UK.
 In this survey, although most BSUG members admitted that screening for FSD was 
important, only half of them regularly screened for it. Both members of AUGS and BSUG 
considered screening for FSD is important, but 77% of AUGS members screened for it com-
pared to 50% of BSUG members. Lack of time was the most important barrier for screening, 
both at clinic visits as well as after surgery. Although lack of time was the reason given as the 
most important barrier for FSD screening by both groups, a more plausible explanation would 
be that they were inadequately trained to approach this subject as only 22% of respondents 
felt adequately trained in this area. Screening for FSD need not be cumbersome. It has been 
shown that a simple questionnaire consisting of three questions is as effective as a detailed en-
quiry. A study conducted by Plouffe12 used a simple questionnaire, to assess sexual function, 
consisting of three questions: (1) Are you sexually active?, (2) Are there any problems?, and (3) 
Do you have any pain with intercourse? This questionnaire was able to elicit all cases in which 
a sexual complaint was detected by a more detailed interview. When the simple questionnaire 
was administered by a medical student or intern with no special training in sexual history 
taking, the same number of women admitted to having a problem.
 We suggest that this simple questionnaire, which is easy and quick to use, can be in-
corporated in routine practice as a means to screen patients with a high risk for FSD, such as 
those presenting to urogynecology clinics. Patients can then be triaged for appropriate manage-
ment at a more convenient time or referred to another specialist or psychosexual counselor as 
shown in the algorithm (Fig. 1). This way, physicians have the possibility of referring the pa-
tient if they do not feel adequately trained on the subject of FSD without denying the patient 
treatment.
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 One-fifth (19%) of responders were afraid to offend patients by asking about sexual 
function. It has been previously shown that 96% of women participating in a prevalence study 
for FSD with a 94% response rate were not embarrassed to fill out the survey concerning 
sexual activity and function4. This indicates that some urogynecologist have a wrong image of 
their patient’s feelings with regard to enquiring about sexual experience.
 Many responders were unsure about therapeutic options or did not know what to ask 
when screening for FSD, reflecting a deficiency in this aspect of training. This was confirmed 
by 76% of responders who found their training was unsatisfactory. Only AUGS members 
completing some postresidential training in urogynecology answered this question which 
could explain the lower percentage (50%) of those who found training with respect to FSD 
unsatisfactory. 
 We found common trends when comparing the clinical practice of urogynecologists 
in the UK and USA. Sexual dysfunction in females is an important health problem worldwide 
and studies evaluating the prevalence of FSD have been undertaken in different countries 
with different cultures13-15. A national population cross-sectional study in Iran revealed that 
31.5% had at least one sexual dysfunction of which 21% reported mild, 36% moderate, and 
43% severe FSD13. In a clinic/hospital-based survey of predominantly circumcised, married 
women in Lower Egypt, 68.9% had one or more sexual problems, but as much as 23% were 
not distressed by these issues14. The prevalence of sexual dysfunction in a community-based
sample of Brazilian women was as high as 49%15. Although there have been studies estimating 
prevalence, few studies have been done outside the UK or USA to assess FSD-related practices 
of gynecologists or urogynecologists. A cross-sectional study conducted in Sweden among 
young women called for gynecologic screening showed 22% were dissatisfied with their sex 
life. Ninety-two percent of these women considered it appropriate to be asked about general 
sexuality. However, depending on the area of sexuality, the majority (76–99%) had never been 
asked such questions by a midwife or doctor in connection with a gynecologic examination16.
 This survey had a response rate of 67% which was higher than the previous survey 
amongst AUGS members. In the latter, 966 questionnaires were sent, of which 471 were re-
turned (response rate 49%). A reason for our higher response rate could be the ease of re-
sponding with an anonymous electronic questionnaire compared to a postal questionnaire. 
Nevertheless, selection bias could occur because the nonresponders might have had a different 
view on FSD-related practice. However, we cannot obtain this information because this ques-
tionnaire was anonymous.
 Although the same questionnaire was used as previously used in the survey amongst 
AUGS members, we did make some minor changes to modify the questionnaire to be used in 
the UK. This could have affected our results when it comes to the comparison made between 
responses of the BSUG members and those of AUGS. However, it was important to acknow-
ledge differences in clinical practice and terminology between the USA and UK and, there-
fore, we found it necessary to modify the questionnaire.
Figure 1 Simple algorithm to help clinicians in managing patients with female sexual dysfunction
Screen all patients with 3 questions:
•  Are you sexually active?
•  Are there any problems?
•  Do you have any pain with intercourse?
Sexual
complaints
No sexual
complaints
Confident to
treat
Not confident to
treat
No personal
distress
Reassurance
Personal distress
•  Sexual, medical, and psychosocial history
• Physical examination
Medically
treatable cause
found
No medically
treatable cause
found
Refer to
psychosexual
counselor
Start treatment
Refer to
appropriate
specialist
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 Another limitation of this study was that the exact numbers of AUGS members, our 
control group, were not known which made it impossible to calculate the significance of the 
differences. The demographic differences between the UK and USA survey include a larger
percentage of trainees and consultants with less than 5 years of experience in the UK and a 
larger percentage of consultants working more than 20 years in the USA. A larger percentage 
of responders in the UK see all urogynecology or mainly urogynecology patients compared 
to the USA (80% versus 62%). Forty-nine percent of AUGS members worked solely in pri-
vate practice compared to 1% of BSUG members. More responders in the USA were over 60 
years and between 31 and 40 years of age compared to BSUG members, and more respond-
ers of BSUG were between 41 and 50 years of age compared to AUGS members. The male 
and female distribution was equal. BSUG members mostly work in cities with population 
sizes <500,000 while AUGS members generally worked in larger cities with population sizes 
>500,000. However, these differences should not confound our results as both studies showed 
no significant differences in frequency of screening between different demographics.
 In conclusion, we found that FSD is not included in the regular assessment of patients 
by a large group of BSUG members even though they felt it was important to do so. The 
subject of FSD should be given more importance in the undergraduate and postgraduate cur-
riculum so that clinicians enquire about this embarrassing problem that can have a devastat-
ing impact on marital and social relationships. The similarity in trends between the UK and 
USA highlights that this may be a more global problem that needs wider exploration. With 
increasing interest of the media and women’s perceptions of sexuality, this is a problem that 
gynecologists will increasingly encounter. Urogynecologists along with the colorectal sur-
geons have made considerable progress in resolving the politics of the pelvic floor. Given the 
high prevalence and potential morbidity associated with pelvic floor dysfunction, perhaps it 
is time to work in close liaison with psychosexual counselors to develop a holistic approach to 
pelvic floor problems.
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Appendix 1
1. In your clinic/practice you see: 
 	All urogynaecology patients
 	Mainly urogynaecology, some general gynaecology patients   
 	Mainly gynaecology and some urogynaecology patients
 	General gynaecology patients
2. How long have you been in practice? 
 	 I am still in training (fellowship, subspecialty trainee, SpR)  
 	Consultant <5 years
 	Consultant 5-10 years 
 	Consultant 11-20 years
 	Consultant > 20 years 
 	 I am currently a retired consultant
3. Area of clinic/practice? 
 	England
 	Scotland
 	Wales
 	Northern Ireland
4. What is the population of the area your clinic/practice is located? 
 	< 50,000 inhabitants
 	50,000-500,000 inhabitants
 	> 500,000 inhabitants 
5. Is your clinic/practice: 
 	Teaching Hospital
 	University District General Hospital
 	District General Hospital
 	Private Practice
 	Other
6. What is your gender: 
 	Male
 	Female
7. What is your age? 
 	20-30 
 	31-40 
 	41-50
 	51-60
 	>60
8.  Below is a list of questionnaires some physicians use to assess female patients for sexual dysfunction. 
 Please indicate all those you are familiar with: 
 	Female Sexual Function Index (FSFI)
 	Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire (PISQ)
 	Female Sexual Distress Scale
 	Sexual Function Questionnaire (SFQ-V1)
 	Derogatis Interview for Sexual Functioning (DISF/DISF-SR)
(Appendix 1 continued)
 	Other
 	Not familiar with any
9. Compared to other medical conditions you deal with, how important is it to screen patients for 
 female sexual dysfunction? 
 	Not important
 	Somewhat important  
 	Very important   
 	Extremely important  
10. How frequently do you screen female patients for sexual dysfunction? 
 	Never (go to question 13)   
 	Rarely (go to question 13)  
 	Most of the time (continue with question 11)  
 	Always (continue with question 11)  
11. If you Most of the time or Always screen for female sexual dysfunction, what methods do you use? 
 (Mark all that apply) 
 	1 or 2 questions about sexual activity   
 	1 or 2 questions about dyspareunia  
 	1 or 2 questions about libido  
 	1 or 2 questions about arousal/lubrication  
 	1 or 2 questions about orgasm  
 	Validated questionnaire/Index of sexual function  
12. How is the information from Question 10 elicited from the patient? 
 	 I ask patient questions  
 	Patients fill out form   
 	Patients fill out form and we discuss the answers  
 	Research/clinical nurse/physician assistant asks patient  
13. What are some barriers to screening for sexual dysfunction? (Mark all that apply) 
 	Not enough time  
 	Don't know what/how to ask  
 	 If patient has a problem, I am unsure about therapeutic options  
 	Most of my patients are elderly  
 	Afraid to offend patients (e.g. cultural taboos)  
 	Other  
14. What percentage of female patients that you see do you believe experience sexual dysfunction? 
 	<5%  
 	5-10%  
 	11-20%  
 	21-30%  
 	31-40%  
 	41-50%  
 	51-60%  
 	61-70%  
 	71-80%   
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(Appendix 1 continued)
 	81-90%   
 	>90%   
QUESTIONS 15 TO 19 RELATE TO SEXUAL DYSFUNCTION AFTER SURGERY 
15. How frequently do you screen patients for sexual dysfunction after surgery? 
 	Never (go to question 16)   
 	Rarely (go to question 16)   
 	Most of the time (go to question 17)   
 	Always (go to question 17)   
16. What are some barriers to screening for sexual dysfunction? (Mark all that apply) 
 	Not enough time   
 	Don't know what/how to ask   
 	Don't think surgery is typically related to changes in sexual function   
 	 If patient does have a problem, I am unsure about therapeutic options   
 	Most of my patients are elderly   
 	Afraid to offend patients (e.g. cultural taboos)   
 	 I see the patients too early to determine if there is a problem (e.g. not sexually active yet)   
 	Other  
17.  If you Most of the time or Always assess for sexual dysfunction after surgery for prolapse
 or incontinence, what methods do you use? (Mark all that apply) 
 	1 or 2 questions about sexual activity   
 	1 or 2 questions about dyspareunia   
 	1 or 2 questions about libido   
 	1 or 2 questions about arousal/lubrication   
 	1 or 2 questions about orgasm   
 	Validated questionnaire/Index of sexual function   
18. How is the information from Question 17 elicited from the patient? 
 	 I ask patient questions   
 	Patients fill out form   
 	Patients fill out form and we discuss the answers   
 	Research/clinical nurse/physician assistant asks patient   
19. How would you rate the training with respect to female sexual dysfunction? 
 	Unsatisfactory   
 	Somewhat satisfactory   
 	Very satisfactory   
 	Extremely satisfactory   
20. Do you have access to a psychosexual counsellor? 
 	Yes   
 	No
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Introduction
Sexual function is commonly affected in women suffering from pelvic floor dysfunction 
(PFD), including pelvic organ prolapse (POP) and urinary incontinence (UI). Prevalence es-
timates have shown that up to 64% of sexually active women attending an urogynecology 
clinic suffer from sexual dysfunction1. Despite this, worldwide many health-care professionals 
who treat women with PFD feel inadequately trained to approach the subject of sexual func-
tion: they do not know what/how to ask or are unsure about therapeutic options2-5. Without 
health-care professionals understanding patients’ concerns, distressing sexual problems could 
go unnoticed as many women hesitate to present these symptoms to their doctors themselves6. 
 Research on the impact of POP and/or UI on women’s sexual function has increased 
over the last decade. In women suffering from UI, an unsatisfying sex life can be a result of 
the fear of leakage during intercourse, worries regarding body odor, or embarrassment due to 
the need for pads7. Mechanical obstruction and vaginal laxity may be the reason for reduced 
sexual satisfaction in women with POP8. However, recent work has suggested that the impact 
of POP goes beyond a local effect and sexual dysfunction may be more related to a decrease 
in women’s self-perceived body image9.
 Female sexual dysfunction (FSD) as a diagnostic term incorporates four categories: 
sexual desire, sexual arousal, orgasm, and sexual pain10. Results on how POP and/or UI affect 
the different FSD categories are inconsistent. For example, Handa et al.11 showed that POP 
and/or UI were associated with decreased arousal, infrequent orgasm, and increased dyspa-
reunia. However, Rogers et al.12 showed that, although the overall score of sexual function, as 
measured by the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire 
(PISQ)13, was lower in women with POP and/or UI, no differences were noted in arousal and 
orgasm.
 These conflicting results may be a reflection of differences in the population’s charac-
teristics, differences in the assessment of POP and/or UI, or differences in the assessment of 
sexual function. To date, assessment of sexual function has been primarily quantitative using 
either general or condition-specific sexual function questionnaires. General sexual function 
questionnaires are not specifically designed to assess changes in sexual health specifically 
caused by POP and/or UI and may therefore not be sensitive enough to detect a meaningful 
change in sexual function in women with these disorders14. Currently, there is only one vali-
dated condition-specific sexual function questionnaire for women suffering from POP and/
or UI: the PISQ13. However, a condition-specific questionnaire is best used for comparison 
within groups of women suffering from POP and/or UI and is less useful in comparing sexual 
function between women with and without these conditions15. Furthermore, the PISQ does 
not calculate domain scores according to the FSD categories, which makes it difficult to diag-
nose FSD using it.
 A qualitative study can complement the prevailing empirical approach by providing 
Abstract
Introduction 
Sexual function of women suffering from pelvic organ prolapse (POP) and/or urinary incontinence (UI) is adversely 
affected. However, our current understanding of the exact relationship between female sexual dysfunction and POP 
and/or UI is incomplete. A qualitative study can improve our understanding by describing what women themselves 
perceive as the real problem. 
Aim
To gain a more in-depth understanding of the impact of POP and/or UI on the different categories of female sexual 
dysfunction by way of a qualitative study.
Methods 
Qualitative semi-structured interviews were conducted in 37 women scheduled for pelvic floor surgery. One was 
excluded from analysis due to incomplete recordings.
Main outcome measures
The impact of POP and/or UI on female sexual function.
Results
Only 17% of women were completely positive about their sex life. Both POP and UI had a negative effect on body 
image. Women with POP had a negative image of their vagina, which caused them to be insecure about their part-
ner’s sexual experience, while women with UI were embarrassed about their incontinence and pad use, and feared 
smelling of urine. Worries about the presence of POP during sexual activity, discomfort from POP, and reduced 
genital sensations were the most important reasons for decreased desire, arousal, and difficulty reaching an orgasm in 
women with POP. Fear of incontinence during intercourse affected desire, arousal, and orgasm and could be a cause 
for dyspareunia in women with UI. Desire was divided into two main elements: “drive” and “motivation.” Although 
“drive,” i.e. spontaneous sexual interest, was not commonly affected by POP and/or UI, a decrease in “motivation” or 
the willingness to engage in sexual activity was the most common sexual dysfunction mentioned.
Conclusions 
Body image plays a key role in the sexual functioning of women with POP and/or UI with the biggest impact on 
women’s “motivation.”
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meaning and context to the quantitative results published so far. Qualitative research is in-
creasingly being accepted as a valuable method of research in the field of urogynecology16. 
Qualitative studies have been conducted to gain understanding of the impact of overactive 
bladder on women’s sexual health17 and to describe perceptions of prolapse-specific body im-
age18. However, to date, no qualitative studies have been conducted that specifically aimed to 
understand the impact of POP and/or UI on female sexual function.
Aims
The aim of our study was to gain a more in-depth understanding of the impact of POP and/
or UI on the different categories of FSD by way of a qualitative study. These data can be used 
to increase understanding and awareness among health-care professionals involved in the 
care of women suffering from POP and/or UI and to improve the evaluation after treatment. 
Furthermore, this information can be used to suggest changes in current assessment tools in 
sexual function for women with POP and/or UI.
Methods
Women with POP and/or UI, scheduled to undergo corrective surgery, were recruited in two
urogynecology outpatient clinics at a large university hospital (Croydon University Hospi-
tal, UK), led by two consultant urogynecologists (R.T./A.H.S.). Inclusion criteria included 
the following: age above 18 years and a good comprehension of verbal and written English. 
We selected partnered women who were sexually active, and women with terminal illness or 
malignancy were excluded. The women were selected when considered to be “good” infor-
mants, i.e., articulate, reflective, and likely to share as much information as possible with the 
interviewer19. Inclusion was over a period of 17 months, from April 2008 until August 2009. 
As the analysis described in this article was part of a larger study that aimed to study the im-
pact of pelvic floor surgery on women’s sexual function, recruitment of participants finished 
when the cohort of women had reached maximum variation with regards to types of surgery 
and combinations of procedures that would be performed. Ethical approval was granted by 
the Outer South East London Research Ethics Committee (Lewisham Local Research Ethics 
Committee) (07/Q0701/2), and all participants signed informed consent before entering into 
the study.
 Consented participants underwent semi-structured face-to-face interviews regarding 
their sexual function in relation to their POP and/or UI symptoms. We made use of face-to-
face interviews as sexual function is a sensitive topic and interviews allow for information to 
be gathered in a detailed, elaborative, and precise way. All interviews were conducted within 
the hospital premises in the privacy and comfort of a consulting room. Each interview was 
conducted by the first author (A.-M.R.), who had been trained in qualitative research methods 
and interviewing techniques. The interviewer was a female medical doctor working as a re-
search fellow and was introduced as such. She was not involved in the treatment of the women 
and was not present during their clinic visits. Although not a native speaker, she was fluent in 
the English language.
 At the start of the interview, the interviewer explained the purpose of the study and 
assured the confidentiality of the collected data to the participant. The interviewer followed 
an interview guide that was developed prior to the start of the study with the help of a clinical 
psychologist with an expertise on the evaluation of sexual function. The interview guide in-
cluded open-ended questions addressing different topic areas based on the available literature 
on sexual function in women with POP and/or UI and included the four categories of FSD 
(desire, arousal, orgasm, and pain) and body image. During data collection, questions were 
refined and ultimately the interview guide became supplemented with additional questions. 
The complemented interview guide is presented in Table 1. By using follow-up questions such 
as “You mentioned . . . , please tell me a bit more about it, what you mean by this?”, “Can you 
tell me if it has always been like this or if it has changed recently?”, and “Did the prolapse/incon-
tinence have any effect on that?”, the experiences of the participants were further elaborated 
in order to obtain a more in-depth understanding of the impact of POP and/or UI on the 
women’s sexual function.
 Each interview was audio-taped and transcribed verbatim. For systematic analysis of 
the gathered data, we made use of data matrices as described by Huberman and Miles20. After 
immersion into the raw data of transcripts and field notes, we developed a start list of broad 
categories for organizing the data into meaningful clusters for analysis. Categories were either 
introduced into the interviews by the questions in the interview guide or issues raised by the 
participants themselves. During analysis, we kept the possibility open to add any additional 
categories. Eventually, the list consisted of 15 categories, including: evaluation of sex life, body 
image, desire (including drive, avoidance, and masturbation), frequency of sexual activity, 
arousal (including subjective arousal and genital arousal), orgasm, dyspareunia, partner, coping 
mechanism, wishes and expectations for surgery, symptoms, and others. All interviews were 
subsequently coded and the data from the interviews were coupled to the corresponding cat-
egories. Meta-matrices were created for each category separately using Microsoft Excel 2010. 
The columns of these matrices contained subcategories, which were elaborated and comple-
mented during the data analysis. The rows assembled the data from the different participants. 
In first instance, the cells were filled with literal passages from the interview transcripts. Fol-
lowing this, summary tables were constructed. Using these tables, we were able to search for 
common patterns and differences in the sexual function of our participants. All interviews 
were coded by the first author (A.-M.R.). The second author (R.T.) went through 25% of the 
transcripts and independently coded the data from the interviews according to the list of 
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categories. There were minor discrepancies, mainly in four out of the 15 categories. These dis-
crepancies were discussed between the two researchers, and consensus on coding was always 
reached.
Main Outcome Measures
The main outcome measure for this study was the impact of POP and/or UI on female sexual
function.
Results
Thirty-seven women consented for participation and were subsequently interviewed. Due 
to a technical error in the recording of the interview, one woman was excluded from the 
analysis. The median duration of the 36 interviews was 21 minutes (range 8–72). The de-
mographics of the included women are presented in Table 2. All women but one were in a 
committed relationship; one woman had separated from her long-term partner 2 weeks prior 
to the interview. Another woman who was married had a long-term sexual relationship out-
side of her marriage due to sexual difficulties of her spouse. All women but one considered 
themselves to be sexually active; one woman had been avoiding sexual activity because of her 
POP symptoms but wished to resume sexual activity following surgery. Seventeen women 
were planned to have POP surgery (group 1), 8 anti-incontinence surgery (group 2), and 11 
both POP and anti-incontinence surgery (group 3). The types of surgery planned in group 1 
Table 1 Refined and complemented interview guide for semi-structured interview
Topic area Example of question
1. Sexual experience “Can you tell me a bit about your sex life, how it is right now?”
 - Desire “How about your desire for sex?”
 - Arousal “When you have sex do you get aroused?”
 - Orgasm “How about reaching an orgasm?”
 - Dyspareunia “Do you experience any pain during sexual intercourse?”
  - Satisfaction “Do you find your sexual actions are satisfactory?”  
2.   Level of intimacy in current  “Does ….  effect the level of intimacy with your partner?
 sexual relationship 
3.  Partner related domaina “Are there any other sexual partners right now?”
  “Is it any different with a different sexual partner?”
4.  Solo sex acts  “How about masturbation or pleasuring yourself?” 
5.  Body image   “Do you feel that the prolapse/incontinence has an effect 
  on the way you feel about your body? 
  “Do you think the prolapse/incontinence has changed 
  how you feel sexually?”
6.  Anything else relevant to the study  “Is there anything else that you think might be helpful for 
  me to know at this stage?”
Additional topic areas
7.  Expectations of upcoming surgeryb “What are your expectations for this surgery?”
8.  Receiving oral sexc “Some women comment on oral sex, how is that for you?”
9.  Symptomsd “Can you tell me about the symptoms that you’re having now?”
aThe topic got deleted after 12 interviews as women responded surprised and offended, which was thought to affect 
rapport. Furthermore, the question did not bring any additional information.
bTopic introduced after second interview
cTopic introduced after third interview
dTopic introduced after 30th interview
Table 2 Demographics of 36 included women
   N (%)
Agea  49 (31 – 64)
Childbirtha Parityb 2 (0-5)
  Vaginal parity 2 (0-5)
BMIa  28.4 (19.9 – 36.4)
Ethnicity Caucasian 34 (94%)
  Other 2 (6%)
Menopause Premenopausal  15 (42%)
  Postmenopausal 18 (50%)
  Unsure: post hysterectomy 3 (8%)
Using HRT  6 (17%)
Previous surgery  
 Types of surgeryc: Vaginal repair  7 (19%)
  Anti-incontinence surgery 4 (11%)
  Hysterectomy 11 (31%)
aPresented as median (range)
bAll women but one had given birth to at least one child
cMultiple surgeries possible
BMI = body mass index; HRT = hormone replacement therapy
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included the following: anterior repair (AR) (N = 1), vaginal hysterectomy with AR (N = 3), 
vaginal hysterectomy with AR and posterior repair (PR) (N = 1), PR as a sole procedure (N 
= 5), AR combined with PR (N = 2), AR and enterocele repair (N = 1), sacrocolpopexy (N = 
2), stapled transanal resection of the rectum (STARR) (N = 1), and vaginal excision of cervi-
cal stump (N = 1). The procedures planned in women from group 2 included the following: 
tension-free vaginal tape (TVT) (N = 6) and transobturator tape (N = 2). Women from group 
3 were planned to undergo the following: vaginal hysterectomy with TVT (N = 1), vaginal 
hysterectomy with AR and TVT (N = 3), AR with TVT (N = 2), PR with TVT (N = 2), STARR 
with TVT (N = 2), and colposuspension with sacrohysteropexy (N = 1).
Evaluation of Sex Life
Only six (17%) women evaluated their sex live positively and did not find their POP and/or 
UI had impacted on it. Fourteen (39%) women were negative, and 16 (44%) women described 
an overall good sex life but were negative about certain aspects of it. The distribution per 
surgical group is shown in Figure 1. Of the six women who were positive, three (two from 
group 2 and one from group 3) explained that their UI did not have an impact on their sex 
life, as they never experienced incontinence during intercourse or had implemented success-
ful mechanisms to prevent it. The other three women (two from group 1 and one from group 
3) explained that despite being aware of the presence of POP, it did not affect their sexual 
frequency, behavior, or enjoyment. The (partly) negative evaluation by the other 30 women
was a consequence of changes in sexual function and/or frequency as a result of POP and/or 
UI and/or “other factors”, including relationship problems and male sexual dysfunction. The 
dominant themes that emerged from the analysis are outlined below. A summary of the im-
pact of POP and UI on sexual function is presented in Table 3 and the distribution of sexual 
dysfunction per surgical group in Table 4. The “other factors” were addressed separately.
Body Image
Body image, which refers to an individual’s perceptions and attitudes toward his/her own 
body, was affected by POP and/or UI in the vast majority of women. Women suffering from
POP generally had a negative image of their vagina, describing it as “not normal”, “ugly”, “not 
what it should be”, “dirty”, “big”, “loose”, or “a car park for obstructive defecation”.
“You feel almost a bit sort of medically: ‘Oh, what’s that and why is that there?’ And often I feel I want to 
push everything back in.” (participant 9)
The presence of POP was associated with negative emotions such as embarrassment, depres-
sive feelings, and lower self-confidence, as women could not understand what they did wrong 
to get POP. Furthermore, POP could lead to a general loss of attractiveness by feeling old, 
not sexy, and less feminine. The majority of women with POP were less confident about their 
partner’s sexual experience, despite most partners being reassuring or not complaining. Sex 
was thought to be less satisfactory for their male partner because he might feel or see the 
prolapse during sexual activity or because of lack of tightness. Some women were worried 
about their partner feeling the prolapse during penetration, while others were more worried 
regarding oral sex or manual stimulation.
 “I think I’m also very conscious, I think, for my husband how does it feel like. So I’m very conscious thinking 
well it can’t be pleasurable, if that makes sense, because it feels like I, you know, in terms of sensation, that 
I’m very loose (. . .)” (participant 9)
 “(. . .) if he’s going to have oral sex and that, I wouldn’t let him. (. . .) because I think I can’t imagine anything 
worse than actually looking at a lady with a huge like bulge there out.” (participant 19)
Incontinence (anal/urinary) affected body image as women felt embarrassed about (coital) 
incontinence and the need to wear incontinence pads. Women felt that they should be able 
to control this basic bodily function at their age as incontinence was something that was 
believed to happen in either young children or “old women.” To the majority of women, the 
Figure 1  Evaluation of sex life per surgical group
Positive: women with a positive evaluation of their sex life who did not find their pelvic organ prolapse and/or urinary 
incontinence had impacted on it. 
Negative aspects: women who described an overall good sex life but were negative about certain aspects of it. 
Negative: women with a negative evaluation of their sex life.
70%
60%
50%
40% positive
negative aspects
negative
30%
20%
10%
0%
total (n=36) group 1 (n=17) group 2 (n=8) group 3 (n=11)
17%
12%
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62,5%
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length of the relationship and reassurance from the partner were irrelevant in this respect, 
although knowing someone with the same problem did reduce embarrassment. Furthermore, 
many women felt unclean and worried regarding giving off a urine smell.
Table 3 Summary of impact of pelvic floor dysfunction on body image and sexual function
 Incontinence Pelvic organ prolapse (POP)
Body image  • Embarrassed about  • Negative image of vagina (n=19)
  incontinence and pad use (n=11) • Insecure about partner’s sexual
 • Feeling dirty and fear of smelling  satisfaction (n=23)
  of urine (n=10) • Loss of general attractiveness: feeling old, 
 • Feeling unattractive, not sexy,   not sexy and less feminine (n=10)
  old (n=9) • Loss of confidence, embarrassment
 • Loss of confidence, feeling depressed   and feeling depressed (n=7)
  (n=6) 
“Drive” • Occurrence of coital incontinence  • Sex unsatisfactory (n=2)
  (n=1) • Feeling depressed due to pelvic floor 
 • Too busy controlling bladder/bowel  dysfunction (n=1)
  function (n=1) 
“Motivation” • Presence / fear of coital incontinence  • Body image issues (n=16)
  (n=7) • (Fear of) pain/discomfort (n=8)
 • Fear of smelling of urine and  • Difficulties with penetration (n=2)
  feeling dirty (n=3) • Fear to damage POP (n=2)
 • Lack of spontaneity because of need  • Reduced sensations (n=1)
  to void or wash prior to sexual activity  • Tired of dealing with the symptoms (n=2)   
  (n=3) 
Arousal • Difficult to relax due to fear of  • Mentally distracted because of POP (n=6)
  incontinence (n=4) • Fear of, or presence of pain because  
 • Hurry through sex due to fear of   of POP (n=2)
  incontinence (n=1)
 • Interruptions: need to urinate during 
  intercourse, occurrence of coital 
  incontinence (n=1) 
Orgasm • Difficult to relax and let go out of fear  • Reduced genital sensations (n=3)
  of incontinence (n=5) • Mentally distracted: worried about
 • Do not allow climax to avoid urinary   the presence of POP (n=5)
  leakage (n=2) • Do not allow climax (n=1)
Dyspareunia • Tense due to fear of incontinence  • Discomfort or obstruction from POP (n=11)
  (n=2) • Urogenital/abdominal pain after 
    intercourse (n=3)
“Because there is a sense of, you know, real embarrassment that this isn’t something that should be happening, 
that you should be able to control yourself, and you just can’t.” (participant 11)
Because of the presence of (coital) incontinence, the need to wear incontinence pads, and the
perceived presence of a urine smell, women felt unattractive, not sexy, and old. Eventually, 
incontinence could cause women to dislike their own body and feel less confident and de-
pressed. Some women expressed disappointment about being incontinent. They wondered: 
“why me?” and “what did I do?”, comparing their age and parity to women who should be 
incontinent in their eyes.
Sexual Desire
Responses on sexual desire could be divided into two main elements. These included the fol-
lowing: “drive”, i.e. spontaneous sexual interest, and “motivation”, or the willingness to engage 
in sexual activity. We found that these two elements of sexual desire were affected differ-
ently by the presence of POP and/or UI. Nearly half of women described diminished “drive”, 
however only few attributed this to their POP and/or UI symptoms. More often, POP and/
or UI would affect “motivation”. Of the 27 (75%) women whose “motivation” was absent or 
diminished, 24 (67%) would mention POP and/or UI as the cause for this. Women would try 
to avoid all sexual activity or penetrative sex only, hurry through sex, or stop initiating sexual 
activity. 
 POP affected women’s motivation for a couple or reasons. The most frequently men-
tioned reasons were body image issues such as being aware of the vagina being “not normal”, 
a general loss of attractiveness, and insecurity about their partner’s sexual experience. Furthermore, 
women avoided sexual activity because of (fear of) pain/ discomfort during sex, following sex or in 
Table 4  Frequency of negative changes in body image and sexual function occurring as a result 
of pelvic floor dysfunction, per surgical group, in N (%)
 Total  Group 1 Group 2 Group 3
 N= 36 N=17 N= 8 N= 11 
Body image  33 (92%) 15 (88%) 7 (87.5%) 11 (100%)
Sexual desire    
- drive 5 (14%) 2 (12%) 1 (12.5%) 2 (18%)
- motivation 24 (67%) 10 (59%) 6 (75%) 8 (73%)
Arousal 10 (28%) 6 (35%) 2 (25%) 2 (18%)
Orgasm 12 (33%) 5 (29%) 4 (50%) 3 (27%)
Dyspareunia 13 (36%) 8 (47%) 2 (25%) 3 (27%)
Group 1: women planned for POP surgery; group 2: women planned for anti-incontinence surgery; and group 3: women 
planned for both POP and anti-incontinence surgery
POP = pelvic organ prolapse
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general from POP, feeling awkward about difficulties with penetration as a result of obstruc-
tion, fear to damage the prolapse, reduced sensations that made sex unsatisfactory, and being 
tired of dealing with the symptoms.
 “Compared to a lot of other people we hardly ever do it. And it is (. . .) the main thing is the lump; it’s 
uncomfortable and I just, I’m very conscious of it, and I know [partner] can feel it so, you know.” (partici-
pant 24)
 “And also I feel that [penetrative sex] might hurt. You know, it might sort of uhm do damage. Uhm, so I just 
sort of try to avoid it.” (participant 8)
Incontinence affected “motivation” because of the presence or fear of coital incontinence, fear 
of smelling of urine and feeling dirty, a lack of spontaneity, and the need to void or wash prior 
to sexual activity.
 “[Desire to have sex] is still there and that hasn’t gone. (. . .) But the reality is that if you do have intercourse 
you will leak and so you avoid it.” (participant 11)
 “Uhm, I suppose I’m paranoid, because I leak. I wonder if I smell. I’m scared that it might happen during 
intercourse. So therefore if I can avoid it, I do.” (participant 29)
Sexual Arousal
Sixteen (44%) women described difficulty getting aroused, and for 10 (28%) women this was 
because of their POP and/or UI. For women with POP, getting aroused was difficult as they 
were mentally distracted during intercourse: they worried about their vagina being “not nor-
mal” and their partner’s sexual experience because of this, or felt awkward because of ob-
struction from POP during penetration. Furthermore, arousal was affected by (fear of) pain 
because of POP.
 “Whereas now it’s very mechanical and I’m more worried what’s down there. (. . .) I convinced myself that 
I enjoy it, but it takes a long time and usually it’s sort of done before I get to really enjoy it.” (participant 37)
For women with incontinence, the fear of coital incontinence made it difficult to relax or 
caused them to hurry through sex, which affected arousal. One woman who had no difficulty 
getting aroused described her arousal would diminish when intercourse would be interrupted 
by the need to urinate or the occurrence of incontinence during intercourse.
 “No, because you can’t, you can’t give yourself to the moment if you’re thinking: ‘Am I still wet?’, or ‘Am 
I going to leak?’, or ‘Is he going to feel that I leak?’, ‘How is that going to feel for him?’ ” (participant 11)
Orgasm
Seventeen (47%) women described changes related to reaching an orgasm and for 12 (33%) of 
them this was because of their POP and/or UI. For women with POP, reduced genital sensations 
and being worried about the presence of POP could lead to difficulties reaching an orgasm or the 
orgasm being less intense. Women with incontinence described difficulty or inability to climax 
because they could not relax and let themselves go out of fear for coital incontinence.
“I think it takes you longer now, for me anyway, because that is when I’m scared, that I’m just going to let go 
and that [incontinence] could happen. So you find you’re trying to fight [reaching an orgasm].” (participant 29)
Furthermore, three women had no difficulty reaching an orgasm but did not allow themselves 
to climax because orgasm would increase the size of their POP, or to avoid urinary leakage at 
the time of orgasm.
“I mean sometimes I won’t orgasm, because I’m worried that I might, that [incontinence] might happen 
during that.” (participant 38)
Dyspareunia
Eighteen (50%) women were suffering from dyspareunia, and for 13 (36%) this was related to 
their POP and/or UI. Dyspareunia was mostly caused by POP and very rarely seen as a result 
of UI. Women with POP mentioned discomfort during sex that was dependent on sexual po-
sition and bladder/bowel fullness, discomfort because of obstruction from POP primarily at 
the start of penetration, and/or urogenital or lower abdominal pain following penetrative sex.
 “It’s where the lump is. I get like an ache, like, like a dragging . . . . (. . .) It just feels like a dragging, horrible 
pain. (. . .) It’s different positions. Uhm laying down I can still feel it, but not as bad, to be honest. Uhm but 
when we are sort of like in another position it is just there. (. . . .) Also when you orgasm everything seems 
to move down there and I know I’m going to get a tummy pain.” (participant 24)
Fear of coital incontinence and being tense because of this could cause dyspareunia in women 
with UI.
 “It’s just there and you just can’t put it out of your brain, you know. You think: ‘oh, is [urinary leakage] going 
to happen before I reach orgasm, or . . .?’ (. . .) so that’s why it probably hurts a bit, because I’m tense.” 
(participant 25)
There were different ways women coped with dyspareunia while having sexual intercourse, 
including “grin and bear”, avoiding certain sexual positions, and guide penetration or trying 
to reduce POP in case of obstruction.
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Coital Incontinence
Of the 10 women who feared urinary/anal incontinence during intercourse, only one of them 
had never experienced coital incontinence. Nine women tried to prevent coital incontinence 
primarily by emptying the bladder before intercourse. Other coping mechanisms included: 
avoiding certain positions, hurry through sex, doing more pelvic floor exercises, or avoiding 
orgasm. These mechanisms were successful for four of them.
Other Factors Impacting on Sexual Functioning
Besides POP and/or UI, other factors impacted on the sexual function and frequency of 
sexual activity of the included women. This included male sexual dysfunction, relationship 
problems, long duration of relationship, tired/stress, older age/menopause, low mental state, 
fear of pain (other causes), other diseases, previous vaginal surgery, time constraints, partner’s 
physical problems, and avoidance of sex by partner because of POP and/or UI. Body image 
was further affected by weight issues and being negative about appearance.
Discussion
In this study, we have shown how POP and/or UI impact on the different categories of FSD. 
This qualitative study demonstrates that the changes in body image that occur as a result 
of POP and/or UI play a central role in the sexual function of women suffering from these 
conditions. Embarrassment about incontinence causes a fear of incontinence occurring dur-
ing intercourse. This fear for coital incontinence has the potential to impact on all stages of 
sexual excitement. Fear of coital incontinence was mostly present in women who had actu-
ally experienced this, a finding supported by the previous literature21. Jha et al.21 showed that 
anxiety and avoidance of sexual activity because of bladder problems were significantly more 
frequent in women who were incontinent during intercourse compared with those who were 
not. Furthermore, our results showed that the reason for women suffering from UI to be 
positive about their sex life was the absence of coital incontinence and that successful coping 
mechanisms had the potential to improve the evaluation of women’s sex life.
 Women with POP have a negative image of their vagina, causing them to feel less at-
tractive and insecure about their partner’s sexual experience. This can affect sexual desire, 
arousal, and orgasm. The impact of POP on body image was initially recognized by Jelovsek 
and Barber22. Further research showed a correlation between decreased body image and de-
creased sexual function9. Our results show that women themselves perceive body image issues 
as the most important factor altering their sex life.
 The data in this article have been presented around the different categories of FSD10. 
An important finding of our study is the distinction women make between “drive” and “moti-
vation”. Previously, it has been suggested that desire comprised three discrete but interrelated 
components: “drive,” “cognitive,” and “motivation”23. “Drive” is the biological component evi-
denced by spontaneous sexual interest. The second component, “cognitive”, reflects a person’s 
expectations, beliefs, and values related to sex. “Motivation” is characterized by the willing-
ness of a person to engage in sexual activity. The distinction between “drive” and “motivation” 
was specifically present in the responses of our participants. However, this distinction is not 
commonly addressed in general sexual function questionnaires24-26, except for the Golombok 
Rust Inventory of Sexual Satisfaction27 that measures avoidance of sex. The only validated 
condition-specific sexual function questionnaire for women suffering from POP and/or UI, 
the PISQ13 and its short form the PISQ-1228, does include questions on avoidance of sexual 
activity. However, as the PISQ does not calculate domain scores according to the FSD catego-
ries, it is difficult to diagnose FSD using it.
 When we look at the PISQ specifically, there are some changes that can be made to im-
prove the assessment of sexual function in women with POP and/or UI. We feel that the PISQ 
could be made more useful for the clinical setting if it would assess the impact of POP and/
or UI on the different FSD categories. For example, the question on pain during intercourse 
should be followed by four subquestions on the impact of pain on sexual drive, motivation, 
arousal, and orgasm. Furthermore, in addition to questioning women’s ability to reach an 
orgasm, it might be worthwhile to add a question on preventing orgasm, as some women do 
not allow themselves to climax to prevent coital incontinence or pain associated with POP.
 Although this was primarily a qualitative study, some interesting trends were seen in 
Table 4 and Figure 1.Women from group 2 (anti-incontinence surgery) were more likely to 
have a negative evaluation of their sex life (62.5%), while women from group 1 (POP surgery) 
were more likely to have an overall positive evaluation but with negativity about certain as-
pects (59%). Furthermore, dyspareunia was more common in women from group 1, while 
orgasm was more affected among women from group 2. However, as the numbers in each 
surgical group were small, these results need to be interpreted with caution.
 We acknowledge that our study has some limitations. Women scheduled to undergo 
pelvic floor surgery are more likely to have an affected sex life than women who do not opt for 
surgery. Therefore, the percentages and types of sexual problems might not be representative 
for all women suffering from POP and/or UI. Furthermore, women who suffer from sexual 
dysfunction might have been more keen to enter into the study as it would give them the op-
portunity to discuss their concerns. However, as we selected participants planned for various 
types of pelvic floor surgeries, our sample of women is a good representation of the popula-
tion of women scheduled to undergo pelvic floor surgery. As saturation was reached with 
respect to the information that was gained from the interviews, with 36 participants, we feel 
that we have an adequate sample to elaborate on the common themes and give a meaningful 
explanation of the impact of POP and/or UI on sexual function. However, we were unable to 
give a more detailed explanation of the specific sexual problems occurring in certain groups 
of women, such as women who have had previous pelvic floor surgery. We therefore recommend 
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future qualitative research to be undertaken in women with POP and/or UI who have decided 
not to undergo corrective surgery as well as in women who have had previous pelvic floor 
surgery.
 A second limitation is the lack of a control group. However, our aim was to gain under-
standing of the impact of POP and/or UI on sexual function and not to compare the preva-
lence of sexual problems between women with and without POP and/or UI. Sexual function 
of our participants was not just affected by POP and/or UI. Other factors including male 
sexual dysfunction, relationship problems, stress, and menopause were also mentioned as 
affecting the sex life of our participants. Despite the profound effect of POP and/or UI, the 
confounding effect of these factors should not be overlooked when assessing female sexual 
function.
 Unfortunately, both sexual (dys)function and POP or UI are taboo issues women do 
not easily talk about. The interviews were conducted face to face and by a female doctor, 
which was thought to make it easier for the participants to express their concerns. Impor-
tantly, women reported being embarrassed about their POP and/or UI, mainly as a result of 
the misconception that POP and/or UI occur only in the “elderly.” Women who did find that 
POP and/or UI were more common among their peers felt less embarrassed after knowing 
this. We therefore feel that it is important that healthcare professionals explain to women that 
POP and/or UI are common conditions, as this could reduce women’s embarrassment and 
improve confidence.
Conclusions
Sexual dysfunction in women suffering from POP and/or UI is strongly related to women’s 
body image. Most commonly, the willingness to engage in sexual activity is affected, but ad-
verse effects are also seen on arousal, orgasm, and dyspareunia. Given the amount of women 
expressing concerns, health-care providers should be open in the discussion on sexual health. 
By bringing up the subject of sexual health, doctors acknowledge the importance of this part 
of well-being, which would validate women’s sexual concerns and could modify their help-
seeking behavior in the future.
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Introduction
Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) form a major health bur-
den to women. In the USA 11.8% of women undergo at least one surgery for these conditions 
by the age of 80 years1. Women with POP and SUI are at a higher risk of sexual dysfunction2,3. 
However, studies following POP and anti-incontinence surgery show conflicting results re-
garding the impact on sexual function, ranging from overall improvement4-6, via no change7,8 
to even deterioration9. These variable results may be a reflection of differences in population 
characteristics, differences in treatment or differences in the measurement of outcome. 
 In urogynaecology female sexual function has been evaluated using various ques-
tionnaires. Questionnaires measure “subjective” information in an “objective” fashion and as 
such they provide a reproducible method for evaluating female sexual function. Early studies 
mostly used nonvalidated sexual function questionnaires. Recently, validated sexual func-
tion questionnaires have been developed, subdivided into general or condition-specific types. 
Condition-specific sexual function questionnaires are designed to assess changes in sexual 
health specifically caused by POP and SUI. Currently, the Pelvic Organ Prolapse/Urinary In-
continence Sexual Function Questionnaire (PISQ)10 (including its short-form PISQ-1211) is 
the only validated condition-specific female sexual function questionnaire available. Other 
validated condition-specific questionnaires that have been used to assess sexual function fol-
lowing pelvic floor surgery, including The King’s Health Questionnaire12 and International 
Consultation on Incontinence Questionnaire – Vaginal Symptoms (ICIQ-VS)13, are quality 
of life questionnaires or symptom severity questionnaires. Although these questionnaires in-
clude a few questions addressing sexual function, they really deal with the overall impact of 
POP or SUI on the patient’s quality of life or measure the presence and severity of symptoms.
 The PISQ10 is optimised to discriminate between women with and without sexual dys-
function, within the group of women with POP and SUI. However, such a questionnaire may 
not be optimal to detect sexual dysfunction following treatment. This is particularly the case if 
only selective aspects of sexual function improve, or new aspects due to the treatment become 
relevant. Our study’s objective was to establish whether PISQ10 provides full insight in, and 
covers all relevant aspects of, sexual function following pelvic floor surgery. For this, a mixed 
quantitative and qualitative study was performed. In comparison to a quantitative study, a 
qualitative study is able to provide the woman’s view as well as the context of problems, which 
are necessary to understand the surgery-specific impact on sexual function. 
Methods
Women were recruited from two urogynaecology outpatient clinics, led by two consultant 
urogynaecologists (RT/AHS), in a large university hospital (Croydon University Hospital, 
Abstract
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Croydon, UK). Study inclusion criteria included the following: (1) having consented to un-
dergo corrective surgery for POP or SUI; (2) being over 18 years of age; (3) having good com-
prehension of verbal and written English; (4) having a partner and (5) being sexually active. 
Exclusion criteria included: malignancy or terminal illness. 
 Women were selected by the consultant urogynaecologist running the clinic, who 
tried to select those women who were considered to be “good” informants, i.e. articulate, 
reflective and likely to share as much information with the interviewer as possible14. The idea 
behind qualitative research is to purposefully select participants that will best help the re-
searcher understand the problem and the research question. This does not necessarily suggest 
random sampling of participants as is typically found in quantitative research15. The selection 
of participants was unrelated to whether the woman expressed any concerns regarding her 
sexual function before surgery. 
 The indication for having surgery would be the presence of subjective complaints, 
including feeling of bulge, obstructive defecation or urinary incontinence, explained by an 
objective indication of disease, such as descent of one or more vaginal compartments (POP) 
or SUI. Surgery would be indicated when conservative treatment, including pelvic floor exer-
cises and vaginal pessary, was unsuccessful or not wanted (in case of vaginal pessary).
 Recruitment occurred over a period of 17 months, from April 2008 to August 2009, 
until the cohort of women had reached maximum variation with regards to types of surgery 
and combinations of procedures performed. Over this time period, 220 women were operated 
on and 37 women were included (17%). 
Outcome measures
All participating women were seen before and 3 months after surgery. For quantitative assess-
ment women were asked to complete the PISQ10. The PISQ is a condition-specific question-
naire validated to evaluate sexual function in sexually active women with POP or SUI. The 
questionnaire consists of 31 questions that are divided into 3 domains including: ‘Behavioural/
Emotive’ (15 questions), ‘Physical’ (ten questions), and ‘Partner-related’ (six questions). The 
Behavioural/Emotive domain covers sexual desire, frequency of sexual activity, arousal and 
orgasmic capabilities, whereas the Physical domain assesses more directly the effect of POP 
and SUI on sexual function. The Partner-related domain assesses the woman’s perception of 
her partner’s response to the effect of POP and SUI on their sexual functioning, as well as her 
partner’s own sexual functioning. Questions are scored on a Likert-type scale from 0 (always) 
to 4 (never). Summary scores, for the entire questionnaire as well as for the different domains, 
are obtained by unweighted summation of the score for each question. The PISQ total score 
ranges from 0 to 125 with higher scores reflecting better sexual functioning.  
 Qualitative assessment consisted of a semi-structured face-to-face interview. All face-
to-face interviews were conducted by the first author (AMR), who had been trained in quali-
tative research methods and interviewing techniques. The interviewer was a female medical 
doctor working as a research fellow and was introduced as such. The interviewer was not in-
volved in the treatment of the women and was not present during their clinic visits. Although 
not a native speaker, she was fluent in the English language. Participants were interviewed 
within the hospital premises in the privacy of a consulting room without the presence of their 
partner. At the start of the interview, the interviewer explained the purpose of the study and 
assured the confidentiality of the collected data to the participant. An interview guide was 
developed before the start of the study with the help of a clinical psychologist with an exper-
tise on the evaluation of sexual function. The interview guide included open-ended questions 
addressing different topic areas from which both the interviewer or the interviewee could 
diverge to pursue an idea in more detail. The template of questions used after surgery is shown 
in Table 1. The wordings used were not standardised to reflect the women’s own vocabulary 
while framing the questions. The interview process was audio-taped and each interview was 
transcribed verbatim. 
Table 1 Template for semi-structured interview
Aim of question Example of question
To introduce the topic and to ascertain the  “As you know we are interested in knowing
baseline health after surgery. how conditions like leaking of urine and or sagging
 of womb, bladder and bowel affects sexual life 
 and also how surgical treatment for these 
 conditions affects sexual life. Could you therefore 
 please tell me as to how you are presently?”
To find out participant’s sexual function after  “Could you please tell me if you have resumed
surgery and reasons, if any, for inactivity. sexual activity at present and how your present sexual 
 experience is?” 
 “In case you haven’t resumed sexual activity could 
 you tell me why you are not comfortable with sexual 
 activity as of now?”
To explore the domains of sexual function after  “You mentioned this..........................please tell me
surgery further as well as the severity of any problems. a bit more about what you mean by this?”
To explore body image and the impact, if any,  “How do you feel presently physically and sexually?
of the pelvic floor. Is it any different than before?”
To explore the impact of surgery on sexual  “Could you please describe how it feels the same
function further. or how it feels different than before?”
To ascertain the level of intimacy, comfort and  “Could you please describe how it is, to have sex
satisfaction in sexual relations. with your partner at present?”
To explore the impact of surgery on sexual relations,  “Could you please tell me if you feel your sexual
as well as any change in partner’s sexual needs  relations with your partner are the same or not quite
and function. the same as before and why you think they feel the 
 same or not the same as before?”
To find anything else relevant to the study once  “Is there anything else that you think might be helpful
the participant is at ease. for me to know at this stage?”
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Data analysis
Quantitative data analysis was done using the statistical SPSS program (SPSS version 16, SPSS 
Inc, Chicago, IL, USA). First, descriptive analyses of baseline characteristics were compared 
between women who did and did not return for follow-up using chi-square or Fisher’s exact 
test for proportions and Student’s t-test or Mann-Whitney U test for continuous variables. 
Total PISQ and domain scores were calculated and preoperative and postoperative values 
were compared using Wilcoxon signed rank test. The change in total PISQ and domain scores 
(delta score) was calculated for each participant by subtracting the preoperative score from 
the postoperative score. This delta score was normally distributed and a one sample t test was 
used to analyse whether the delta scores were significantly different from 0. A P-value of < 
0.05 was considered significant.
 For analysis of the qualitative data we made use of data matrices16. First, a list of 12 
broad categories was developed to cluster the data. Categories were either introduced into the 
interviews by the questions in the interview guide or as issues raised by the participants them-
selves. The 12 categories were: ‘resuming sexual activity’, ‘evaluation of sex life after surgery’, 
‘desire’, subdivided into ‘drive’ (spontaneous sexual interest) and ‘motivation’ (willingness to 
engage in sexual activity), ‘arousal’, ‘orgasm’, ‘dyspareunia’, ‘symptoms’, ‘body image’, ‘overall 
feelings regarding surgery’, ‘partner domain’, ‘relationship’ and ‘others’. All interviews were 
subsequently coded and the data from the interviews were coupled to the corresponding cate-
gories. In the next step, subcategories were created within each category and each ‘verbal unit’ 
of the interview was assigned to a subcategory. Structured as spreadsheet data, the columns 
were respondents, the rows the detailed subcategories, which were only filled if such response 
had been given.  All interviews were coded by the first author (AMR). A second researcher 
(AP) went through 25% of the transcripts independently to check for agreement in coding 
categories. Any discrepancies in coding were discussed between the two researchers and con-
sensus on coding was always reached. There were two main reasons for discrepancy between 
the researchers. The first cause for discrepancy was a result of overlap between the ‘symptoms’ 
and ‘resuming sexual activity’ categories. Physical complaints were often a cause for delay in 
resuming sexual activity in which case it was coded both as ‘symptoms’ and ‘resuming sexual 
activity’. The second cause was the unclear definition of the ‘dyspareunia’ category.  After dis-
cussion it was agreed that duration, evaluation and cure of dyspareunia would be coded in the 
‘dyspareunia’ category.
Results
Thirty-seven women were included and 30 (81%) came for follow up after surgery. The in-
terquartile ranges of follow up were: 12-13, 14-15, 16-19 and 20-54 weeks after surgery. One 
woman had cancelled her surgery because of personal circumstances and the other six were 
lost to follow up. The participants demographic data as well as that of the seven women not 
attending follow up are included in Table 2.
 The types of POP surgery performed included: vaginal hysterectomy, anterior repair, 
posterior repair, sacrocolpopexy, stapled transanal resection of the rectum and vaginal exci-
sion of cervical stump either as sole or combined procedures. The types of anti-incontinence 
surgery performed included: tension-free vaginal tape and transobturator tape.  Additionally 
one woman had a salpingo-oophorectomy, one a laparoscopic aspiration of ovarian cyst and 
one underwent adhesiolysis. 
Table 2 Demographics of women who did and did not return for follow up
 Included women Women not attending follow up P-value
 (n= 30) (n= 7)
Age a 49 (36 – 64) 47 (32 – 63) 0.830
Body mass index a 28 (20 – 36) 29 (24 – 36) 0.260
Ethnicity
Caucasian 28 (93%) 7 (100%) 1.000
Other 2 (7%) 0 
Parity a 2 (0 – 5) 2 (1 – 3) 0.671
Vaginal parity a 2 (0 – 5) 2 (1 – 3) 0.791
Menopausal   
Postmenopausal 14 (47%) 4 (57%) 0.651
Premenopausal 13 (43%) 3 (43%) 
Unsure, post-hysterectomy 3 (10%) 0 
Hormone replacement therapy 6 (20%) 0 0.569
Hypertension 9 (30%) 2 (29%) 1.000
Diabetes 0 1 (14%) 0.184
Previous hysterectomy 11 (37%) 0 0.084 
Previous incontinence surgery 6 (20%) 0 0.569 
Previous prolapse repair 7 (23%) 0 0.309 
Surgery performed
POP surgery 16 (53%) 2 (29%) 0.644
UI surgery 6 (20%) 1 (14%)
POP and UI surgery 8 (27%) 3 (43%)
Surgery cancelled 0 1 (14%)
a Represented as median (range).
Quantitative results
Of the 30 included women, four had not resumed sexual intercourse at follow up. For the 
26 women who were sexually active both before surgery and at follow up, total PISQ scores 
had significantly improved after surgery (Table 3). When analysed by domain, improvement 
was seen in the Physical domain, which measures the direct effect of POP and SUI on sexual 
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function, as well as in the Partner-related domain, which includes the woman’s perception of 
her partner’s response to the effect of POP and SUI on their sexual functioning. There was no 
change seen in the Behavioural/Emotive domain which evaluates sexual desire, frequency of 
sexual activity, arousal and orgasmic capabilities (Table 3). 
Table 3 PISQ results for 26 sexually active women
 Group analysis Individual analysis
 Preoperativea Postoperativea P-valueb Delta scorec P-valued
PISQ total 85 (49-105) 98.5 (56-112) 0.003 9.77 (14.66) 0.002
Domain score
Behavioural/Emotive 39 (15-46) 42.5 (16-52) 0.220 1.77 (9.24) 0.338
Physical 29 (14-40) 36.5 (23-40) <0.001 6.35 (6.42) <0.001
Partner-related 18 (12-22) 20 (14-24) 0.002 1.65 (2.24) 0.001
a Represented as median (range). 
b Using Wilcoxon signed-rank test.
c Delta score: change in score per participant, represented as mean (standard deviation).
d Using one-sample t-test, test value = 0.
Qualitative results
Of the 30 included women the median duration of the interviews before surgery was 21 minutes 
(range 8 – 72 minutes) and after surgery 24 minutes (range 10 – 43.5 minutes). One woman’s 
interview before surgery was missing because of a technical recording error. The qualitative 
results are described around the two main categories: “resuming sexual activity” and “evalu-
ation of sex life after surgery”.
Resuming sexual activity
At the time of interview four women had not resumed sexual intercourse. Three of these four women 
had not resumed sexual intercourse out of fear to undo the effect of surgery, and one woman had 
separated from her partner.  All three women who had not resumed sexual activity out of fear of 
doing damage, had had previous surgery for the same complaint for which they were currently 
operated on, i.e. POP or SUI. Women were afraid the transobturator tape sling could be damaged 
‘when you've got your legs open’ (n=1), or the mesh used for sacrocolpopexy (n=2) could dislodge 
during penetrative sex. Additional factors relating to the failure to resume sexual activity in these 
three women were: partner’s physical difficulties and partner's fear of causing pain.
“I suppose it’s just this fear that because the mesh is in there and full penetration might sort of… I’m sure it 
won’t do any harm or dislodge anything but I’ve just got that fear of… that something might happen and I 
might sort of be back to square one again.” (participant 19)
 Of the 26 women who had resumed sexual activity at the time of follow up, nine (34%) 
had started sexual intercourse around 6 weeks after surgery, and 15 (58%) were sexually active 
by 10 weeks after surgery. For two women (8%) the resumption of sexual activity was delayed 
to 3 to 4 months after surgery. The reason why sexual activity had been delayed by 3-4 months 
was that women wanted to make sure everything was healed completely so as to avoid dyspa-
reunia and doing damage.
 Eleven of the 26 women who had resumed sexual activity had had sex only once or 
twice at the time of their follow up visit. Two of these eleven women had delayed resuming 
sexual activity by 3-4 months and therefore had not had sex regularly yet. The other women 
mentioned one or more reasons for this low frequency, either related or unrelated to the sur-
gery. Reasons related to the surgery included: dyspareunia, not being well after surgery, new 
symptoms such as faecal urgency, used to not having sex (because of avoiding sex when in-
continent), and partner afraid of causing pain. Reasons unrelated to the surgery included: no 
time together, tired, and partner’s physical restrictions.
Evaluation of sex life
Twenty women (67%) expressed overall improvement of their sex lives, although 15 of these 
20 women also mentioned some factors affecting their sex life negatively. Two women (7%) 
were negative about their sex lives. Four women (13%) were positive as their sex lives were 
unchanged and another four women (13%) were not able to comment on their sex lives, be-
cause they were not sexually active yet. Both the reasons for improvement, as well as the nega-
tive factors, are described in more detail below.
Positive effects on sexual function
Cure of prolapse symptoms 
A positive effect on the evaluation of women’s sexual lives was seen from the cure of prolapse 
symptoms for four main reasons. The first reason was an improvement in body image. Follow-
ing surgery, women described their vagina as “normal” again, which made them feel more 
confident and more attractive. This improved the evaluation of their sex life, because they no 
longer had to worry about the presence of POP during sexual activity. Furthermore, worries 
about their partner’s sexual experience, because he might feel or see the prolapse or because 
of lack of tightness, were resolved.
“It was just awkward before, because there was like this lump there and it was, it was, it wasn’t very nice, 
it was awkward with that like, it’s like a growth there. You know, now I haven’t got that, it’s much better, 
much, much better.” (participant 1)
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“It’s just a relief really that it’s not there. I can’t say that it, it’s just that is all really; it’s just, it’s gone. And 
uhm…. It was funny because it felt as if it was, you know, an intrusion and because it has gone everything 
is a lot more relaxed.” (participant 8)
 The second reason was an improvement in genital sensations following POP surgery: 
women felt more sensitive and tighter. 
“Oh yeah, because obviously you can’t feel a lot you know, when everything’s collapsed inside. You can’t, can 
you, really, because you know, there’s loss of sensation, simply because everything’s you know, well, floppy 
really, you know. I mean, you know, it obviously does make a difference.” (participant 17)
 The last two reasons were related either to relief of discomfort from POP during sexual 
activity or relief of fear of doing damage to POP during sexual activity.
“It’s a lot better, because obviously I had that, whatever it was, hanging down. That was quite painful, that 
was quite uncomfortable. Of course now I haven’t got that and it’s a lot better.” (participant 1)
“And, I just felt that if there was going to be any penetration then it would… And I didn’t know looking back, 
I didn’t know whether penetration could damage it, you know, or whether there would be, make a hole in 
it or, you know, and what that side effect would be. And I was really worried that it could do damage and 
then that would cause more damage, and that was in my mind all the time.” (participant 8)
 As a result of these four reasons women were less worried about having sex, were more 
relaxed to let things happen, and were not avoiding sexual activity anymore. A less profound 
effect was mentioned on arousal and orgasm. Only few women described improvement in 
their ability to arouse as they did not have to worry about the presence of POP during sexual 
activity or the possibility of doing damage. For some women orgasm had improved, because 
of the improvement in genital sensations.
Cure of incontinence
A second positive effect on the evaluation of sex life was as a result of the cure of incontinence, 
either urinary or anal incontinence. With the cure of coital incontinence women were more con-
fident and more relaxed during sexual activity, because they no longer feared incontinence during 
intercourse. Furthermore, without the need to empty their bladder or wash before sexual activity 
(because they had been afraid of smelling of urine or faeces), sex was more spontaneous.  
“So maybe let myself go a bit more, and you know not, because you’re not worrying about [incontinence] 
in the back of your mind, you’re just enjoying it, rather than, you know maybe holding back a bit because 
of that.” (participant 38)
“I knew I passed urine and I hated that. It made me feel very dirty and very uncomfortable and tense, you 
know, uhm and so to be able to not do that is great.” (participant 9)
 As women did not have to worry about the possibility of coital incontinence their 
drive, motivation, arousal and orgasm improved. Women were more relaxed and more con-
fident regarding being sexually active and initiating sex and they were more confident during 
sexual activity. Furthermore, arousal improved as there was no need to void during sexual 
activity. A further improvement in orgasm occurred, because women did not have to prevent 
climaxing, which they would have done to prevent coital incontinence. 
“Well it makes me feel more confident about orgasm, if that makes sense. That when you kind of, you know, 
whereas before I was almost like not wanting to orgasm, because, you know, I know that if,  when that happens 
I’m going to pass urine and then that, then that spoils the moment, because you then feel immediately dirty, 
you know.” (participant 9)
Other positive effects of surgery
Two women described positive effects specifically following hysterectomy: they were no longer 
afraid of becoming pregnant during sexual activity, there was no need for contraception and no 
menstrual periods interrupting sexual activity anymore. Furthermore, having a new partner im-
proved one woman’s sexual activity, especially since he complimented her on her vaginal tightness.
Negative effects on sexual function
Dyspareunia
The most common factor negatively influencing the evaluation of sex life after surgery was 
the presence of dyspareunia. A total of 13 women complained of dyspareunia after surgery. 
Nine of these women also suffered with dyspareunia before surgery. However, before surgery 
dyspareunia was caused by the presence of prolapse, whereas after surgery the healing and 
scar tissue were causing the complaint. In eight of the 13 women postoperative dyspareunia 
affected their evaluation of their sex life; six women who had had POP surgery as a sole pro-
cedure and two who had had POP surgery combined with anti-incontinence surgery. For one 
woman full penetrative sex was impossible because of dyspareunia. None of the women who 
had had anti-incontinence surgery as a sole procedure had experienced dyspareunia after 
surgery.  
 Due to dyspareunia sex was not enjoyable which affected drive and motivation, resulting 
in avoidance of sex. Dyspareunia also had an impact on arousal and consequently orgasm, be-
cause women were tense because of (fear of) pain, and were more focused on the discomfort 
than on enjoying sexual stimulation.
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Worried about doing damage
For three women their sex life was affected by their worries regarding doing damage to the 
surgical repair. All three had had POP surgery only. Two of these three women felt their va-
gina was shorter which also caused dyspareunia.
“It seems that there is an ending, whereas before there didn't seem to be. You seem to hit something.  (…) 
And the feeling that it was going to break, does that make sense? It feels as if it was, it was stretching.” 
(participant 27)
 Because of worrying about doing damage with penetrative sex, drive and motivation 
could be affected and women found it more difficult to become aroused.
“ I just imagine in my head that blood is coming out and you know. You can imagine you’re having sex: “Oh 
my god blood’s coming out.”  If it comes out what am I going to do? And this and that. It’s so many things 
going through my mind that I don’t, I’m not thinking about what I’m doing. That’s the reason that I’m not 
enjoying sex at all.” (participant 32)
New symptoms
Sex life could also be affected by the presence of new physical symptoms, including faecal 
urgency, prolapse feeling, rectal bleeding and discomfort and swelling of labia. Faecal urgency 
as a new symptom following combined POP and anti-incontinence surgery was affecting the 
sex life of one woman, because this symptom required her to plan having sex, rather than it 
being spontaneous.
“It is horrible to have to plan sort of sex, but we sort of do have to now. I mean we have got to know how 
my body is working and what time is sort of really bad for me. Like if I eat, within half an hour of eating 
I’m going to the toilet.” (participant 5)
 Of the 30 included women, five mentioned prolapse feeling following surgery and for 
two it affected their sex life. Physical examination showed POP in a different compartment 
after combined POP and anti-incontinence surgery in one of these women, but no POP was 
objectified in the other woman. Although both women felt less confident during sex because 
of it, due to the concomitant cure of SUI for one woman it did not affect her drive, motivation, 
arousal or orgasm. The second woman with POP symptoms, that were not objectified, did feel 
less motivated to be sexually active because of discomfort and because she was afraid to do 
damage to the prolapse. However, there was no impact on arousal and orgasm.
“Sometimes it makes you not want to do it. If you, if you can feel that it’s prolapsed any way during the 
course of the day, and if I can feel that it’s hanging right down, yeah you do feel that you don’t want to do it 
sometimes, you just can’t be bothered, because you know that it’s already uncomfortable, so all that’s going 
do is make it worse.” (participant 10)
 For one woman drive and motivation were low because she was still suffering with 
rectal bleeding and pain associated with rectal granulation tissue following a stapled transanal 
resection of the rectum procedure. Her arousal was low, because mentally she was distracted 
focusing on the discomfort. Furthermore, she was not completely confident regarding her 
bladder/bowel function, therefore it was difficult to reach orgasm. Another woman felt her 
left labia had swollen, and because she was mentally focused on this the intensity of her or-
gasm was affected.
Unsatisfactory result of surgery
Two women specifically hoped surgery would improve vaginal tightness and genital sensa-
tions. After surgery they were unsatisfied with the result, because they had hoped for more 
tightness, and this negatively affected the evaluation of their sex life. 
“Because, you know, I was told that it would be quite tight to start with. Why don’t I feel that it is? (…) I 
suppose I was expecting things to be a bit tighter than they are.” (participant 17) 
Other factors with negative effect
Other factors with a negative effect on the evaluation of sex live postoperatively were: part-
ner’s physical restrictions, relationship problems, partner worried about causing pain, low 
sexual drive related to long recovery from surgery or depression and anti-depressant use, 
which consequently affected arousal and orgasm.
Discussion
Main findings
The objective of this study was to assess whether assessment of sexual function using the 
PISQ10 provides full insight into female sexual function following pelvic floor surgery. We 
showed that although PISQ is complete in representing the positive effects of surgery, most 
negative effects are not included. Following surgery improvement was seen in PISQ’s Physical 
and Partner-related domains, which measure the impact of POP and SUI on sexual function-
ing and the woman’s perception of her partner’s response to this. With the cure of POP and/
or SUI as a result of surgery it seems logical that questions such as “Do you avoid sexual inter-
course because of bulging in the vagina?”, “Are you incontinent of urine with sexual activity?”, 
and  “Does fear of incontinence restrict your sexual activity?” show improvement. The results 
from the qualitative interviews confirmed that the improvement in sexual function following 
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surgery was as a result of the cure of prolapse and incontinence symptoms. Furthermore, the 
qualitative results gave context and insight as to why the cure of prolapse and incontinence 
symptoms improve sexual function, including improvement in body image, improvement 
in genital sensations and the relieve of fear of being incontinent during sexual activity. After 
surgery, there was no significant change in PISQ’s Behavioural/Emotive domain, which evalu-
ates sexual desire, arousal and orgasmic capabilities. Questions such as “Do you feel sexually 
excited (turned on) when having sexual activity with your partner?”, “Do you feel your vagina 
is so “dry” that sexual intercourse cannot occur?”, and “How often are you able to achieve or-
gasm (climax)?”, did not show any change after surgery.  In the qualitative interviews women 
indicated that although there was a positive effect of the cure of prolapse and incontinence 
symptoms, there was a negative effect on desire, arousal and orgasm from postoperative dys-
pareunia, new symptoms, a disappointing result of surgery, or being worried about doing 
damage to the surgical repair. Other than dyspareunia, these negative aspects are not specifi-
cally part of the PISQ. Furthermore, the included questions on dyspareunia form only a small 
part of PISQ’s Physical and Partner-related domain scores. Therefore, a deterioration in pain 
may be neutralised by simultaneous improvement in POP- and SUI-related factors.
Strengths and limitations
Our findings should be interpreted in light of the study limitations. First, our study had a 
relatively short follow up time of a median of 17 weeks. Some women had not resumed sexual 
intercourse and others had not had sex regularly yet. The reason for us to choose this follow 
up time was that women were generally allowed to resume sexual activity 6 weeks postopera-
tively and with longer follow up time changes unrelated to surgery might impact on sexual 
function as well. An added advantage is that we now obtained an insight into the reasons why 
women were reluctant to resume sexual activity. Nevertheless, we acknowledge that our fol-
low up time might not have allowed for full physical recovery from surgery especially when 
complications occurred. With full physical recovery, issues such as confidence and trust might 
be regained as well. Future qualitative studies should therefore be conducted at a longer follow 
up time to study these issues further. 
 A second limitation is in our patient selection. We chose to use a sample with a large 
variation of surgical procedures performed in our hospital, so we would be able to comment 
on common themes associated with pelvic floor surgery. However, we cannot make any con-
clusions regarding the impact of specific surgeries on the sexual function of women. Further-
more, we did not include any women with vaginal mesh surgery as this type of surgery is not 
part of our routine practice. The impact of synthetic mesh augmentation at the time of vaginal 
prolapse repair has been debated in the current literature, as some studies showed increased 
rates of dyspareunia17,18 compared to native tissue repair. Therefore, results from our study 
might not be representative for this group of women.
 A third limitation is in selecting the “good” informants.  Experiences and feelings re-
garding sexual function might have been different in women unwilling to discuss their con-
cerns with their consultant. However, the idea behind selecting participants in qualitative 
research is to select those women who best help the researcher understand the research ques-
tion. This does not necessarily involve random sampling of participants as typically found in 
quantitative research15. In fact three good descriptions can be better than 12 poor ones. Fur-
thermore, as the women were selected before surgery, we were not able to select participants 
based on their sexual experiences after surgery, so eliminating bias. 
Interpretation
The PISQ10 was validated to discriminate women with sexual dysfunction from those with-
out, within the group of women suffering with POP and SUI. Although the PISQ has shown 
its responsiveness to change after pelvic floor surgery4,5, it might not be optimal to detect 
sexual dysfunction following surgery as new aspects due to the treatment become relevant. 
By neglecting the negative impact of pelvic floor surgery, PISQ’s  evaluation of sexual func-
tion following surgery might be too positive. Future studies should therefore be conducted to 
either confirm or reject this questionnaire as a validated tool for diagnosing sexual dysfunc-
tion after pelvic floor surgery. This is important, because when counselling women for pelvic 
floor surgery, information regarding the impact of surgery on sexual function is mandatory. 
Without a validated tool, research carried out to study the impact of surgery on sexual func-
tion is not reliable.
 Before resuming sexual activity after surgery women commonly need reassurance 
about healing from their doctor as well as reassurance that sexual activity is “allowed”. As 
a result of this, sexual problems will not occur until after the postoperative review by the 
consultant. As women are commonly reluctant to seek help for their sexual concerns19-21, it is 
possible that sexual problems as a result of surgery will go unnoticed. It is therefore impor-
tant to specifically address the possibility of dyspareunia and other sexual problems following 
surgery at the early postoperative review and give women the opportunity to return to clinic 
when sexual problems occur.  Furthermore, our qualitative results showed that sexual inac-
tivity can last up to 3 months postoperatively as a result of the fear of doing damage to the 
surgical repair. Early postoperative counselling should also in part be directed at reassuring 
women that tapes and meshes are unlikely to dislodge during penetrative sex. 
 We are not aware of another study that has used a mixed qualitative and quantitative 
approach to study sexual function following pelvic floor surgery. By comparing qualitative 
interviews to the results of the PISQ10 we were able to show both confirmation and disconfir-
mation between the two. Compared to quantitative research, the qualitative interviews gave a 
deeper explanation of changes in sexual function and it helped us to understand the context 
and associations. 
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ReferencesConclusions
Our study has shown that the current condition-specific sexual function questionnaire for 
assessment of sexual function in women with POP and SUI (PISQ10) does not measure most 
surgery-specific deteriorating effects on sexual function. This questionnaire might therefore 
not be able to discriminate between women with and without sexual dysfunction following 
pelvic floor surgery. Future studies should therefore be conducted to either confirm or reject 
this questionnaire as a validated questionnaire for diagnosing sexual dysfunction after pelvic 
floor surgery. 
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Introduction
Prevalence studies have shown that women with pelvic floor disorders, including pelvic organ 
prolapse (POP) and urinary incontinence (UI), are more likely to report sexual dysfunction 
than women without these complaints1. Based on evidence from studies involving  men with 
erectile dysfunction we know that sexual dysfunction in one half of a couple can result in 
sexual dysfunction of the other partner as well2,3. Unfortunately, there is scanty data assessing 
sexual function in partners of women suffering with pelvic floor disorders. Two studies focus-
ing on the partner showed that female bladder problems had a negative effect on the sexual 
life of one out of five male partners4 and that female UI was associated with lower male sexual 
functioning and sexual satisfaction5. 
 Pelvic floor surgery is the mainstay of therapy for female pelvic floor disorders which 
seems to have a positive effect on the male partner’s sexual function. Improvement in male 
sexual function is seen both after POP surgery6 as well as following female anti-incontinence 
surgery7. 
 The available data are not only sparse but also limited as they do not explain ‘why?’ and 
‘how?’ female pelvic floor disorders and surgery impact on the sexual function of the partner. 
The aim of our study was to obtain a precise idea of the partner’s thoughts and experiences 
with regards to the effect of female pelvic floor disorders and surgery on his sexual life. As 
the currently available male sexual function questionnaires only measure broad diagnostic 
categories, we conducted qualitative face-to-face interviews to be able to achieve our aim8,9. 
Materials and Methods 
The qualitative analysis described in this article is part of a larger prospective study on sexual 
functioning of women undergoing surgery for pelvic floor disorders along with that of their 
partners. The results on the sexual functioning of the women prior to and after surgery are 
published elsewhere10,11. Ethical approval was granted by the Outer South East London Re-
search Ethics Committee (Lewisham Local Research Ethics Committee) (07/Q0701/2), and 
all participants signed informed consent before entering in the study.
Recruitment and sample size
Recruitment of participants was dependent on the women as only partners of participating 
women could be included. Women scheduled for pelvic floor surgery were recruited at two 
urogynecology outpatient clinics at Croydon University Hospital, UK, led by two consultant 
urogynecologists (RT/AHS). Eligible women were over 18 years of age, considered themselves 
to be sexually active and had good comprehension of verbal and written English. Women 
with malignancy or terminal illness were not invited. All but one woman were in a committed 
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relationship at the time of participation. If the partner was not present during the clinic visit, 
women willing to participate in the study were given written information to give to the part-
ner explaining the details of the proposed study. The women were contacted at a later time 
to ask whether her partner was willing to participate in the study as well. Inclusion was from 
April 2008 until August 2009. Recruitment of the women, and consequently that of the part-
ners, finished when the cohort of women had reached maximum variation with regards to 
types of surgery and combinations of procedures performed. Since no woman reported having 
a female partner, all participants were men. Ultimately eight of 37 eligible men (i.e. the parti-
cipants) were included. 
Data collection
Data were gathered by means of a semi-structured face-to-face interview prior to and at three months 
after surgery. A three month follow up was chosen, because it was expected that the couples would 
have resumed sexual intercourse by that time, as they were generally advised to refrain from sexual 
intercourse until only six weeks after surgery. If they hadn’t resumed intercourse we were able to 
identify problems that withheld couples from doing so. The participants were interviewed by the 
same researcher each time (AMR), separate from their female partners, in the privacy of a consulting 
room within the hospital premises. This researcher was not involved in the treatment of the women. 
 The interviewer used a semi-structured interview guide which was developed prior to the 
start of the study. The interview guide included open-ended questions which were aimed at esta-
blishing a general direction for the interview. The interview guides used prior to and after surgery 
are presented in Table 1 and 2 respectively. By using follow-up questions like: “Has this always been 
like this, or has it been a recent change?”, “Can you tell me how and why it feels different now?”, and 
“Do you feel that your partner’s incontinence/prolapse had an effect on this?”, the experiences of the 
participants were further elaborated. The median duration of the interviews was 8.3 minutes (range 
5.5 – 16.5) prior to surgery and 14.8 minutes (range 10 – 19.5) after surgery. The interview process 
was audiotaped and each interview was transcribed verbatim. 
Table 1 Interview guide for semi-structured interview prior to surgery
Topic area Example of question
Sexual experience “Can you tell me how it is now, having sex with your partner?”
Level of intimacy in current sexual relationship “And do you think that ….. has had  an effect on the intimacy 
 between you and your partner?” 
Views and expectations about the forthcoming “Do you feel that there is something that could enhance
surgery your present sexual experience?”
 “Do you feel like anything would change after surgery?”
Changing needs and/or ability of the female partner “Do you feel that your sexual role has changed?”
Anything else relevant to the study  “Do you think there is anything else we didn’t address that 
 might be important at this stage?”
Table 2 Interview guide for semi-structured interview after surgery
Topic area Example of question
Sexual function after surgery and reasons   “Can you tell me whether you have resumed
for inactivity  sexual intercourse?”
 “And can you tell me how that is right now?
Views on the impact of surgery on sexual function “Do you feel that the operation done for your partner 
 had any effect on your present sex life?”
Changing needs and/or ability of the female partner “Do you feel that your sexual role is the same or is 
 different than before?”
Anything else relevant to the study  “ Is there anything else that you think might be helpful 
 for me to know at this stage?”
Data analysis
To systematically analyse the gathered data we made use of data matrices12.  After immersion 
into the raw data of transcripts and field notes, a ‘start list’ of broad categories for organising 
the data into meaningful clusters for analysis was developed. During data analysis, we kept 
the possibility open to add any additional categories. The final list of categories is presented 
in Table 3. Meta-matrices were created for each category. The columns of these matrices con-
tained the subcategories, which were elaborated and complemented during the data analysis. 
The rows assembled the data from the different participants. The cells were filled according 
to a technique termed ‘bracketing’13, which couples brackets of corresponding information 
gained from interviews to the different categories. In first instance, the brackets consisted of 
so-called thick descriptions, i.e. literal passages from the interview transcripts, which were 
later summarized into thin descriptions. The different aspects of the sexual experience of our 
participants were derived from and compared on the basis of the matrices containing thin 
descriptions. All interviews were coded by the first author (AMR). To increase objectivity the 
second author (AP) went through 25% of the transcripts and independently coded the data 
from the interviews according to the list of categories produced by the first author. In author 
meetings between the first and second author the categories, the subcategories and part of the 
coding were discussed and consensus was formed on how to categorize the data. 
Results
Prior to surgery, eight men were interviewed. Their mean age was 53 (range 36 - 63) years. 
With four participants their partner was having POP surgery only, for three POP surgery was 
combined with anti-incontinence surgery and one participant’s partner suffered from fecal 
urgency and incontinence for which she underwent anal sphincter repair combined with perineal 
reconstruction. Six men attended their follow-up visit after surgery at a median follow-up of 
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18 weeks (range 13 – 24). Of the two participants lost to follow-up, one partner had had POP 
surgery and one partner combined POP and anti-incontinence surgery. 
Sexual experience prior to surgery
The majority of participants (n=5) evaluated their sexual life as either positive or unchanged 
compared to before the pelvic floor disorder occurred. The other participants (n=3) were 
negative about the quality of their sexual life.
 Although the majority gave a good evaluation of their sexual life, changes in the sexual 
life as a result of their partner’s pelvic floor disorder were described by seven of the eight par-
ticipants. Changes were divided into direct or indirect effects. Direct effects were defined as 
changes in the participant’s physical sensations or changes in his own sexual behaviour.  This 
included: awareness of the presence of the prolapse, i.e. seeing or feeling it, fear of causing 
pain or damage to the prolapse, and a decrease in the variety of sexual positions because in 
certain sexual positions the prolapse is more prominent or certain positions increase partner’s 
urge to use the bathroom in case of incontinence. These direct effects are illustrated by the 
following quotations:
“I can actually feel [the prolapse] as well, so it’s a little off putting.” (participant 8)
“I mean I’ve seen the, I’ve seen, and I think how can she walk about with that prolapse hanging out of her 
like that? For me to impose myself on her is just not in my nature.” (participant 7)
“I would say [the things I can do are] limited, because of, because of the situation it’s limited. (…) because 
in certain positions she feel likes she wants to go to the toilet. So, it’s definitely affecting me in that way, both 
of us.” (participant 5)
 Indirect effects were defined as changes in the female partner’s body confidence or 
sexual behaviour which affected the participant’s sexual experience. Body confidence issues 
included: being embarrassed about the prolapse or incontinence, not feeling tight enough to 
satisfy their partner, or feeling less of a woman as a result of the pelvic floor disorder. Changes 
in the female partner’s sexual behaviour included: being focused on the possibility of inconti-
nence, incontinence or urge to use the bathroom during sexual activity and a decrease in the 
initiation of sexual activity / wish to have sex. As the participants indicated:
“…because obviously with the prolapse she feels very awkward about it. Having sex just doesn’t, doesn’t 
enter her mind, you know.” (participant 8)
“There is always not, not being entirely focused on being intimate with each other. It’s always keeping an ear 
open for the need to go to the bathroom or… . but it doesn’t allow things to flow smoothly. It’s always inter-
ruption, interruption, interruption. So that can be a bit annoying sometimes.” (participant 5)
 Factors influencing the sexual life that were not associated with the female partner’s 
pelvic floor disorder included: lifestyle (work, children), participant’s physical problems, and 
erectile dysfunction.
 There were four different types of emotive responses of the participants to the changes 
in their sexual life as a result of the female’s pelvic floor disorder. These included:  (1) believing 
POP or incontinence is not an obstacle for sexual activity, (2) respecting partner’s wish not 
to have sex as partner’s health is more important, (3) denying a negative effect from female’s 
pelvic floor disorder and (4) frustration. As indicated per response: 
(1) “I mean, be nice if [the prolapse] wasn’t there, but it is, so it’s something that we have to just work 
around.” (participant 2)
(2) “And the most important thing is that she is healthy and ok, you know, that’s, as far as I’m concerned, 
you know. I’m not going to worry about anything else providing that she is ok (…) It’s not as though we are 
looking at having any more children or anything, you know.” (participant 4)
(3)“No she seems to think I can’t feel her when I’m inside her, but I can, you know, I can feel her.” (participant 6)
(4) “I suppose, it’s more frustrating, I’m frustrated, because obviously we are not having sex as often as 
we used to. And I believe sex is a big, it’s an important role in a relationship, it’s closeness.” (participant 8)
Table 3 List of categories for data analysis
Time of interview Data category
Prior to surgery • Evaluation of sex life prior to surgery
 • Factors influencing sex life prior to surgery
 •  Behavioural and emotional response to changes in sex life caused by 
  the female’s pelvic floor disorder
 • Views and expectations about the forthcoming surgery
 • Effect of changes in sex life caused by the female’s pelvic floor disorder
   on relationship as a whole
 • Others
After surgery • Evaluation of sex life after surgery
 • Reason for improvement in sex life, or absence of negative change, after surgery
 • Factors that affect resuming sexual activity
 • Factors that affect sex life negatively after surgery
 • Effect of surgery on the relationship as a whole
 • Change in sexual role after surgery
 • Thoughts / activities in the waiting to start penetrative sex 
 • Others
105104  chapter 6 | Female pelvic floor surgery and the male partner’s sexual experience
Sexual experience after surgery
At follow up three of the six participants had not resumed regular sexual activity.  The delay 
in resuming sexual activity was caused by the physical recovery of the partner and her will to 
commence penetrative sex, the partner’s fear of pain, their own fear of causing pain and life 
stressors like taking care of an unwell mother or a busy work schedule. Two of the three re-
spondents who had fully resumed intercourse had also experienced fear of causing pain with 
the resumption of sexual activity, however this had improved since and was not influencing 
their current sexual life. 
“I think personally, she wanted, she would have been ok. It was me who was a bit apprehensive to push in, 
you know, into all of that, but... I didn’t, I didn’t, although she said it wouldn’t hurt, it wouldn’t hurt her, but 
I, I was a bit worried, I was a bit worried.” (Participant 7)
 Overall the evaluation of the participants sexual life following surgery was positive. 
The participants who had fully resumed sexual activity had noticed an improvement in their 
sexual experience or no change in a sexual life unchanged by the pelvic floor disorder prior to 
surgery. The participants who had not resumed regular sexual activity yet were positive about 
the experience they had had, or hadn’t noticed any negative changes. 
 The cure of the female pelvic floor symptoms had a positive effect on the men’s sexual 
experience. With the relief of POP the male’s physical sensations were better. Furthermore, 
the majority of men commented on an improvement, or the absence of a negative change, in 
vaginal tightness. 
“The feel, yeah, it wasn’t very nice before; there was obviously a prolapse there. It didn’t, not only it didn’t 
feel nice, it didn’t look very nice either, cause it actually prolapsed out. But because that’s not there anymore, 
so, you know, it’s much better.” (participant 2)
 Participants also noticed positive changes in their partner’s body confidence and be-
haviour during sex as a result of the cure of the pelvic floor disorder. The female partner was 
no longer worried about incontinence, the presence of the prolapse or lack of vaginal tight-
ness during sexual activity. This had an indirect positive effect on the man’s sexual satisfaction 
and reduced his anxiety about erectile dysfunction. 
“I think she is more confident. Obviously her prolapse was quite pronouncing it’s bound to affect your con-
fidence to a certain extent. (…) It’s just satisfaction-wise I think … just having the satisfaction for myself 
isn’t, I mean obviously it’s nice, but for her to be enjoying as well is a big thing for me, you know. And she 
does seem to be enjoying it and says she’s enjoying it. Like for me I don’t think that she always did before.” 
(participant 2)
“I think before because where she used to think she was big and I couldn’t feel her now she knows I can. Well 
I could before, but she would never believe me because she always believed she was that big. (…) I don’t get 
the 3 degree, the third degree afterwards, which is good. Cause, you know, you haven’t got to worry about 
it, it’s, it’s nice.” (participant 6)
 Factors that affected the sexual life negatively following surgery included: partner’s 
post-operative dyspareunia, her reduced interest in sex and vaginal dryness.
Discussion 
This study has provided an insight into a mostly neglected area of urogynecology: the im-
pact of female pelvic floor disorders and surgery on the male partner’s sexual experience. 
Although previously explored with general sexual function questionnaires, to the best of our 
knowledge we are the first to use qualitative semi-structured face-to-face interviews. 
 We previously reported that pelvic floor disorders have a negative effect on women’s 
body image which leads to a decrease in women’s motivation to be sexually active10. During 
sexual activity women are mentally distracted, because of worries related to the presence of 
the prolapse or the fear of incontinence10. As is shown in the current analysis, in addition 
to direct changes in the man’s physical sensations and behaviour during sex, this changed 
behaviour of the female can also contribute negatively to the sexual experience of the male 
partner. Despite this most men had a positive response to these changes in their sexual life 
and evaluated their sexual life in a positive way. This is in line with a previous study on this 
subject which showed that compared to their female partner, men are less likely to consider 
their female partner’s urinary problems to negatively affect their sexual life4. 
 Previous research has shown a general improvement in men’s sexual interest, sexual 
drive and sexual satisfaction following surgery for POP6 and an increase in sexual desire follow-
ing anti-incontinence surgery7. Furthermore, following POP surgery, men considered their 
erectile and orgasmic difficulties as less of a problem6. The current analysis showed that following 
female pelvic floor surgery the cure of pelvic floor disorders and changes in vaginal tightness 
caused direct improvements in the man’s physical sensations, as well as indirect improvements 
in his sexual experience as a result of positive changes in the woman’s sexual behaviour and 
body confidence. A positive change in the woman’s sexual behaviour and body confidence 
can improve the man’s sexual satisfaction and reduce his anxiety about erectile dysfunction. 
Despite this improvement, we have previously shown11  that women’s motivation to be sexually 
active can also be negatively affected following surgery as a result of postoperative dyspareunia, 
new symptoms, a disappointing outcome of surgery and fear of doing damage to the surgical re-
sult11. In the current analysis the men described that the physical recovery of the women, her fear 
of pain and also the men’s fear of causing pain caused a delay in resuming regular sexual activity. 
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References There are some limitations to consider. Unfortunately, we were only able to recruit 
eight of the 37 potential partners and only six returned for follow-up (16%). The reason for 
the difficulties in recruitment of the partners could be embarrassment of the men to talk 
about sexual issues. Furthermore, reliance on the assistance of the women to recruit their 
partners might have influenced the number of men that decided to participate as well, as 
previous studies have shown that women can be embarrassed to communicate openly with 
their partner regarding their pelvic floor disorders4,14. This may have caused selection bias as 
well, as couples that are willing to openly discuss sexual matters may have different views on 
sexual function as compared to non-communicative couples. The embarrassment that sur-
rounds talking about sex could also be the reason for the relatively short duration of the inter-
views. Most men had never talked about their sex life with a healthcare professional and some 
showed relief when the interview was finished. However, the shortest interviews were held 
with the men who found their sex live was unchanged by their partner’s pelvic floor disorder, 
so this impacted on the interview duration as well.
 All interviews were done by the same interviewer which means all participants were 
interviewed in the same manner. Nevertheless, talking about sexual experiences with a female 
interviewer could have contributed to the embarrassment. Some men might have also been 
reluctant to “complain” about their sex life, because their partner was having a problem that 
necessitates surgery. Men may have had a different attitude to the effects of the pelvic floor 
disorder if their partner had  not been seeking treatment for it. 
 As a result of the small number of men we were able to recruit we cannot guarantee 
saturation of results and therefore the results should be interpreted with caution. However, 
while not encompassing all possible sexual health difficulties experienced by the men, we be-
lieve the findings can provide guidance to clinicians on possible aspects to explore with their 
patients and can provide a basis for further qualitative studies and for formulating condition-
specific tools for quantitative studies on this subject.
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General discussion and conclusion 
The focus of this thesis is on sexual dysfunction in urogynaecology, which was studied in a 
large university hospital in the greater London region, United Kingdom. A number of pre-
vious studies have demonstrated an association between pelvic floor disorders, including 
pelvic organ prolapse (POP) and stress urinary incontinence (SUI), and female sexual dys-
function1-6. This indicates that women who seek urogynaecological care will be of increased 
risk of experiencing sexual dysfunction and the physician who treats these women should 
be aware of this problem. In this chapter a general discussion with regards to the research 
questions is presented, taking into consideration methodological strengths and limitations. 
Finally, conclusions are presented and recommendations with regards to future research and 
clinical practice are proposed.
General discussion
Question 1: “What is the prevalence of sexual problems in women attending urogynaecology 
clinics when using a short screening tool?”  
In chapter 2 we established the prevalence of sexual problems in the general gynaecology and 
urogynaecology clinics of a large university hospital by using a simple screening tool7. We 
demonstrated that sexual complaints are highly prevalent, as we were able to identify sexual 
complaints in 38% of new patients presenting with a urogynaecological complaint and in 35% 
of women presenting with a gynaecological complaint. Multivariate analysis showed that, 
after adjustment for confounding factors, having a urogynaecological complaint compared to 
having a gynaecological complaint independently increased the risk of suffering with a sexual 
problem. 
 Furthermore, we found that one out of five women with a sexual complaint volun-
teered this as part of their main complaint, while the remaining only mentioned it after com-
pleting the three screening questions regarding sexual function. This indicates that if physi-
cians ask specifically about sexual problems, patients are more likely to admit having a sexual 
problem than when the patient has to bring up the subject herself. 
 In order to diagnose sexual dysfunction, one should not just assess the presence of a 
sexual problem, but also the “personal distress” caused by the problem. This is in accordance 
with the definition of female sexual dysfunction by the International Consensus Development 
Conference on female sexual dysfunction8. According to their definition a sexual problem can 
only be considered as dysfunction when it causes personal distress. By introducing a fourth 
question (“Are any of your sexual problems bothersome?”) we showed that only 45% of the 
women with sexual complaints actually found them to be bothersome. This confirms that 
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when considering subjectively experienced distress as a necessary criterion for the diagnosis 
of female sexual dysfunction prevalence estimates decrease significantly9,10. 
Question 2: “Is assessment of female sexual dysfunction part of routine practice for British 
urogynaecologists?” 
As patients are more likely to admit to have sexual problems when asked directly, a proactive 
attitude from the physician is warranted to identify these problems. In chapter 3 the results 
from a survey on the practice of members of the British Society of Urogynaecology (BSUG) 
with respect to patient assessment of sexual dysfunction were presented. Although 97% of re-
spondents thought screening for sexual dysfunction was important (ranging from somewhat 
to extremely important), only half of them regularly did with lack of time being the most im-
portant barrier. Furthermore, many respondents mentioned “being unsure about therapeutic 
options” or “don’t know what or how to ask” as barriers for screening. This reflects a deficiency 
in knowledge and training, which was confirmed by 76% of respondents who found their 
training with respect to female sexual dysfunction was unsatisfactory. 
 There is a similarity in trends between the UK and other countries. In a survey 
amongst members of the American Urogynecologic Society11 50% of respondents who com-
pleted some post-residency training in urogynaecology stated that the training with respect 
to female sexual dysfunction was unsatisfactory. Another survey amongst urologists and 
urology residents in The Netherlands12 showed that Dutch urologists tend to underestimate 
the prevalence of female sexual dysfunction in their practice and lack of knowledge on thera-
peutic options is the main reason for 13.6% of them to avoid asking patients about sexual 
dysfunction. This highlights the global need for more attention to female sexual dysfunction 
both in the undergraduate and postgraduate curriculum. More education and training will 
increase urogynaecologists’ and urologists’ competence to enquire about these problems and 
to adequately treat them. 
 It is ultimately challenging for physicians to deal with sexual problems as the nature of 
this matter is quite sensitive. Finding the correct way to ask questions is essential. Therefore, 
clinicians should be made familiar with quick screening tools for female sexual dysfunction 
so they will be able to identify sexual problems without adding lots of time to the clinic visit. 
Question 3: “How do POP and SUI impact on the different sexual dysfunction categories?”
It is important for physicians who treat patients with POP and SUI to understand the impact 
of these conditions on sexual function. Previous studies have found conflicting results on how 
POP and SUI affect the different female sexual dysfunction categories including sexual desire, 
arousal, orgasm and sexual pain3,13. The results presented in chapter 4 showed that sexual 
dysfunction in women suffering from POP and SUI is strongly related to women’s body im-
age. Previously, a correlation between decreased (genital) body image and decreased sexual 
function was shown in women with POP14,15. In addition to this, our results show that women 
themselves perceive body image issues as the most important factor altering their sexual life. 
 The sexual dysfunction category desire is most commonly affected as a result of POP 
and SUI. An important finding of our study is the distinction women make between two 
components of desire: ‘drive’ and ‘motivation’. ‘Drive’ is described as the biological component 
of desire evidenced by spontaneous sexual interest, while ‘motivation’ is characterized by the 
willingness of a person to engage in sexual activity16. Although ‘drive’ was not commonly af-
fected by POP and SUI, a decrease in ‘motivation’ was the sexual dysfunction most frequently 
mentioned. The distinction between ‘drive’ and ‘motivation’ was specifically present in the 
responses of our participants, however this distinction is not commonly addressed in general 
sexual function questionnaires. When just asking a general question on desire, the specific 
impact of POP and SUI on either ‘drive’ or ‘motivation’ will be missed.  
Question 4:
a. How does pelvic floor surgery impact on the sexual functioning of the female patient? 
b. Does the current condition-specific sexual function questionnaire (PISQ17) cover all
relevant aspects of  sexual function following pelvic floor surgery? 
As POP and SUI have an adverse effect on female sexual function, we would expect that 
surgery to cure these conditions automatically leads to an improvement in sexual function. 
However, current evidence on sexual function following pelvic floor surgery is conflicting. In 
chapter 5 it is shown that improvement in sexual function following pelvic floor surgery was 
seen as a result of the cure of POP and SUI symptoms. However, a negative effect on sexual 
desire, arousal and orgasm was seen from postoperative dyspareunia, new symptoms, a dis-
appointing result of surgery or being worried about doing damage to the surgical repair. By 
comparing the results from the qualitative interviews to the prospective quantitative results 
from the PISQ17 we found that in the assessment of sexual function following pelvic floor 
surgery the PISQ is complete in representing the positive effects of surgery, but most negative 
effects are not included. Other than dyspareunia, the surgery-specific negative aspects are not 
part of the PISQ. The PISQ17 was originally validated to discriminate the women with sexual 
dysfunction from those without, within the group of women suffering with pelvic floor disor-
ders. Although the PISQ has shown its responsiveness to change after pelvic floor surgery18,19, 
it is not an optimal tool to identify women with sexual dysfunction following surgery, because 
new aspects of sexual dysfunction become relevant after treatment. As a result of not measur-
ing the negative impact of pelvic floor surgery, PISQ’s evaluation of  sexual function following 
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surgery might be too positive. Future studies should therefore be conducted to either reject 
or validate this questionnaire for the evaluation of sexual function after pelvic floor surgery. 
 Recently, the International Urogynecological Association (IUGA) created a revised 
version of the original PISQ: PISQ IUGA-Revised (PISQ-IR)20. This questionnaire addresses 
some limitations of the original PISQ, including evaluating  the impact of pelvic floor dys-
function on a woman’s decision not be sexually active and also creating a condition-specific 
measure of sexual function for women with anal incontinence. However, the PISQ-IR20 also 
fails to address the possible negative effects of surgery.  Therefore, it is also not an optimal tool 
for the evaluation of sexual function following pelvic floor surgery.
Question 5: What are the partner’s individual thoughts and experiences with regards to the 
effect of POP and SUI, as well as pelvic floor surgery, on his/her sexual life?
Chapter 6 of this thesis described the results of our qualitative study on the impact of POP 
and SUI, as well as their surgical treatment, on the partner’s sexual experience. Previous stud-
ies on this subject used male sexual function questionnaires which didn’t give information re-
garding the partner’s individual thoughts and experiences with regards to this. Our qualitative 
study, conducted solely in male partners, showed that prior to surgery, the vast majority of 
partners experienced changes in their sexual life as a result of female POP or SUI. There were 
direct changes in the male’s physical sensations and behaviour during sex, and also indirect 
changes as a result of the female partner’s altered sexual behaviour and reduced body confi-
dence. Most men in our study population however had a positive response to these changes 
and evaluated their sex life in a positive way despite the occurrence of these changes. Follow-
ing female pelvic floor surgery resuming penetrative sex was mostly dependent on the physi-
cal recovery of the women, but the men’s fear of causing pain could also be the cause of delay. 
Our study showed that the relief of POP and SUI symptoms and changes in vaginal tightness 
following surgery caused direct improvements in the male partner’s sexual sensations, as well 
as indirect improvements as a result of positive changes in the woman’s sexual behaviour and 
body confidence. 
 As a result of the small number of men we were able to recruit we cannot guarantee 
saturation of results and therefore the results should be interpreted with caution. However, 
while not encompassing all possible sexual health difficulties experienced by the men, we be-
lieve the findings can provide guidance to clinicians on possible aspects to explore with their 
patients and can provide a basis for further qualitative studies and for formulating condition-
specific tools for quantitative studies on this subject.
Methodological considerations of qualitative results
Selection of study population and generalizability of results
There are some choices in the selection of study participants that could have an impact on the 
generalizability of our results presented in chapter 4 and 5. However, one should keep in mind 
that generalization is a term that is used in a limited way in qualitative research, since the in-
tent of this form of research is not to generalise findings to individuals, sites, or places outside 
of those under study21. In fact, the value of qualitative research lies in the particular descrip-
tion and themes developed in context of a specific site. All patients recruited for the studies 
described in this thesis were recruited at Croydon University Hospital in Croydon, United 
Kingdom. Croydon University Hospital is a large university hospital within the municipality 
of Croydon; a large town in the Southern Greater London region. Cultural differences in ideas 
about sexuality might have an impact on the generalizability of our results to women from 
rural areas as well as to women from outside of the United Kingdom. 
 Secondly, we selected women planning to have pelvic floor surgery. Women scheduled 
to undergo pelvic floor surgery are more likely to have an affected sexual life than women who 
do not opt for surgery. In addition to this, women who suffer from sexual dysfunction might 
have been more keen to enter into the study as it would give them the opportunity to discuss 
their concerns. Therefore, the severity of the sexual problems presented in the participating 
women might not be representable to all women suffering with POP or SUI. 
 We chose to use a sample with a large variation of surgical procedures performed in 
Croydon University Hospital. This way we were able to comment on common themes of sex-
ual function associated with pelvic floor surgery. However, we cannot draw any conclusions 
regarding the impact of specific surgeries on the sexual function of women. Furthermore, we 
did not include any women with vaginal mesh surgery as this type of surgery is not part of 
the clinic’s routine practice. The impact on sexual function of synthetic mesh augmentation at 
the time of vaginal prolapse repair has been debated in the current literature, as some studies 
showed increased rates of dyspareunia compared to native tissue repair22,23. Therefore, results 
from our study might not be representable for this group of women.
 Despite these limitations in the selection of the participants, we believe that the sample 
composition was sufficiently heterogeneous to represent a larger group of women undergoing 
pelvic floor surgery.  
Follow-up
The studies presented in chapter 5 and 6 had a relatively short median follow-up time of 
respectively 17 and 18 weeks after surgery. As a result of this, some couples had not resumed 
sexual intercourse and others only had had sex once or twice at the time of their follow-up 
visit. The reason for us to choose this follow-up time was that it was expected that the couples 
would have resumed sexual intercourse by that time, as women were generally advised to 
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refrain from sexual intercourse until only six weeks after surgery.  With a longer follow-up a 
higher percentage of participants might get lost to follow-up. Furthermore, time changes un-
related to surgery might impact on sexual function as well. These time changes could include 
for example further ageing effects of the pelvic floor, changing hormone levels, development 
of a chronic illness, and so on. An added advantage is that with our follow-up time we got an 
insight into the reasons why women or their partners were reluctant to resume sexual activity. 
Nevertheless, we do acknowledge that our follow-up time might not have allowed for full 
physical recovery from surgery especially when complications occurred. With full physical 
recovery, issues such as confidence and trust might be regained as well. Future qualitative 
studies should therefore be conducted at a longer follow-up time to study these issues further. 
Qualitative analysis
The qualitative data presented in this thesis were systematically analysed using data matrices 
as described by Huberman and Miles24. Validity and reliability in qualitative research do not 
carry the same connotations as in quantitative research21. Qualitative validity means that the 
researcher employs certain procedures to check for the accuracy of the findings. In this thesis 
this has been done by using patient quotes to convey the findings throughout the various 
chapters. Qualitative reliability indicates that the research approach is consistent across dif-
ferent researchers. This has been established by cross-checking 25% of coding by a second 
researcher and to check for agreement between the two. 
 All interviews were done by the same interviewer which means all participants were 
interviewed in the same manner and the interviewer only had to build rapport during the first 
interview. Seeing a familiar face after surgery could improve the atmosphere of feeling at ease 
and could increase and deepen the information that was shared. Nevertheless, the researcher’s 
personal characteristics could have also biased the responses of the participants21. Talking 
about sexual experiences one on one with a female interviewer was thought to make it easier 
for the women to express their concerns. However, for the men this could have contributed 
to the embarrassment already associated with talking about sexual function. It is possible 
that the men in this study might have spoken differently and more openly with a male inter-
viewer. Furthermore, bias could have also occurred due to the fact that participants might 
have wanted to please the interviewer by giving her information and examples of situations 
they wouldn’t normally see as problems. 
Conclusions and recommendations 
Clinical practice
The results presented in this thesis show that sexual concerns are highly prevalent amongst 
women suffering with POP and SUI. However, the majority of women do not bring up these 
sexual concerns themselves. Therefore physicians should be open in the discussion on sexual 
health and actively try to discover sexual concerns by direct questioning. By bringing up the 
subject of sexual health, doctors acknowledge the importance of this part of well-being, which 
would validate women’s sexual concerns and could modify their help-seeking behaviour in 
the future. Unfortunately, many physicians who treat women with pelvic floor disorders feel 
they do not have sufficient knowledge to approach the subject of sexual health. This highlights 
that there is a need for more emphasis on female sexual function and dysfunction in the train-
ing of (uro)gynaecologists. Furthermore, it is recommended that clinicians are made familiar 
with short screening tools to identify sexual problems, as quick screening tools are more likely 
to be incorporated in clinical practice than lengthy questionnaires. However, when screening 
for sexual dysfunction bother associated with the sexual problems should always be estab-
lished in order not to over-diagnose sexual dysfunction. 
 After diagnosing sexual dysfunction the clinician can determine whether (a) the con-
cern can be addressed during the current appointment, (b) a follow-up visit is needed to allow 
more time to address the concern adequately, or (c) the sexual problem is beyond the physi-
cian’s scope of training and it’s better to refer the patient to another colleague or specialist, 
for example  a psychosexual counsellor. This way, physicians have the possibility of referring 
the patient if they do not feel adequately trained on the subject of sexual dysfunction without 
denying the patient treatment.
 Since pelvic floor disorders are not life-threatening disorders and corrective surgery 
is elective, the presence or absence of sexual dysfunction should be taken into account when 
selecting the appropriate management for POP and SUI. In order to have realistic expecta-
tions of their sexual functioning after surgery, patients need to be informed prior to surgery 
that despite the possible positive effect on their sexual function from the cure of prolapse or 
incontinence symptoms, improvements in sexual function are not always guaranteed and oc-
casionally there may be deteriorations as a result of the treatment itself.
 Sexual functioning is a dynamic issue which generally occurs with a partner. Clini-
cians should be aware that female POP and SUI, as well as pelvic floor surgery do not just 
impact on the sexual experience of the women, but on that of the male partner as well. It is 
important to discuss these concerns openly with couples and to take this into consideration 
when counselling for treatment.
Future research
The results of this thesis gave more insight into the aetiology of sexual dysfunction in women 
with POP and SUI prior to and after surgery. The results showed us that the PISQ17 is limited 
in the assessment of sexual function following surgery as this questionnaire does not repre-
sent most new aspects of sexual dysfunction that can occur due to the treatment. In addition 
to this, we believe that the PISQ17 is less useful for the clinical and research setting, because 
it doesn’t assess the impact on the different female sexual dysfunction categories, including: 
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sexual desire, arousal, orgasm and sexual pain. Furthermore, as the level of distress associated 
with the sexual problem is not established, which is a necessary criterion for the diagnosis 
of sexual dysfunction according to the formal classification systems8,25-27, the questionnaire 
cannot be used for the diagnosis of female sexual dysfunction. In the revised version of the 
PISQ (PISQ-IR20) unfortunately only one of these issues has been addressed: the PISQ-IR 
now includes a subscale for both arousal and orgasm and one for desire. However, it is still not 
possible to diagnose sexual dysfunction using the PISQ-IR as the level of distress associated 
with, for example, problems with arousal or desire is not established. Furthermore, the PISQ-
IR does not assess the surgery specific impact on sexual function and is therefore not optimal 
for diagnosing sexual dysfunction following pelvic floor surgery.   
 We therefore propose a concept for a new condition-specific sexual function question-
naire that, after validation, may be used in women suffering with POP and incontinence (either 
urinary or faecal), prior to and after pelvic floor surgery (addendum 1 and 2). The PISQ17, 
PISQ-IR20 and FSFI28 were selected as the basis of this new condition-specific questionnaire, 
making corrections and additions according to the new insights gained in chapter 4 and 5 of 
this thesis. 
 The proposed new concept questionnaire is divided into four major categories “General”, 
“Prolapse”, “Incontinence” and “Surgery”. Each category is further divided into five categories: 
drive, motivation, arousal, orgasm and sexual pain. The “General” domain is aimed to be used 
to diagnose sexual dysfunction as it also includes questions on personal distress. In addition 
to this, the “General” domain can be used to compare the presence of sexual dysfunction 
prior to and after surgery. The “Prolapse” and “Incontinence” domains are aimed to be used 
to objectify the impact of these conditions on sexual function and preoperative results can be 
compared to results after surgery. The “Surgery” domain is created to ascertain the impact of 
surgery and can be compared between different groups of patients and types of surgery. To 
simplify the completion of the questionnaire, separate questionnaires were designed for use 
prior to treatment (addendum 1) and for use after treatment (addendum 2). Furthermore, the 
new questionnaire incorporates a separate part for women who are not sexually active, which 
can be used to evaluate the impact of POP, incontinence and pelvic floor surgery on women’s 
decision not to be sexually active. 
 Compared to the currently available sexual function questionnaires, the proposed new 
concept questionnaire is expected to have multiple advantages. As opposed to the general 
sexual function questionnaires FSFI28 and Golombok-Rust Inventory of Sexual Satisfaction29, 
the “General” domain of the proposed new questionnaire also takes into account “personal 
distress” and is therefore expected to be able to actually diagnose female sexual dysfunc-
tion. Compared to the condition-specific PISQ17 the new concept questionnaire evaluates the 
condition-specific impact of POP and incontinence on the different female sexual dysfunc-
tion domains, which makes it more useful for diagnosis of sexual dysfunction in the clinical 
and research setting. Furthermore, the proposed questionnaire will be the first questionnaire 
measuring the specific impact of pelvic floor surgery on female sexual function. This way one 
is able to evaluate the prevalence of female sexual dysfunction following pelvic floor surgery. 
However, it is important to emphasize that before this questionnaire can be used in clinical 
practice and research, validation studies need to be conducted to ensure our questionnaire 
meets established psychometric principles, including validity, reliability and responsiveness.
 Furthermore, the results from chapter 6 of this thesis can form the basis for formulating 
tools for quantitative assessment of the effect of female POP and incontinence, as well as pelvic 
floor surgery, on male sexual functioning.
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English summary
The aim of this thesis is to enhance the understanding of sexual dysfunction within the field 
of urogynaecology and to draw the attention of the healthcare providers to this subject. The 
focus is on the prevalence of sexual problems in urogynaecology clinics, the clinical attention 
of the urogynaecologist to female sexual dysfunction, the impact of pelvic organ prolapse 
(POP), stress urinary incontinence (SUI) and pelvic floor surgery on the sexual functioning 
of the female patient, as well as the impact on the sexual functioning of the partner. 
Chapter 1 of this thesis gives an overview of the current literature on sexual dysfunction 
within the field of urogynaecology and presents the research questions of this thesis. POP 
and SUI are frequently occurring conditions. Although conservative management, including 
pelvic floor muscle training, is usually the first line of treatment, more than one out of ten 
women will undergo at least one operation for either POP or SUI in her life. Sexual dysfunc-
tion is described as the absence or impairment of the sexual response or the physical reactions 
during sexual activity despite adequate stimulation. Sexual dysfunction is subdivided into 
four categories: sexual desire disorder, sexual arousal disorder, orgasmic disorder and genital 
or abdominal pain during or after sexual activity (dyspareunia). A necessary criterion for the 
diagnosis of sexual dysfunction is the presence of the person’s distress caused by the sexual 
disorder. 
Women with POP and SUI are more likely to suffer from sexual dysfunction compared to 
women without these complaints. Among sexually active women presenting to a urogynae-
cology clinic the prevalence of sexual dysfunction ranges from 48 to 64%. Population based 
studies showed that women don’t easily seek help for their sexual concerns and only one out 
of  five women with a sexual concern contacts a healthcare provider. Reasons for this could be 
embarrassment, believing that the healthcare provider will not be able to provide help and the 
perception that sexual problems are not a real health problem. A sexual problem is therefore 
often only identified when a healthcare provider specifically informs about it. 
 Generally spoken, to this day, the attention of urogynaecologists to sexual dysfunction 
seems to be insufficient. A survey amongst urogynaecologists in the United States of America 
showed that only a minority screened their patients for sexual dysfunction, with lack of time 
as the most important barrier. As cultural believes are an important factor in discussing sex-
ual problems, the question is whether similar results will be found in other countries as well. 
The use of a standardized questionnaire may ease the identification of patients with sexual 
problems. A short screening questionnaire can be very useful in identifying a sexual problem 
without adding too much time.  In chapter 2 we describe the prevalence of sexual problems 
within  patients presenting to a general gynaecology or a urogynaecology clinic in a large 
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teaching university hospital in the United Kingdom. The prevalence of sexual problems was 
assessed using a simple screening questionnaire. All new patients answered three short ques-
tions regarding their sexual functioning: (1) Are you sexually active? (yes/no). If not active, 
state reason. (2) Is sex painful? (yes/no). (3) Do you have any problems with sex? (yes/no). 
If yes, state problem. As distress caused by the sexual problem is a necessary criterion for 
the diagnosis of sexual dysfunction a forth question was introduced: Are any of your sexual 
problems bothersome? (yes/no).
 A total of 1.194 new patients presenting to a general gynaecology and urogynaecology 
clinic answered the three short questions regarding their sexual functioning. Thirty-five per-
cent of the women with a general gynaecological complaint and 38% of the women with 
an urogynaecological complaint admitted having a sexual problem. A multivariate analysis 
showed that urogynaecological complaints were significantly associated with the presence of 
sexual problems. 
 Seventeen percent of women with a sexual problem presented her complaint to the 
physician herself,  while the remaining only mentioned it after completing the three screening 
questions regarding sexual function. We conclude that physicians need to be alert in identify-
ing sexual dysfunction, because most women will only admit  having a sexual problem when 
asked directly. The use of a short screening questionnaire can be helpful with the identifica-
tion.  
 Two hundred and ninety questionnaires also included the question on bother. Only 
45% of women with sexual complaints found them to be bothersome. To prevent over-diagnosis 
of sexual dysfunction physicians always need to establish the presence of personal distress 
from the sexual problem. 
Chapter 3 describes the results of a study on the general practice of members of the British 
Society of Urogynaecology (BSUG) with respect to the identification of sexual dysfunction. 
Furthermore, this study compares the general practice of members of BSUG to the results of 
a study on the general practice of members of the American Urogynecologic Society (AUGS) 
previously reported. An anonymous digital questionnaire was send to all members of BSUG 
(n=150). Of the 100 questionnaires that were returned 95 (63.3 %) were suitable for analysis. 
 Ninety-eight percent of respondents thought screening for sexual dysfunction was 
important to a greater or lesser extent. However, only 50% of respondents regularly screened 
for sexual dysfunction at clinic visits and 49.5% after surgery. Amongst AUGS members 77% 
regularly screened during clinic visits and 76% after surgery. The most important barrier for 
screening was lack of time, both for members of BSUG as well as for members of AUGS. 
Other barriers often mentioned were insecurity about therapeutic options (25%) and don’t 
know what or how to ask (20%). This reflects a deficiency in knowledge and training, which 
was confirmed by 76% of respondents who found their training with respect to female sexual 
dysfunction was unsatisfactory.
 These results show that screening for sexual dysfunction is not part of routine practice 
for half of BSUG members. This highlights the need for improvement in both the education 
of medical students as well as the postgraduate curriculum and training. (Uro)gynaecolo-
gists need to be made more competent and familiar with enquiring about sexual problems and 
adequately treating them. Physicians should also be made more familiar with the existence of 
short screening questionnaires to identify sexual problems that don’t take too much time. 
Although previous literature has shown that women with POP and SUI have a higher risk of 
suffering from sexual dysfunction compared to women without these complaints, the results 
with respect to the effect of POP and SUI on the different sexual dysfunction categories are 
conflicting. While some studies showed an association of POP and SUI with reduced sexual 
arousal and difficulties in reaching an orgasm, others did not confirm this association. These 
conflicting results could be the result of discrepancies in patient’s characteristics or discrepan-
cies in the definition of disease, but they could also be the result of the use of different ques-
tionnaires to diagnose sexual dysfunction. Owing to the subjective nature of sexual function, 
there is no gold standard for the diagnosis of sexual dysfunction.
 To explain these conflicting results a qualitative study can be very useful. A qualitative 
study describes the view of the women themselves and does not rely on predetermined answers 
as is the case with questionnaires. A qualitative study not only describes the experiences of the 
women, but also explains the context of the problems and is therefore able to explain ‘why?’ 
and ‘how?’ POP and SUI impact on the different sexual dysfunction categories. 
Chapter 4 describes the results of a qualitative study on the effect of POP and SUI on the dif-
ferent sexual dysfunction categories. Thirty-seven women awaiting pelvic floor surgery in a 
large university hospital in the United Kingdom underwent a semi-structured interview on 
the effect of their prolapse or SUI symptoms on their sexual functioning.  The most important 
cause for the negative effect of the prolapse and incontinence symptoms on the sexual life was 
a negative effect of these symptoms on the woman’s body image. Both POP and SUI had a 
negative impact on the woman’s body image. Women with POP had a negative image of their 
vagina as a result of the presence of the prolapse which led to insecurity regarding their part-
ner’s sexual experience. Women with SUI were embarrassed about their incontinence and the 
need to wear pads. Furthermore, they feared smelling of urine. Worries during sexual activity 
about the presence of prolapse, discomfort from the prolapse and reduced genital sensations 
were the most important reasons for reduced desire and arousal and difficulties reaching an 
orgasm in women with POP. Fear of incontinence during intercourse affected desire, arousal, 
and orgasm and could be a cause for dyspareunia in women with SUI. 
 Desire was divided into two main elements: “drive” and “motivation”. Although “drive,” i.e. 
spontaneous sexual interest, was not affected by POP and SUI, a decrease in “motivation”, or the 
willingness to engage in sexual activity, was the most common sexual dysfunction mentioned. 
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Most sexual function questionnaires do not include this division in desire. However, by 
just including a general question regarding desire, the specific impact on motivation can be 
missed. This could leave the association between reduced desire and pelvic floor problems 
undiscovered.
As the presence of POP and SUI directly and indirectly causes sexual dysfunction, one can 
assume that surgery to cure these conditions would automatically lead to an improvement 
in sexual function. However, current evidence on sexual function following pelvic floor sur-
gery is conflicting. Some studies have shown improvement in sexual function following pel-
vic floor surgery, while others showed no change or even deterioration. The discrepancies 
in outcome of sexual function following surgery might be a reflection of the use of different 
questionnaires to diagnose sexual dysfunction. The currently available sexual function ques-
tionnaire designed specifically for the use in women suffering with POP and urinary inconti-
nence (Pelvic Organ Prolapse / Urinary Incontinence Sexual Function Questionnaire (PISQ)) 
has been validated to discriminate women with and without sexual dysfunction within the 
group of women suffering with POP and urinary incontinence. However, it is unsure whether 
this questionnaire can be used to identify sexual dysfunction following pelvic floor surgery. If 
only selective aspects of sexual function improve, or if different aspects become relevant as a 
result of the treatment, the ability of the questionnaire to identify sexual dysfunction could be 
affected. In order to establish whether the PISQ covers all relevant aspects of sexual function 
following pelvic floor surgery a qualitative study can be useful. In comparison to a quantita-
tive study, a qualitative study is able to provide the woman’s view as well as the context of 
problems, which are necessary to understand the surgery specific impact on sexual function.
Chapter 5 describes the results of a prospective mixed quantitative and qualitative study on 
the impact of pelvic floor surgery on female sexual function. Women undergoing corrective 
surgery for POP or SUI in a large university hospital in the United Kingdom were seen prior 
to and at 17 weeks (median) after surgery. At both visits the women completed the PISQ ques-
tionnaire and underwent a semi-structured qualitative interview. 
 After surgery a significant improvement was seen in the total PISQ score (p=0.003) as 
well as in the ‘Physical’ (p<0.001) and ‘Partner Related’ (p=0.002) domains, but not in the ‘Be-
havioural/Emotive’ domain (p=0.220). This means a reduction in the direct effect of POP and 
SUI on sexual function (‘Physical’ domain) and an improvement in the woman’s perception 
of her partner’s response to the impact of POP and SUI on their sexual life (‘Partner Related’ 
domain). No difference was seen in desire, frequency of sexual activity, arousal and orgasm 
(‘Behavioural/Emotive’ domain). Analysis of the qualitative data confirmed that the improve-
ment in sexual function was as a result of the cure of prolapse and incontinence symptoms. 
There was, however, also a negative effect on desire, arousal and orgasm from postoperative 
dyspareunia, fear of damaging the surgical result, new symptoms and a disappointing result 
of surgery. Other than dyspareunia these factors are not part of the PISQ questionnaire. How-
ever, they are important in the diagnosis of sexual dysfunction following pelvic floor surgery. 
We therefore conclude that the PISQ is not optimal for identifying the specific negative effects 
on sexual function after pelvic floor surgery. By neglecting the negative impact of pelvic floor 
surgery, PISQ’s  evaluation of sexual function following surgery might be incomplete or too 
positive. Future studies should therefore be conducted to either confirm or reject this ques-
tionnaire as a validated tool for diagnosing sexual dysfunction after pelvic floor surgery. 
Chapter 6 describes the results of a study on the effect of female POP and SUI on the sexual 
functioning of the male partner. Sexual functioning generally occurs with, and is dependent 
on a partner. A person’s sexual dysfunction can therefore result in sexual dysfunction of the 
partner as well. Until now very little research has been done to assess the sexual functioning 
of partners of women suffering of POP and SUI. Most previous studies used general question-
naires used for diagnosing sexual dysfunction in the male partner. However, by using general 
questionnaires they didn’t yield specific information regarding the male partner’s individual 
thoughts and experiences with regards to the effect of POP and SUI on the couple’s sexual life. 
To understand how female pelvic floor disorders, and their surgical treatment, influence the 
sexual functioning of the partner, a qualitative study was performed in partners of women 
undergoing surgery for pelvic floor disorders. 
 Eight men underwent semi-structured face-to-face interviews prior to and at 18 weeks 
(median) after their partner’s surgery. The men described both direct changes in their physi-
cal sexual sensations or sexual behaviour as a result of their female partner’s pelvic floor dys-
function, as well as indirect changes in their sexual experience as a result of changed sexual 
behaviour of their female partner. However, most men were understanding of these changes 
and still evaluated their sex life in a positive way. 
 Postoperatively, resuming sexual activity was influenced by both the physical recovery 
of the female partner as well as by the fear of the man to hurt his partner. The evaluation of the 
sex life following surgery was positive. The cure of the pelvic floor disorder and the improve-
ment in the tightness of the vagina resulted in both a direct positive effect on the physical 
sexual sensations of the man, as well as in a positive indirect effect as a result of an improve-
ment of the female partner’s self-confidence.
 As only a small group of men participated in this study, the results should be inter-
preted with caution. However, while not encompassing all possible sexual health difficulties 
experienced by the men, the findings can provide guidance to clinicians on possible aspects 
to explore with their patients and can provide a basis for further qualitative studies and for 
formulating condition-specific tools for quantitative studies on this subject.
The studies presented in this thesis focus on sexual dysfunction in the field of urogynaecology. 
As POP and SUI have a large impact on the female sexual function, understanding and awareness 
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of female sexual dysfunction is crucial amongst healthcare professionals involved in their care. 
More emphasis on female sexual function and dysfunction in the training of (uro)gynaecologists 
is therefore necessary. The results of this thesis have given insight into how we can improve 
our current questionnaires for diagnosing sexual dysfunction within the group of women 
suffering with pelvic floor disorders both before and after surgery. In the addendum a propo-
sition for a new questionnaire is presented. However, before this questionnaire can be used in 
clinical practice and research, validation studies need to be conducted to ensure its validity, 
reliability and responsiveness.
Nederlandse samenvatting
Het  doel van dit proefschrift is het verbeteren van de kennis over seksuele disfunctie binnen 
de uro-gynaecologie en het vestigen van de aandacht van de zorgverleners hierop. De focus 
ligt op de prevalentie van seksuele problemen binnen een gespecialiseerd uro-gynaecologie 
spreekuur, de aandacht van gynaecologen met een subspecialisatie in uro-gynaecologie voor 
seksuele disfunctie in de dagelijkse praktijk, de invloed van verzakkingen van de inwendige 
geslachtsorganen (prolaps), stressincontinentie en bekkenbodemchirurgie op het seksueel 
functioneren van de vrouwelijke patiënt, alsmede de invloed hiervan op het seksueel func-
tioneren van de partner. 
Hoofdstuk 1 van dit proefschrift geeft een overzicht van de huidige literatuur op het gebied 
van seksuele disfunctie binnen de uro-gynaecologie. Ook worden in dit hoofdstuk de onder-
zoeksvragen van het proefschrift gepresenteerd. Prolaps en stressincontinentie zijn frequent 
optredende aandoeningen. Hoewel conservatieve behandeling, waaronder bekkenbodemfysio-
therapie, meestal de behandeling van eerste keus is, zal meer dan een op de tien vrouwen op 
enig moment in haar leven een operatie voor prolaps of stressincontinentie ondergaan. Seksuele 
disfunctie wordt omschreven als het ontbreken, of het in mindere mate optreden, van de 
seksuele respons of de lichamelijke reacties bij seksuele activiteit ondanks adequate stimu-
latie. Seksuele disfunctie is onderverdeeld in vier categorieën: verstoring van het seksueel 
verlangen, de seksuele opwinding, of het bereiken van een orgasme of de aanwezigheid van 
genitale of abdominale pijn tijdens of na seksuele activiteit (dyspareunie). Er kan alleen van 
seksuele disfunctie gesproken worden wanneer de persoon de verminderde seksuele functie 
ook daadwerkelijk als een klacht ervaart. 
Vrouwen met prolaps en stressincontinentie hebben een hoger risico op seksuele disfunctie in 
vergelijking met vrouwen zonder deze klachten. Onder seksueel actieve vrouwen die een ge-
specialiseerd uro-gynaecologie spreekuur bezoeken, varieert de prevalentie van seksuele dis-
functie tussen de 48 en 64%. Populatiestudies hebben aangetoond dat vrouwen niet makkelijk 
hulp zoeken voor hun seksuele problemen en slechts één op de vijf vrouwen met een seksueel 
probleem zoekt contact met een zorgaanbieder. Dit kan het gevolg zijn van schaamte, het ge-
voel dat de zorgaanbieder geen hulp zou kunnen bieden en de opvatting dat seksuele problemen 
geen echt gezondheidsprobleem zouden zijn. Seksuele problemen worden daarom vaak alleen 
ontdekt als de zorgaanbieder hier actief naar vraagt.  
 Tot op heden lijkt de aandacht voor seksuele problematiek van gynaecologen met een 
subspecialisatie in uro-gynaecologie echter onvoldoende. Uit onderzoek onder gynaecologen 
met deze subspecialisatie in de Verenigde Staten van Amerika bleek dat slechts een minder-
heid zijn patiënten vroeg naar het bestaan van seksuele problemen. De belangrijkste barrière 
die hiervoor werd aangegeven was het gebrek aan tijd. Cultuur is een belangrijke factor in het 
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bespreken van seksuele problematiek en de vraag is dan ook of in andere landen vergelijkbare 
resultaten gevonden zouden worden. 
Het gebruik van gestandaardiseerde vragenlijsten kan het identificeren van patiënten met 
seksuele problematiek vergemakkelijken. Een korte screenende vragenlijst kan heel nuttig 
zijn om een seksueel probleem op te sporen zonder dat het veel tijd kost. In hoofdstuk 2 
beschrijven wij de prevalentie van seksuele klachten binnen de groep patiënten die een al-
gemeen gynaecologie of een uro-gynaecologie spreekuur bezochten in een groot opleidings-
ziekenhuis in Engeland. De prevalentie van seksuele problemen werd geïnventariseerd met 
behulp van een eenvoudige screenende vragenlijst. Alle nieuwe patiënten beantwoordden 
drie korte vragen over hun seksueel functioneren: (1) Bent u seksueel actief? (ja/nee). Wan-
neer u niet seksueel actief bent, benoem de reden. (2) Is geslachtsgemeenschap pijnlijk? (ja/
nee). (3) Ondervindt u problemen in het seksueel functioneren? (ja/nee). Indien ja, omschrijf 
dan uw probleem. Omdat het als een klacht ervaren van het seksuele probleem een essentieel 
criterium is voor het stellen van de diagnose “seksuele disfunctie” werd een vierde vraag geïn-
troduceerd: Ondervindt u hinder van een van uw seksuele problemen? (ja/nee).
 In totaal beantwoordden 1.194 nieuwe patiënten die het algemene gynaecologie en het 
uro-gynaecologie spreekuur bezochten de drie korte vragen over het seksueel functioneren. 
Vijfendertig procent van de vrouwen met een algemene gynaecologische klacht en 38% van 
de vrouwen met een bekkenbodemklacht gaf aan een seksueel probleem te hebben. Een multi-
variate analyse toonde aan dat bekkenbodemklachten significant geassocieerd waren met het 
bestaan van seksuele problemen. 
 Zeventien procent van de vrouwen met een seksueel probleem presenteerde deze klacht zelf 
aan de arts, terwijl de overige patiënten de klacht alleen meldden bij het invullen van de drie vragen 
over het seksueel functioneren. Wij concluderen hieruit dat artsen alert moeten zijn op het identifi-
ceren van seksuele disfunctie, omdat de meeste vrouwen seksuele problemen alleen melden wanneer 
zij hier specifiek naar gevraagd worden. Een korte screenende vragenlijst kan hierbij behulpzaam zijn. 
 Tweehonderdnegentig vragenlijsten bevatten ook de vraag over het ervaren van hinder 
van het seksuele probleem. Slechts 45% van de vrouwen zei dit daadwerkelijk te ervaren. Om 
te vermijden dat de diagnose “seksuele disfunctie” onjuist wordt gesteld, moeten artsen altijd 
aantonen dat een patiënt haar seksuele probleem ook als klacht ervaart.
In hoofdstuk 3 worden de resultaten van een onderzoek naar het gebruikelijke beleid van de leden 
van de British Society of Urogynaecology (BSUG) met betrekking tot het identificeren van seksuele 
disfunctie beschreven. In dit onderzoek werd tevens het gebruikelijke beleid van leden van BSUG 
vergeleken met de resultaten van het onderzoek onder leden van de American Urogynecologic 
Society (AUGS) dat eerder werd gepubliceerd. Een anonieme digitale vragenlijst werd gestuurd 
naar alle leden van BSUG (n=150). Van de 100 vragenlijsten die werden teruggestuurd waren er 95 
(63,3%) bruikbaar voor analyse. 
 Achtennegentig procent van de respondenten vond het identificeren van seksuele dis-
functie in meer of mindere mate belangrijk. Echter, slechts 50% van de respondenten screen-
den hun patiënten regelmatig op het bestaan van seksuele disfunctie tijdens een polibezoek en 
49.5% deed dit ook postoperatief. Onder leden van AUGS screenden 77% regelmatig tijdens 
een polibezoek en 76% postoperatief. De belangrijkste barrière om te screenen was het gebrek aan 
tijd, zowel bij leden van BSUG alsook bij leden van AUGS. Andere vaak genoemde barrières 
waren onzekerheid over therapeutische opties (25%) en niet weten wat of op welke manier te 
vragen (20%). Dit duidt op een deficiëntie in kennis en training, wat werd bevestigd door 76% 
van de respondenten die hun training ten aanzien van seksuele disfunctie onbevredigend vond. 
 Deze resultaten laten zien dat seksuele disfunctie geen standaard onderdeel vormt van 
de dagelijkse praktijk voor de helft van de leden van BSUG. Er lijkt daarom een noodzaak te 
bestaan voor het verbeteren van zowel het onderwijs voor studenten Geneeskunde alsook 
het postacademisch onderwijs en training. (Uro)gynaecologen dienen meer competent en 
vertrouwd te raken met het vragen naar seksuele problematiek en met het adequaat behan-
delen hiervan. Artsen zouden ook bekend moeten worden gemaakt met het bestaan van korte 
screenende vragenlijsten om seksuele problematiek te identificeren zonder dat dit veel tijd kost.
Hoewel de bestaande literatuur laat zien dat vrouwen met prolaps en stressincontinentie een 
hoger risico op seksuele disfunctie hebben in vergelijking met vrouwen zonder deze klachten, 
zijn de resultaten met betrekking tot de invloed van prolaps en stressincontinentie op de ver-
schillende categorieën van seksuele disfunctie inconsistent. Terwijl sommige onderzoeken een 
associatie van prolaps en stressincontinentie met verminderde opwinding en moeilijkheden 
met orgasme lieten zien, konden andere onderzoeken deze associatie niet bevestigen. Deze 
inconsistente resultaten kunnen het gevolg zijn van verschillen in karakteristieken van de 
onderzoekpopulaties of verschillen in de definitie van de aandoening. Daarnaast kunnen deze 
inconsistenties ook het gevolg zijn van verschillen in de gebruikte vragenlijsten om seksuele 
disfunctie te diagnosticeren. Seksuele functie is een subjectieve beleving en  er is geen gouden 
standaard voor het diagnosticeren van seksuele disfunctie.
 Om de inconsistente resultaten te begrijpen kan een kwalitatief onderzoek heel nut-
tig zijn. Een kwalitatief onderzoek geeft de mening van de vrouwen zelf weer en is niet af-
hankelijk van vooraf bepaalde antwoorden zoals in vragenlijsten. Een kwalitatief onderzoek 
beschrijft niet alleen de eigen ervaringen van de vrouwen, maar verklaart ook de achtergrond 
van de problemen en kan daarom verklaren ‘waarom?’ en ‘hoe?’ prolaps en stressincontinentie 
de verschillende categorieën van seksuele disfunctie beïnvloeden. 
Hoofdstuk 4 beschrijft de resultaten van een kwalitatief onderzoek naar het effect van prolaps 
en stressincontinentie op de verschillende categorieën van seksuele disfunctie. Zevenendertig 
vrouwen die op de wachtlijst stonden voor een bekkenbodemoperatie in een groot opleidings-
ziekenhuis in Engeland ondergingen een semi-gestructureerd interview over het effect van hun 
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prolaps- of stressincontinentieklachten op hun seksueel functioneren. De belangrijkste oorzaak 
voor het negatieve effect van prolaps- en stressincontinentieklachten op het huidige seksleven 
was een negatief effect van deze klachten op  het eigen lichaamsbeeld van de vrouwen. Zowel pro-
laps als ook stressincontinentie hadden een negatieve invloed op het eigen lichaamsbeeld van 
de vrouw. Vrouwen met prolaps hadden een negatief beeld van hun vagina als gevolg van de 
prolaps wat tot onzekerheid leidde over de seksuele ervaring van hun partners. Vrouwen met 
stressincontinentie schaamden zich voor hun incontinentie en de noodzaak tot het gebruik 
van incontinentieverband. Tevens waren zij bang dat zij naar urine zouden ruiken. Zorgen 
tijdens de seksuele activiteit over de aanwezigheid van de prolaps, pijn als gevolg van de pro-
laps en verminderde genitale sensibiliteit, waren de belangrijkste redenen voor verminderd 
verlangen en opwinding en moeilijkheden met het bereiken van een orgasme voor vrouwen 
met prolaps. Angst voor incontinentie tijdens geslachtsgemeenschap beïnvloedde verlangen, 
opwinding en orgasme en kon een reden zijn voor dyspareunie in vrouwen met stressincon-
tinentie. 
 Verlangen was verdeeld in twee elementen: ‘seksuele drift’ en ‘motivatie’. Alhoewel 
‘seksuele drift’, beschreven als spontane seksuele interesse, niet beïnvloed werd door prolaps 
of stressincontinentie, was verminderde ‘motivatie’, ofwel de bereidheid om seksueel actief 
te zijn, het meest genoemde seksuele probleem. De meeste seksuele vragenlijsten gebruiken 
deze verdeling binnen verlangen niet. Echter door slechts in het algemeen te vragen naar ver-
langen wordt het specifieke effect op motivatie mogelijk gemist. Dit kan er voor zorgen dat de 
associatie tussen verminderd verlangen en bekkenbodemproblematiek niet wordt gevonden. 
Aangezien de aanwezigheid van prolaps en stressincontinentie zowel direct als indirect seksuele 
disfunctie veroorzaken, kan men aannemen dat een corrigerende operatie automatisch zal 
leiden tot een verbetering van het seksueel functioneren. Desondanks is de huidige literatuur 
tegenstrijdig over dit onderwerp. Er zijn onderzoeken die een verbetering laten zien, maar 
ook onderzoeken die geen verandering of zelfs verslechtering van het seksueel functioneren 
na bekkenbodemchirurgie laten zien. De discrepantie in deze resultaten kunnen het gevolg 
zijn van het gebruik van verschillende vragenlijsten om seksuele disfunctie te diagnosticeren. 
De huidige seksuele vragenlijst die speciaal ontwikkeld is voor vrouwen met prolaps en in-
continentie (Pelvic Organ Prolapse / Urinary Incontinence Sexual Function Questionnaire 
(PISQ)) is gevalideerd voor het onderscheiden van vouwen met en zonder  seksuele disfunctie 
binnen de groep vrouwen met prolaps- of incontinentieklachten. Het is echter onzeker of 
deze vragenlijst ook gebruikt kan worden voor het op de juiste wijze detecteren van seksuele 
disfunctie na bekkenbodemchirurgie. Wanneer alleen bepaalde aspecten van het seksueel 
functioneren verbeteren of wanneer als gevolg van de operatie andere aspecten van het seksueel 
functioneren belangrijk worden, zou dit de juiste beoordeling van seksuele disfunctie kunnen 
beïnvloeden. Om te beoordelen of de PISQ alle relevante aspecten van het seksueel functio-
neren na bekkenbodemchirurgie bevat kan een kwalitatief onderzoek uitkomst bieden. In 
vergelijking tot een kwantitatief onderzoek kan een kwalitatief onderzoek de mening van de 
vrouw zelf en de context van de problemen verschaffen die noodzakelijk zijn om de invloed 
van de operatie op het seksueel functioneren te begrijpen.
In hoofdstuk 5 worden de resultaten van een prospectief gemengd kwantitatief én kwali-
tatief onderzoek naar de invloed van bekkenbodemchirurgie op het seksueel functioneren 
beschreven. Vrouwen die een operatie voor de correctie van prolaps en/of stressincontinentie 
ondergingen in een groot opleidingsziekenhuis in Engeland, werden zowel voor de operatie, 
als ook 17 weken (mediaan) na de operatie gezien. Zowel voor als na de operatie beantwoord-
den de vrouwen de PISQ vragenlijst en ondergingen zij een semi-gestructureerd kwalitatief 
interview. 
 Na de operatie was er een significante verbetering in de totale PISQ score (p=0.003) 
alsmede in de domeinen ‘Lichamelijk’ (p<0.001) en ‘Partner Gerelateerd’ (p=0.002), maar 
niet in het domein ‘Gedrag/Gevoel’ (p=0.220). Dit betekent dat het directe effect van pro-
laps en incontinentie op het seksueel functioneren was verminderd (‘Lichamelijk’ domein) 
en de perceptie van de vrouw met betrekking tot de reactie van de partner op het effect van 
prolaps en incontinentie op het seksleven was verbeterd (‘Partner Gerelateerd’ domein). Er 
werd geen verschil gezien in seksueel verlangen, frequentie van seksuele activiteit, opwinding 
en orgasme (‘Gedrag/Gevoel’ domein). Analyse van de kwalitatieve data bevestigde dat ver-
betering in het seksueel functioneren het resultaat was van de genezing van de prolaps- en/of 
stressincontinentieklachten. Er was echter ook een negatief effect op verlangen, opwinding en 
orgasme als gevolg van postoperatieve dyspareunie, angst voor het beschadigen van het resul-
taat van de operatie, nieuwe symptomen en een teleurstellend resultaat van de operatie. Be-
halve dyspareunie komen deze factoren niet aan bod in de PISQ, maar zij zijn wel belangrijk 
voor het diagnosticeren van seksuele disfunctie na bekkenbodemchirurgie. Wij concluderen 
daarom dat de PISQ niet geschikt is om specifieke negatieve effecten op het seksueel functio-
neren na bekkenbodemchirurgie op te sporen. Beoordeling van het seksueel functioneren na 
operaties voor bekkenbodemklachten met behulp van de PISQ kan daarom een onvolledig 
of te positief beeld opleveren. Validatie van deze vragenlijst voor de diagnostiek van seksueel 
disfunctioneren na bekkenbodemchirurgie is daarom noodzakelijk.
In hoofdstuk 6 worden de resultaten beschreven van een onderzoek naar het effect van pro-
laps en stressincontinentie op de seksuele ervaring van de mannelijke partner. Seksualiteit 
wordt meestal beleefd met, en is mede afhankelijk van, een partner. Seksueel disfunction-
eren van een persoon kan daarom leiden tot seksueel disfunctioneren van de partner. Tot op 
heden is er weinig onderzoek gedaan naar het seksueel functioneren van partners van vrou-
wen met prolaps en stressincontinentie. De meeste onderzoeken die gedaan zijn gebruikten 
algemene vragenlijsten voor het diagnosticeren van seksuele disfunctie bij de mannelijke part-
ner. Daarmee geven zij echter geen specifieke informatie over de gedachten en ervaringen van 
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de partner met betrekking tot het effect van prolaps en stressincontinentie op het seksleven. 
Om te begrijpen hoe vrouwelijke bekkenbodemproblemen, en de chirurgische behandeling 
hiervan, het seksueel functioneren van de partner kunnen beïnvloeden, werd een kwalitatief 
onderzoek gedaan bij partners van vrouwen die een operatie voor bekkenbodemproblematiek 
ondergingen.  
 Acht mannen ondergingen kwalitatieve semi-gestructureerde interviews voorafgaand 
aan en achttien weken (mediaan) na de operatie van hun partner. De mannen beschreven 
zowel directe veranderingen in hun fysieke seksuele sensaties of seksueel gedrag als gevolg 
van de vrouwelijke bekkenbodemproblematiek alsook indirecte veranderingen in hun seksuele 
beleving als gevolg van veranderd seksueel gedrag van hun vrouwelijke partner. De meeste 
mannen waren echter begripvol voor deze veranderingen en beoordeelden hun seksleven 
toch positief. 
 Postoperatief werd het hervatten van de seksuele activiteit beïnvloed door zowel het 
fysieke herstel van de partner alsook door de angst van de man om zijn partner pijn te doen. 
De evaluatie van het seksleven na de operatie was positief. De genezing van de bekkenbodem-
klachten en het verbeteren van de weefselspanning van de vagina zorgde voor zowel een di-
rect positief effect op de fysieke seksuele sensaties van de man alsook voor een indirect posi-
tief effect als gevolg van een verbetering in het zelfvertrouwen van de vrouw.   
 Omdat slechts een kleine groep mannen meedeed aan dit onderzoek moeten wij 
voorzichtig zijn met onze conclusies. Hoewel het onderzoek mogelijk niet alle seksuele pro-
blemen omvat die worden ervaren door de mannelijke partner, kunnen de bevindingen als 
leidraad dienen voor artsen over welke eventuele aspecten te bespreken met hun patiënten. 
Verder kunnen de resultaten van dit onderzoek de basis vormen voor  toekomstige kwanti-
tatieve onderzoeken en voor het formuleren van een vragenlijst specifiek voor mannelijke 
seksuele problemen als het gevolg van bekkenbodemproblematiek bij hun partner.   
De in dit proefschrift beschreven onderzoeken behandelen seksuele disfunctie binnen de uro-
gynaecologie. Gezien de grote impact van prolaps en stressincontinentie op het seksleven van 
vrouwen, is het belangrijk dat de specialisten die deze vrouwen behandelen deze seksuele 
problematiek begrijpen en zich bewust zijn van het vóórkomen ervan. Meer aandacht voor 
dit onderwerp binnen de opleiding is daarom aangewezen. De resultaten van dit proefschrift 
hebben ons ideeën gegeven voor het verbeteren van de huidige vragenlijsten voor het diagnosti-
ceren van seksuele disfunctie in vrouwen met bekkenbodem problematiek, zowel voor als na 
operatief ingrijpen. In het addendum wordt een voorstel voor een nieuwe vragenlijst gepre-
senteerd. Echter voordat deze vragenlijst in de praktijk en in onderzoek gebruikt kan worden, 
moet onderzoek uitgevoerd worden om de validiteit en betrouwbaarheid van de vragenlijst 
te verzekeren alsmede de mogelijkheid van de vragenlijst om veranderingen waar te nemen 
(responsiviteit). 
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Sexual Function Questionnaire for Pelvic Floor Surgery (SFQ-PFS)
Pre-treatment version
Subject identifier ......................................................   Date ..........................
Instructions: Following is a list of questions about your sexual life. All information is strictly 
confidential. While answering the questions consider your sexuality during the past 4 weeks. 
If you do not consider yourself to be sexually active only fill out domain D of this question-
naire.
In answering these questions the following definitions apply:
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse.
Sexual intercourse is defined as penile penetration (entry) of the vagina.
Please check the box that best answers the question for you.
CON
CEP
T
CON
CEP
T
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a. general
1. What best represents how you feel about your sex life?
 	 Very satisfied
  	 Satisfied
  	 Not satisfied, nor dissatisfied
  	 Dissatisfied
  	 Very dissatisfied
2.  How would you rate your level (degree) of sexual desire? This can include spontaneous feelings of sexual interest 
or desire, presence of sexual thoughts or fantasies, or a desire triggered when sexually active.
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
3. Do you worry about your level (degree) of sexual desire? 
 	 Almost never or never  
       	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
4.  How would you rate your level (degree) of motivation or willingness to be sexually active with your partner? 
 (Low motivation could include trying to avoid or refusing sexual activity or intercourse)
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
5. Do you worry about your level (degree) of motivation or willingness to be sexually active with your partner?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
6. How would you rate your level (degree) of sexual arousal (“feeling turned on”) during sexual activity?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
7. Do you worry about your level (degree) of sexual arousal (“feeling turned on”) during sexual activity?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
8. How would you rate your ability to become lubricated (“wet”) during sexual activity or intercourse?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
9.  Do you worry about your ability to become lubricated (“wet”) during sexual activity or intercourse?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
10. How often are you able to achieve an orgasm (climax) with sufficient sexual stimulation?
 	 Almost always or always
  	 Most times
  	 Sometimes
  	 A few times
  	 Almost never or never
11. Do you worry about your ability to achieve an orgasm (climax)?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
12. How would you rate the intensity of your orgasm (climax)?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or no orgasm at all
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13. Do you worry about the intensity of your orgasm (climax)?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
14. How would you rate your level (degree) of discomfort or pain during or following sexual activity or intercourse?
 	 Very low or none at all 
  	 Low
  	 Moderate
  	 High
  	 Very high
15. Do you worry about the presence of discomfort or pain during or following sexual activity or intercourse?
 	 Almost never or never
 	 A few times
 	 Sometimes
 	 Most times
 	 Almost always or always
B.  INCONTINENCE
  Next are some questions that will evaluate the impact of several symptoms associated with incontinence (either 
urinary or faecal) on your sexual functioning. If you do not suffer with incontinence (either urinary or faecal) 
please skip this part of the questionnaire and continue with domain “C. PROLAPSE”. 
16.  Are you incontinent of urine with sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
17.  Are you incontinent of stool with sexual activity?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
18.  Do you fear incontinence (either stool or urine) with sexual activity?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
 
 If your answer to question 16 ,17 and 18 was “almost never or never”, please continue with question 20. 
 Otherwise continue with question 19.
19.  Does the occurence or the fear of incontinence (either stool or urine) during sexual activity:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
20. Do you fear smelling of urine?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
21. Do you fear smelling of stool?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
22. Do you feel dirty/unclean because of your incontinence (either from stool or urine)?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
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 If your answer to question 20, 21 and 22 was “almost never or never”, please continue with question 24. 
 Otherwise continue with question 23.
23.  Does the fear of smelling of urine or stool, or you feeling dirty/unclean:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
24. Do you experience an urge to pass urine during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
25. Do you experience an urge to defecate during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
26. Do you interrupt sexual activity because of the need to use the toilet (either for urine or stools)?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always 
 
 If your answer to question 24, 25 and 26 was “almost never or never”, please continue with question 28. 
 Otherwise continue with question 27.
27.  Do interruptions during sexual activity, because of the need to use the toilet (either for urine or stools):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
c.  ProlaPSe
  Next are some questions that will evaluate the impact of prolapse (vaginal bulge) on your sexual functioning. 
 If you do not suffer with prolapse symptoms please skip this part of the questionnaire and return the 
 questionnaire to your physician. 
28.  Do you experience negative emotions because of the prolapse (vaginal bulge) such as embarrassment, 
 feeling less attractive or lower self-confidence? 
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
29.  Do you worry about the presence of your prolapse (vaginal bulge) during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to both question 28 and 29 was “almost never or never”, please continue with question 31. 
 Otherwise continue with question 30.
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30.  Does worrying or thinking about the presence of prolapse (vaginal bulge):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
31. Do you experience pain/discomfort from the prolapse (vaginal bulge) during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
32. Are you afraid of pain/discomfort from the prolapse (vaginal bulge) during or after sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to both question 31 and 32 was “almost never or never”, please continue with question 34. 
 Otherwise continue with question 33.
33.  Does the presence or fear of pain/discomfort from the prolapse (vaginal bulge):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
34. Do you experience reduced sensations in your genital area during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to question 34 was “almost never or never”, please continue with question 36. 
 Otherwise continue with question 35.
35.  Does the reduction of sensations in your genital area during sexual activity: 
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
36. Are you afraid of damaging the prolapse (vaginal bulge) during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
37. Are you afraid sexual activity or intercourse will make the prolapse (vaginal bulge) worse?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
  If your answer to both question 36 and 37 was “almost never or never”, please do not complete question 38 and return  
the questionnaire to your physician. Otherwise continue with question 38.
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38.  Does fear of damaging the prolapse (vaginal bulge) or making it worse:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
D.  not Sexually actiVe
  Please only fill out this part of the questionnaire if you do not consider yourself to be sexually active.
  The following are a list of reasons why you might not be sexually active, for each one, please indicate how strongly you 
agree or disagree with it as a reason you are not sexually active.
  strongly agree . . . strongly disagree
Condition-specific     
• due to bladder or bowel problems 1 2 3 4 5
 (urinary or faecal incontinence)
• due to prolapse (a feeling of a bulge) 1 2 3 4 5
General     
• no partner  1 2 3 4 5
• no interest in being sexually active 1 2 3 4 5
• other health problems  1 2 3 4 5
• pain during or after sexual activity 1 2 3 4 5
Partner     
• because of my partner’s health problems 1 2 3 4 5
• because of my partner’s sexual difficulties 1 2 3 4 5
 (erectile and ejaculation difficulties)
CON
CEP
T
153152  chapter 9 | Addendum 2 SFQ-PFS Post-treatment version
Sexual Function Questionnaire for Pelvic Floor Surgery (SFQ-PFS)
Post-treatment version 
Subject identifier ......................................................   Date ..........................
Instructions: Following is a list of questions about your sexual life. All information is strictly 
confidential. While answering the questions consider your sexuality during the past 4 weeks. 
If you do not consider yourself to be sexually active only fill out domain E of this questionnaire.
In answering these questions the following definitions apply:
Sexual activity can include caressing, foreplay, masturbation and vaginal intercourse.
Sexual intercourse is defined as penile penetration (entry) of the vagina.
Please check the box that best answers the question for you.
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a. general
1. What best represents how you feel about your sex life?
 	 Very satisfied
  	 Satisfied
  	 Not satisfied, nor dissatisfied
  	 Dissatisfied
  	 Very dissatisfied
2.  How would you rate your level (degree) of sexual desire? This can include spontaneous feelings of sexual interest 
or desire, presence of sexual thoughts or fantasies, or a desire triggered when sexually active.
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
3. Do you worry about your level (degree) of sexual desire? 
 	 Almost never or never  
       	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
4.  How would you rate your level (degree) of motivation or willingness to be sexually active with your partner? 
 (Low motivation could include trying to avoid or refusing sexual activity or intercourse)
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
5. Do you worry about your level (degree) of motivation or willingness to be sexually active with your partner?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
6. How would you rate your level (degree) of sexual arousal (“feeling turned on”) during sexual activity?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
7. Do you worry about your level (degree) of sexual arousal (“feeling turned on”) during sexual activity?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
8. How would you rate your ability to become lubricated (“wet”) during sexual activity or intercourse?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or none at all
9.  Do you worry about your ability to become lubricated (“wet”) during sexual activity or intercourse?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
10. How often are you able to achieve an orgasm (climax) with sufficient sexual stimulation?
 	 Almost always or always
  	 Most times
  	 Sometimes
  	 A few times
  	 Almost never or never
11. Do you worry about your ability to achieve an orgasm?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
12. How would you rate the intensity of your orgasm (climax)?
 	 Very high
  	 High
  	 Moderate
  	 Low
  	 Very low or no orgasm at all
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13. Do you worry about the intensity of your orgasm (climax)?
 	 Almost never or never
  	 A few times
  	 Sometimes
  	 Most times
  	 Almost always or always
14. How would you rate your level (degree) of discomfort or pain during or following sexual activity or intercourse?
 	 Very low or none at all 
  	 Low
  	 Moderate
  	 High
  	 Very high
15. Do you worry about the presence of discomfort or pain during or following sexual activity or intercourse?
 	 Almost never or never
 	 A few times
 	 Sometimes
 	 Most times
 	 Almost always or always
B.  INCONTINENCE
  Next are some questions that will evaluate the impact of several symptoms associated with incontinence (either 
urinary or faecal) on your sexual functioning. If you do not suffer with incontinence (either urinary or faecal) and 
have not had treatment for incontinence symptoms please skip this part of the questionnaire and continue with 
domain “C. PROLAPSE”. 
16.  Are you incontinent of urine with sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
17.  Are you incontinent of stool with sexual activity?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
18.  Do you fear incontinence (either stool or urine) with sexual activity?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
 
 If your answer to question 16 ,17 and 18 was “almost never or never”, please continue with question 20. 
 Otherwise continue with question 19.
19.  Does the occurrence or the fear of incontinence (either stool or urine) during sexual activity:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
20. Do you fear smelling of urine?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
21. Do you fear smelling of stool?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
22. Do you feel dirty/unclean because of your incontinence (either from stool or urine)?
 	 Almost never or never  
  	 A few times 
  	 Sometimes 
  	 Most times 
  	 Almost always or always
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 If your answer to question 20, 21 and 22 was “almost never or never”, please continue with question 24. 
 Otherwise continue with question 23.
23.  Does the fear of smelling of urine or stool, or you feeling dirty/unclean:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
24. Do you experience an urge to pass urine during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
25. Do you experience an urge to defecate during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
26. Do you interrupt sexual activity because of the need to use the toilet (either for urine or stools)?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always 
 
 If your answer to question 24, 25 and 26 was “almost never or never”, please continue with question 28. 
 Otherwise continue with question 27.
27.  Do interruptions during sexual activity, because of the need to use the toilet (either for urine or stools):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
c.  ProlaPSe
  Next are some questions that will evaluate the impact of prolapse (vaginal bulge) on your sexual functioning. If 
you do not suffer with prolapse symptoms and have not received treatment for prolapse please skip this part of 
the questionnaire and continue with domain “D. SURGERY”. 
28.  Do you experience negative emotions because of the prolapse (vaginal bulge) such as embarrassment, 
 feeling less attractive or lower self-confidence? 
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
29.  Does the presence of prolapse (vaginal bulge) cause you to worry about your partner’s sexual experience?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to both question 28 and 29 was “almost never or never”, please continue with question 31. 
 Otherwise continue with question 30.
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30.  Does worrying or thinking about the presence of prolapse (vaginal bulge):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
31. Do you experience pain/discomfort from the prolapse (vaginal bulge) during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
32. Are you afraid of pain/discomfort from the prolapse (vaginal bulge) during or after sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to both question 31 and 32 was “almost never or never”, please continue with question 34. 
 Otherwise continue with question 33.
33.  Does the presence or fear of pain/discomfort from the prolapse (vaginal bulge):
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
34. Do you experience reduced sensations in your genital area during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to question 34 was “almost never or never”, please continue with question 36. 
 Otherwise continue with question 35.
35.  Does the reduction of sensations in your genital area during sexual activity: 
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
36. Are you afraid of damaging the prolapse (vaginal bulge) during sexual activity?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
37. Are you afraid sexual activity or intercourse will make the prolapse (vaginal bulge) worse?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
  If your answer to both question 36 and 37 was “almost never or never”, please continue with question 39. 
 Otherwise continue with question 38.
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38.  Does fear of damaging the prolapse (vaginal bulge) or making it worse:
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
D.  Surgery
 Next are some questions that will evaluate the impact of your recent surgery on your sexual functioning. 
39.  Do you feel you have completely recovered physically from surgery? 
 	 Almost always or always
 	 Most times
 	 Sometimes
 	 A few times   
 	 Almost never or never  
  If your answer to question 39 was “almost always or always”, please continue with question 41. 
 Otherwise continue with question 40.
40. Does your lack of physical recovery following surgery ....
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
41.  Following surgery, do you experience vaginal pain or discomfort during sexual intercourse? 
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
42.  Do you feel that after surgery the length of your vagina is causing pain or discomfort during sexual intercourse?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
43.  Do you feel that after surgery the tightness of your vagina is causing pain or discomfort during 
 sexual intercourse?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
  If your answer to question 41, 42 and 43 was “almost never or never”, please continue with question 45. 
 Otherwise continue with question 44.
44. Does pain or discomfort following surgery ....
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
45. Following surgery, do you fear pain or discomfort?
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
 
 If your answer to question 45 was “almost never or never”, please continue with question 47. 
 Otherwise continue with question 46.
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46. Does fear of pain or discomfort ....
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
47. Following surgery, do you worry about damaging the surgical repair? 
 	 Almost never or never  
 	 A few times 
 	 Sometimes 
 	 Most times 
 	 Almost always or always
  If your answer to question 47 was “almost never or never”, please do not complete question 48 and return 
 the questionnaire to your physician. Otherwise continue with question 48.
48. Do worries about damaging the surgical repair ....
 ..... affect spontaneous feelings of sexual interest or desire?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your motivation or willingness to be sexually active with your partner? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to get aroused? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... affect your ability to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... prevent you from trying to reach an orgasm? 
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
 ..... cause tension and pain during sexual activity?
	  Almost never or never  A few times  Sometimes Most times    Almost always or always
e.  not Sexually actiVe
  Please only fill out this part of the questionnaire if you do not consider yourself to be sexually active.
  The following are a list of reasons why you might not be sexually active, for each one, please indicate how strongly you 
agree or disagree with it as a reason you are not sexually active.
  strongly agree . . . strongly disagree
Condition-specific     
• due to bladder or bowel problems 1 2 3 4 5
 (urinary or faecal incontinence)
• due to prolapse (a feeling of a bulge) 1 2 3 4 5
General 
• no partner  1 2 3 4 5
• no interest in being sexually active 1 2 3 4 5
• other health problems  1 2 3 4 5
• pain during or after sexual activity 1 2 3 4 5  
Partner 
• because of my partner’s health problems 1 2 3 4 5
• because of my partner’s sexual difficulties 1 2 3 4 5
 (erectile and ejaculation difficulties)
Surgery 
• pain as a result of the surgery 1 2 3 4 5
• fear of causing damage to the surgical repair 1 2 3 4 5
• not physically recovered following surgery 1 2 3 4 5
• my partner is afraid of causing pain 1 2 3 4 5
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 ICS, 38th Annual Meeting, Cairo, Egypt
178  chapter 10 | Word of thanks / Dankwoord 179
Word of thanks / Dankwoord
Na ruim zes jaar is het moment eindelijk daar: de verdediging van mijn proefschrift. Bij deze 
zou ik graag een aantal mensen willen bedanken die me tijdens mijn promotietraject hebben 
geholpen. 
First of all I would like to thank all the women and men who have participated in the various 
studies and who have had the courage to share their most personal and intimate experiences 
with me. Without you there wouldn’t have been a thesis to defend.
Dear Miss Thakar and Mr Sultan, thank you so much for giving me the opportunity to work 
on this special project. It was a huge inspiration to work with you in such an internationally 
respected unit. Being far away from home you were like a family to me. I want to thank you for 
everything you have taught me such as conducting research projects, writing and presenting
abstracts and research papers, running a perineal clinic, performing endoanal scans and 
many more things. Thank you for taking me to the various annual IUGA and ICS meetings 
where I have been able to present the results of my research projects. Finally, I’d like to thank 
you for all the lovely diners at the many Indian restaurants in and around Croydon. I went 
from a spice level 2 to an 8!
Prof.dr. C.W. Burger, beste Curt, bedankt dat je mijn promotor wilde zijn. Jij had de helikopter 
view om de algemene voortgang en het kwaliteitsniveau te bewaken. Daarnaast zorgde jij 
ervoor dat ik in contact kwam met de juiste mensen die ik nodig had om me verder te helpen 
bij mijn onderzoek. De pragmatisch aanpak die jij hanteert weet ik erg te waarderen. Heel 
hartelijk dank hiervoor. 
Dr. J.W. de Leeuw, beste Jan Willem, na drie maanden te hebben gewerkt in het Ikazia ziekenhuis 
“stuurde” jij me naar Croydon met de opdracht om één artikel te publiceren. Het werd iets 
meer dan dat! Het werd twee en een half jaar en ik heb er uiteindelijk negen gepubliceerde 
artikelen en een proefschrift aan overgehouden. Jij hebt me vanaf het begin gestimuleerd om 
te promoveren en ik heb er geen spijt van gehad. Jij introduceerde me bij Curt en bij mijn 
terugkomst in Nederland had jij een ANIOS plek voor mij in het Ikazia waarbij ik deels aan 
mijn onderzoek kon werken.  Bedankt dat je me al die tijd hebt geholpen en hebt gemotiveerd 
om “de steen rollende te houden”.
Dr. A.T.G. Paulus, beste Aggie, al ontmoette ik je pas later in mijn promotietraject, ik kan eerlijk 
zeggen dat ik zonder jouw hulp mijn proefschrift niet had kunnen afronden. Ik kwam bij jou 
voor hulp met het analyseren van mijn kwalitatieve data, een cruciaal onderdeel van mijn 
onderzoek. Jij dacht mee over de beste manier van analyseren van de data. Stapje voor stapje 
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begeleidde je mij bij de analyse en jouw positieve instelling en aanmoediging hierbij waren 
enorm waardevol voor mij. Dit heeft ervoor gezorgd dat er weer vooruitgang kwam in mijn 
promotietraject en dat ik uiteindelijk tot dit resultaat ben gekomen. Heel veel dank hiervoor.
Furthermore, I would like to thank all the beautiful people I’ve met during my time in Croydon 
(Mayday) University Hospital and whom I was able to share my ups and downs with. Thank 
each one of you for your personal advise, your encouragement, the input for my research projects, 
and your help with collecting and analysing data. But most of all I want to thank you for the 
fun times we have had together, in the research office, during perineal clinic, during one of 
many dinners and at the IUGA and ICS meetings. Ginny, Kirstan, Jacqui, the ladies from the 
Lancaster suite Dahlia, Wendy, and Anne, Reeba, Zeelha, Yemi, Farah, Ksenia, Annette and 
Kim, thank you for being my friends. 
De maatschap gynaecologie van het Ikazia ziekenhuis. Mijn eerste baan was bij jullie en ik 
ben me daarom altijd verbonden blijven voelen met het Ikazia. Bedankt voor de steun en het 
vertrouwen toen ik na twee en een half jaar terugkwam in Nederland en weer als ANIOS aan 
de slag ging bij jullie. Ik ben jullie ook zeer erkentelijk voor de tijd die ik kreeg om te werken 
aan mijn promotieonderzoek.
De vakgroep Health Services Research van de Universiteit van Maastricht, in het bijzonder 
prof.dr Dirk Ruwaard (vakgroepvoorzitter) en prof.dr Silvia Evers. Bedankt dat ik welkom 
was binnen de vakgroep en ik gebruik mocht maken van jullie faciliteiten. Door de dagelijkse 
structuur en de wetenschappelijke omgeving kon ik vaart maken in de data analyse. 
Prof.dr. G.J. Bonsel, prof.dr C.H. Bangma en prof.dr W.C.M. Weijmar Schultz hartelijk dank 
voor uw bereidheid om deel uit te maken van de leescommissie en uw tijd voor het beoordelen 
van mijn manuscript. Prof. Bonsel in het bijzonder wil ik u bedanken voor uw suggesties rondom 
de methode van kwalitatief onderzoek en het schrijven van een kwalitatief onderzoeksartikel. 
Al mijn lieve vrienden en familie wil ik bedanken voor de leuke tijd die we samen hebben en 
voor de steun en interesse tijdens mijn promotietraject. Een aantal vrienden en familie wil ik 
graag apart bedanken.
De tiger girls, Jojanneke, Jacqueline and Marianne. Ik had in Croydon geen collega’s die ook 
met een promotie bezig waren en daarom was het heel fijn om mijn ervaringen met jullie te 
kunnen delen. De weekendjes met jullie waren altijd een heerlijke afleiding van de wetenschap. 
Ik ben heel blij dat wij met z’n vieren zo goed kunnen shoppen, lachen, kletsen en natuurlijk 
dansen! Nu ik ook klaar ben met mijn promotieonderzoek, kunnen we eindelijk dat weekendje 
weg gaan plannen!
Lieve papa en mama, bedankt dat jullie er altijd voor mij zijn en altijd in mij geloven. Het is 
zo belangrijk om te weten dat je ouders altijd achter je staan en trots op je zijn. Zo’n ouder wil 
ik ook voor Robin zijn. Ik wil jullie bedanken voor alle kleine dingetjes, zoals boodschappen 
doen in Croydon als ik al weer aan het werk was, en voor de grote dingen zoals jullie hulp bij 
het organiseren van mijn promotiefeest. Ik houd heel veel van jullie. 
En ten slotte mijn man Pim. Ja, ook jou wil ik bedanken. Heel lang leek er geen einde aan het 
promotietraject te komen en ik weet dat dat niet altijd even makkelijk was voor jou. Maar nu 
is het eindelijk klaar! Bedankt voor je steun en liefde. Ik houd van je.
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